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Human biomonitoring is a well-established field of research with high rate of scientific production. 
Still, there is a lack of integrated information required for the production of adequate knowledge in 
this area. In this context, the development of suitable methods for systematic mapping of available 
evidence and identification of research gaps is needed. 
The main aim of Task 7.1 was to identify existing data and data gaps on the area of human 
biomonitoring (HBM), including biobank samples. To answer to this aim, a triangulation of methods 
was used, including an online questionnaire and literature reviews covering available published 
scientific papers (traditional academic research) and books of proceedings of HBM-related 
conferences containing published and non-published data. 
For the questionnaire data, descriptive analyses and stratification by European-defined region, 
target population and groups of substances were performed. For the literature reviews, a 
systematisation of the search, review and interpretation process of the data was recorded, with the 
data from each selected paper being extracted into a synoptic table. 
The use of three different approaches provided comprehensive though complementary information 
on the existing HBM surveys: 
 Considering the data obtained from the questionnaire, an asymmetry was found in terms of 
countries/regions where the identified studies on HBM have been developed, with Belgium, Italy 
and Spain being the countries where the data collection occurred more frequently. This might 
reflect an under-representation in the studies carried by specific countries, a trend that was 
verified throughout the three approaches used. 
 Although maintaining the abovementioned asymmetry, the results change when considering the 
studies identified using the other two approaches: for the studies from the literature review, data 
was mainly collected in Denmark and Norway, while for the review of the books of proceedings 
data was predominantly collected in Germany, France and United Kingdom. 
 Most of the reported studies identified with the questionnaire and the review of the books of 
proceedings had a regional or national scope while studies from the literature review had mainly 
a regional implementation level. 
 Although the majority of the studies identified with the three approaches were already concluded 
or initiated/ongoing, it was possible to map projects in their planning stage (which was also 
verified in the stratified analysis by European-defined region).  
 The majority of the work that has been developed in the HBM area relates to cross-sectional 
and longitudinal studies as seen in the results from the questionnaire. The other two 
approaches also pointed into the direction of the majority of studies being concluded. 
 Children and adults are the main target population of the studies/projects/activities identified 
with the questionnaire. 
 The analyses of the nine groups of substances under study revealed differences in terms of the 
number of projects dedicated to each substance, being most marked the absence of studies 
focused on the anilin family reported through the questionnaire as well as very few studies on 
Cr VI and emerging chemicals. The undertaken literature reviews did not provide an additional 
understanding of this difference. 
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 An analysis of data collected with the questionnaire by European-defined region reveals that in 
the North and East, the most studied substances were phthalates/DINCH, whereas in the West 
and South was cadmium. 
 Considering the groups of substances distributed by European-defined region, age groups and 
status of the studies/projects/activities undertaken in the community (general population), the 
following was found: the reported studies were mostly concluded, the majority of them had 
adults and children as target population, cadmium as the main substance under study, and they 
were mostly conducted in Southern and Western regions of Europe. 
 For the studies/projects/activities reported as having a national representativeness level, the 
majority involved children and newborns. In studies with children, the most analysed substances 
were cadmium, flame retardants, bisphenols and phthalates. For those studies with newborns, 
the main substances under study were flame retardants. In both cases, these studies were 
mostly conducted in Western Europe. 
 Considering the results of the survey, it was possible to verify that there is a variety of biological 
samples collected, with many projects having several of those samples stored and some of 
them available for access and/or use by other researchers/organisations. 
 Analyses of the studies/projects/activities (general population) with urine samples and blood by 
group of substances and regions and age groups, the largest number of studies report to data 
collected from Western and Northern regions. Concerning the target population and substances 
under study, the focus is put on children and phthalates, respectively. 
 Information about several biomarkers, HBM samples and clinical parameters, anthropometric 
data, physiological indicators, outdoor pollution and occupational exposure has been collected 
with the questionnaire.  
 As for biobanked samples, the majority of the projects allow (partial) access to the database of 
non-biological data and have available for theHBM4EU partners the questionnaire used for data 
collection. 
 The concept of “quality criteria” to classify the studies/projects/activities identified with the 
questionnaire was altered to “criteria that index a level of evidence” given the fact that there is a 
pre-assumption that all projects have internal validity and, therefore, quality. For building up 
overall pictures about collected data and information it is more important to know how 
potentially strong is the collected (or to be collected) evidence. An overarching appreciation of 
the potentially produced (or to be produced) evidence by each study/project/activity found 
through the survey revealed that almost half of them have characteristics that can be of high or 
very high level. 
 A list of metadata available to be uploaded into IPCheM is suggested, being nearly 20% of the 
data accessible for use. For European representative studies, a deeper data analysis of the 
data gaps will be done by VITO in WP 10 and Task 7.2. 
 The categorisation of the single compounds into the categories A-C is not addressed in this 
report and will be done by the CGLs under task 4.4 scoping documents. 
In conclusion, with the developed work for this task an important basis to inform further research 
needs in this realm and to contribute to more targeted policy measures was laid, thus contributing 
to the overarching HBM4EU goal of generating knowledge to inform the safe management of 
chemicals and so protect human health. 
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Human biomonitoring (HBM) has gained considerable importance over the last few years, being a 
well-established field of research with high rate of scientific production. A quick search in the 
PubMed and ISI Web of Science electronic databases using the terms “Human biomonitoring” 
(MeSH) and “Biomonitoring” reflects precisely this rapid increase in the number of published 
papers, as depicted in the figure below. 
 
Figure 1: Number of published papers in human biomo nitoring (PubMed and Web of Science) 
Still, due to a spawn of the complexity of contemporary HBM questions with large number of 
possible competing ideas for research and to different survey designs and analytical 
methodologies, there is a striking lack of integrated information required for the production of 
adequate knowledge in this area1,2. 
Over the last few years, the importance of undertaking research in the areas of environment and 
health has been reinforced given their pivotal role for nowadays society as mentioned in a recent 
World Health Organization (WHO) report2. In fact, several literature reviews have been produced, 
summarising the existing knowledge. Notwithstanding, the documents are very specific in what 
concerns to the substances or contexts under study3-6. 
The current state of affairs poses some difficulties with regard to HBM data comparability1,7. This 
emphasises the need to develop suitable methods for systematic mapping of available evidence 
                                               
1 Bauer S. Societal and ethical issues in human biomonitoring – a view from science studies. Environ Heal. 2008;7(Suppl 1):S10. 
2 WHO Regional Office for Europe. Setting research priorities in environment and health. Copenhagen, Denmark; 2017. 
3 Goodman JE, McConnell EE, Sipes IG, Witorsch RJ, Slayton TM, Yu CJ, et al. An updated weight of the evidence evaluation of 
reproductive and developmental effects of low doses of bisphenol A. Crit Rev Toxicol. England; 2006 May;36(5):387–457. 
4 Kim YR, Harden FA, Toms L-ML, Norman RE. Health consequences of exposure to brominated flame retardants: a systematic review. 
Chemosphere. England; 2014 Jul;106:1–19 
5 Chen C, Xun P, Nishijo M, He K. Cadmium exposure and risk of lung cancer: a meta-analysis of cohort and case-control studies among 
general and occupational populations. J Expo Sci Environ Epidemiol. United States; 2016 Sep;26(5):437–44. 
6 Foster WG, Evans JA, Little J, Arbour L, Moore A, Sauve R, et al. Human exposure to environmental contaminants and congenital 
anomalies: a critical review. Crit Rev Toxicol. England; 2017 Jan;47(1):59–84. 
7 Angerer J, Ewers U, Wilhelm M. Human biomonitoring: State of the art. Int J Hyg Environ Health. 2007;210(3–4):201–28. 
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and identification of research gaps which will ultimately contribute to the development of a coherent 
and harmonised research approach throughout Europe. 
A vast majority of available synthesising strategies are based on narrative and systematic reviews. 
However, these research designs cover mainly literature available via publication, with under-
representation of documents created by other agents of knowledge production. Moreover, the well 
recognised ‘non-significant result’ bias8 impairs the quality of systematic reviews or meta-analyses. 
In this context, the use of a triangulation of methods is necessary in this realm, to continuously 
map and expand an inventory of HBM studies that will help to inform further research. 
  
                                               
8 Weber et al. Unpublished research from a medical specialty meeting: why investigators fail to publish. JAMA. 1998; 280(3):257-259. 
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2 Scope of task 7.1 activities 
The main aim of task 7.1 was to identify existing data and data gaps on the area of  HBM, 
including biobank samples . Overall, the task entailed several activities: 
 
Development of an online questionnaire for the NHCPs (coordinated by the NHC) to do 
an inventory of concluded (within last 10 years), ongoing or planned (for starting up 
within the next five years) relevant studies, projects and activities and stored samples in 
the HBM area. 
 
Detailed and thorough assessment of the available biomonitoring and exposure data 
literature performed on each substance with the collaboration of different partners and in 
close collaboration with CGLs. 
 
Identification of non-published studies through the review of books of proceedings of 
HBM-related conferences, complementarily to the use of other primary sources. 
 
Definition of quality criteria for data comparability. 
 
Categorisation of the single compounds into the 3 “knowledge”-categories (A-C)9. 
 
Identification of spatial and temporal data gaps to answer the policy questions for the 
prioritised substances. 
 
Compilation of a list of metadata that can be uploaded to IPCheM to Task 10.5. 
 
  
                                               
9 The categorization of the single compounds into the categories A-C will be done by the CGLs under task 4.4 scoping documents 
(Category A: Known substances, sufficient existing data; Category B: Known substances, moderate missing data gap; Category C: 
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Given the main aim of Task 7.1 of identifying existing data and data gaps on the area of 
biomonitoring a triangulation of methods was used (Figure 2). This implied the combination of 
approaches with the development of an online questionnaire and literature reviews covering 
available published scientific papers (traditional academic research) and books of proceedings of 
HBM-related conferences containing published and non-published data. This last approach – not 
included in the Annual Work Plan (AWP) for year 1 – was used to get a more complete picture of 
existing data, thus complementing the information collected with the questionnaire and the 
literature review. 
 
Figure 2:  Approaches used to identify existing dat a and data gaps regarding studies developed in 
the area of biomonitoring 
3.1 Questionnaire on existing surveys 
An online questionnaire on existing surveys was developed by FMUL considering the need to 
identify data gaps in the field of human biomonitoring in terms of concluded (within the last ten 
years), ongoing or planned (for starting up within the next five years) relevant studies, projects and 
activities as well as stored samples (within the consortium). 
The questionnaire was sent for review to the task partners who were consulted over two rounds. 
Each partner went through the entire questionnaire though giving specific support according to 
their specific expertise: HSE, NIJZ and ISS on environmental epidemiological and HBM 
surveillance studies; FIOH, DEP, DPH and UKF on occupational studies, and THL and UoA on 
health surveys. 
Additional comments and requests to introduce new questions to the main questionnaire were also 
received mainly from WP 7 and WP 10. It was decided in the HBM4EU kick-off meeting, in 
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February 2017, not to overburden the NHCP with different questionnaires and to integrate some 
additional questions in the questionnaire that was being developed for task 7.1. 
FMUL made the final review of the questionnaire that entailed the 10 sections covering the 
following themes (Appendix 1): 
 General information 
 Description of target population and method of selection of participants 
 Fieldwork and data collection 
 Other data 
 Quality control procedures 
 Data analysis 
 Data protection, availability and conditions of access and use 
 Communication 
 Obstacles, shortcomings and difficulties 
 Additional information 
A specific questionnaire on occupational exposure was also developed by DPH, UKF and FIOH, in 
collaboration with FMUL (Appendix 2). The questionnaire comprised seven main sections: 
 Proponent Institution/Organisation of the study 
 Characteristics of data 
 Study population 
 Characteristics of the study population 
 Occupational exposures 
 HBM data 
 Other institutions that have similar national data 
Both questionnaires were imbedded by FMUL in an online platform were respondents could 
access it (http://hbm4eu.info/). The web platform also included a brief overview about the HBM4EU 
Initiative as well as the contacts that could be used in case of doubts or in case of need of 
technical assistance. 
The survey to the NHCP was launched by the NHC on March 27, 2017 with a request for the form 
completion until April 10, 2017 (confidential responses). The email was accompanied by a pdf 
version of the questionnaire (Appendix 1) and a brief tutorial. 
Given the small amount of completed answers received, the extent of the questionnaire which 
could have been hindering the potential participants to finish its completion and the previewed 
timeline in the AWP (it was expected to receive the answers during the month of April), an 
extended deadline was then decided (April 28, 2017). Six reminders within this period were sent by 
the NHC. 
The small number of answers received was even more pronounced for the occupational exposure 
questionnaire. As such, and attending to the specificity of the posed questions, some of the sent 
reminders targeted particular expert institutions that were developing their work on occupational 
exposure. 
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The last reminder was sent individually to each of the NHCP of the countries who did not answer to 
the questionnaire until then. 
FMUL also elaborated a plan for the statistical analysis of the data collected with the questionnaire 
(Appendix 3). The document presents the strategy for reporting univariate statistics for each 
variable and entails a dictionary of variables, with a detailed description of how the data are 
presented in the database. The statistical analysis plan is structured in five columns: 
 Variable name: The name of the variable in the database 
 Label: The description of the variable (corresponding to the label of each variable on the 
databases) 
 Question: The original question that appeared in the questionnaire 
 Values and codes: The options each variable can assume in the databases 
 Analysis: The planned statistical analysis to follow for each variable 
Given the integration of several additional items to the questionnaire at the request of several task 
partners / WP leaders, the plan was sent to each of them for review to assure that the most 
relevant analysis would be done. 
All statistical analysis performed were operated on SPSS for Windows (version 23.0). Descriptive 
analyses were done for some of the variables in the questionnaire. Moreover, additional data 
analyses stratified by European-defined region10, target population and groups of substances were 
performed. The variables included in the stratified analyses were chosen considering the opinions 
of task 7.1 partners on the most relevant ones of the overall questionnaire. 
                                               
10 The expression “European-defined regions” used in this deliverable expresses an adaptation of the categorization of European 
countries according to the United Nations geoscheme for Europe: https://en.wikipedia.org/wiki/United_Nations_geoscheme_for_Europe 
(accessed: 22.11.2017) North: Denmark, Estonia. Finland, Iceland, Ireland, Latvia, Lithuania, Norway, Sweden, UK 
West: Austria, Belgium, France, Germany, Luxembourg, The Netherlands, Switzerland 
South: Croatia, Cyprus, Greece, Italy, Malta, Portugal, Slovenia, Spain 
East: Bulgaria, Czech Republic, Hungary, Poland, Romania, Slovakia 
Other: Israel 
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3.2 Literature review 
A review of the literature was also undertaken for Task 7.1. The proposed literature review aimed 
to identify the existing studies on biomonitoring and chemicals exposure (including occupational 
exposure) regarding the nine prioritised substances (thus complementing the data collected with 
the questionnaire): phthalates/DINCH, bisphenols, per-/polyfluorinated compounds, flame 
retardants, Cd and Cr, PAHs and air pollutants, anilin family: MOCA, chemicals mixtures and 
emerging chemicals. The review was performed by nominated responsible partners per substance, 
in close collaboration with CGLs. 
Each partner was assigned to the following substances: 
 
Partner /CGL Prioritised substance/s  
UKF Phthalates / DINCH 
THL PFAS and Flame retardants 
FMUL Cd 
ISS Cr VI 
FIOH Anilines (anilines and MOCA, or 




FMUL proposed the following process for the literature review for Cadmium (Appendix 4): 
1. Definition of two sets of key-words to be used as alternatives which were later reviewed by 
some of the partners. For example, the combination of keywords used for Cadmium were: 
Cadmium AND "Human biomonitoring" Cadmium AND "Professional exposure" 
Cadmium AND Environmental monitoring Cadmium AND "Occupational data" 
Cadmium AND Biological monitoring Cadmium AND workers 
Cadmium AND "Environmental surveillance" Cadmium AND exposure AND industry 
Cadmium AND Environmental exposure Cadmium AND Occupational health 
Cadmium AND Health surveys Cadmium AND occupational groups 
Cadmium AND Risk assessment Cadmium AND "workplace exposure" 
Cadmium AND "Health risks" Cadmium AND "non-occupational exposure" 
Cadmium AND "Health effects" Cadmium AND "population exposure" 
Cadmium AND "Effect biomarkers" Cadmium AND "urine analysis" 
Cadmium AND "Exposure biomarkers" Cadmium AND "exposure assessment" 
Cadmium AND Occupational exposure Cadmium AND "HBM values" 
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2. Eligibility criteria | i) electronic databases for the consultation: Medline (PubMed), Web of 
Science and EBSCO; ii) language of the documents: English; iii) publication date: From 
01/01/2007 to 31/12/2016 
3. Inclusion criteria | i) papers referring to studies of the HBM4EU partners; ii) documents with 
empirical HBM data (do not include opinion or conceptual papers that do not mention an 
HBM study); iii) papers produced within the countries of the consortium. 
The proposal for the literature review was then sent to the partners, asking them to comment the 
key-words and the proposed search process. After receiving the comments, each partner was 
invited to do the review for the prioritised substance to which they were assigned to. 
Again, a template document was sent to the partners as a referee to facilitate data extraction for 
the literature review (Appendix 5). 
3.3 Review of books of proceedings of HBM-related c onferences 
A complementary review was undertaken covering books of proceedings of HBM-related 
conferences. With this additional approach, we intended to identify non-published data and 
therefore complement the additional information collected with the questionnaire and the literature 
review. 
The search was undertaken in the grey literature (i.e., Google). Search keywords formed two 
blocks and were combined pairwise. Block 1: conference, congress, seminar, book of proceedings. 
Block 2: human biomonitoring, environmental monitoring, biological monitoring, environmental 
surveillance, environmental exposure, health surveys, risk assessment, health risks. An additional 
manual search for other editions/years of each identified conference was undertaken in order to 
access the books of proceedings. 
The books of proceedings considered eligible for analysis (in case of being related to the goal of 
the review and meeting the same criteria defined for the literature review (date from 01/01/2007 to 
31/12/2016, including studies of the HBM4EU partners and within the countries of the consortium) 
were read and each abstract verified. The studies were selected for data extraction if they were 
done / being done in the countries of the institutions of the HBM4EU consortium. 
Data were then extracted into a synoptic table that recorded the title of the conference, the date, 
the country, the presentation title, the author/s, the institution and the presented 
study/program/initiative. 
This task was an additional activity not included in the description of task 7.1 in the AWP for year 1. 
Therefore, it was a responsibility of FMUL. 
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4 Main results 
4.1 Questionnaire on existing surveys 
The questionnaire on existing HBM surveys aimed to identify concluded (within last 10 years), 
ongoing or planned (for starting up within the next five years) studies, projects and activities related 
to the nine prioritised substances to identify data gaps (including spatial and temporal gaps). 
Data was collected between March 28 and June 8, 2017. A total of 124 questionnaires were filled 
in after NHCPs consultation. The distribution of countries answering to the questionnaire 
(considering the reported institution responsible for the study/project/activity implementation) is 
presented in the following table. 
Table 1: Countries of the institution responsible f or the study/project/activity implementation 
 Frequency (n) Percent (%) 
Austria 8 4,2 
Belgium 23 12,0 
Croatia 5 2,6 
Cyprus 4 2,1 
Czech Republic 8 4,2 
Czech Republic and Slovakia 1 ,5 
Denmark 12 6,3 
Finland 1 0,5 
France 7 3,7 
Germany 8 4,2 
Greece 6 3,1 
Hungary 3 1,6 
Iceland 2 1,0 
Ireland 3 1,6 
Israel 7 3,6 
Italy 17 8,9 
Latvia 1 0,5 
Lithuania 3 1,6 
Luxembourg 3 1,6 
Netherlands 2 1,0 
Norway 3 1,5 
Poland 4 2,1 
Portugal 9 4,7 
Romania 4 2,1 
Slovakia 10 5,2 
Slovenia 10 5,2 
Spain 14 7,3 
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 Frequency (n) Percent (%) 
Sweden 7 3,6 
Switzerland 2 1,0 
United Kingdom 5 2,6 
No answer 1 0,8 
Total 124 100,0 
Hereinafter, overall results (descriptive analysis) are presented considering some of the variables 
in the questionnaire. Moreover, data analyses stratified by European-defined region11, target 
population and groups of substances will be presented. The variables included in the stratified 
analyses were chosen considering the opinions of task 7.1 partners on the most relevant ones of 
the overall questionnaire. Other results of the questionnaire, not presented here, can be consulted 
on the HBM4EU wiki which includes a detailed report with all the performed analysis. 
Additional data analysis can be done by all HBM4EU partners as the data is provided in Excel, 
SPSS and part of it in an ACCESS version of the database which are accessible via the wiki. 
Appendix 3 includes the name of the variable that appears in the database, its description and the 
associated values, information that will support additional data analyses to be done. 
The following results from the questionnaire on existing surveys are presented into two sections, 
one focusing on existing studies/projects/activities, and the other on the existing samples. 
 EXISTING STUDIES/PROJECTS/ACTIVITIES 
Data have been mainly collected in Belgium (15,3%), Italy (12,1%) and Spain (8,1%) (Table 2). 
Table 2:  Country/countries where data were/are/will be colle cted 
 Frequency (n) Percent (%) 
Austria 8 6,5 
Belgium 19 15,3 
Croatia 2 1,6 
Cyprus 2 1,6 
Czech Republic 4 3,2 
Denmark 9 7,3 
Finland 1 0,8 
France 6 4,8 
Germany 4 3,2 
Greece 5 4,0 
Iceland 2 1,6 
Israel 7 5,6 
Italy 15 12,1 
                                               
11 North: Denmark, Estonia. Finland, Iceland, Ireland, Latvia, Lithuania, Norway, Sweden, UK 
West: Austria, Belgium, France, Germany, Luxembourg, The Netherlands, Switzerland 
South: Croatia, Cyprus, Greece, Italy, Malta, Portugal, Slovenia, Spain 
East: Bulgaria, Czech Republic, Hungary, Poland, Romania, Slovakia 
Other: Israel 
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 Frequency (n) Percent (%) 
Latvia 1 0,8 
Lithuania 3 2,4 
Netherlands 1 ,8 
Norway 3 2,4 
Portugal 5 4,0 
Slovakia 6 4,8 
Slovenia 4 3,2 
Spain 10 8,1 
Sweden 4 3,2 
Switzerland 1 0,8 
United Kingdom 1 0,8 
Total 192 100,0 
Note: Data presented in this table refer to a multiple-choice question. The sum of reported studies does not correspond to the total of 
answers given to the questionnaire (n=124). 
 
Following the distribution of countries in the previous table, it can also be seen in Figure 3 that 
Belgium, Italy and Spain were the most frequent countries of data collection reported. 
 
Figure 3: Country/countries where data were/are/wil l be collected 
The studies captured with our survey had mainly a national or regional implementation level, 
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Table 3: Study/project/activity implementation leve l 
 Frequency (n) Percent (%) 
International 15 10,5 
National 57 39,9 
Regional 65 45,5 
Other 6 4,2 
Total 143 100,0 
Note: Data presented in this table refer to a multiple-choice question. The sum of reported studies does not correspond to the total of 
answers given to the questionnaire (n=124). 
More than 50% of the studies identified were concluded but it was possible to obtain information on 
51 initiated/ongoing and nine planned studies, as can be seen in Table 4.  
Table 4: Status of the studies/projects/activities 
 Frequency (n) Percent (%) 
Concluded 64 51,6 
Initiated/ongoing 51 41,1 
Planned 9 7,3 
Total 124 100,0 
Narrowing the perspective and considering the status of the studies by European-defined region 
(Table 5), it can be concluded that the distribution is similar to the one reported above, with most of 
the studies being concluded or initiated/ongoing in all regions. 
Table 5: Status of the studies/projects/activities by European-defined region 












Concluded 12 (42,9) 28 (63,6) 25 (56,8) 8 (50,0) 2 (28,6) 
Initiated/Ongoing 15 (53,6) 14 (31,8) 14 (31,8) 8 (50,0) 4 (57,1) 
Planned 1 (3,6) 2 (4,5) 5 (11,4) 0 (0,0) 1 (14,3) 
* North: Denmark, Estonia. Finland, Iceland, Ireland, Latvia, Lithuania, Norway, Sweden, UK 
West: Austria, Belgium, France, Germany, Luxembourg, The Netherlands, Switzerland 
South: Croatia, Cyprus, Greece, Italy, Malta, Portugal, Slovenia, Spain 
East: Bulgaria, Czech Republic, Hungary, Poland, Romania, Slovakia 
Other: Israel 
Note: Data presented in this table refer to a multiple-choice question. The sum of reported studies does not correspond to the total of 
answers given to the questionnaire (n=124). 
Considering only the studies which reported to have a representative sample for the population or 
the geographical area under study (n=79), the pattern is maintained, although with a slight 
variation considering the division by type of concluded studies (Table 6).  
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Table 6: Status of studies/projects/activities with  representative samples by European-defined region 
 European-defined region ** 
Representative sample (for the 
population or geographical area 











Planned 0 (0,0) 2 (8,0) 4 (12,1) 0 (0,0) 1 (50,0) 
Initiated/Ongoing 11 (73,3) 8 (32,0) 12 (36,4) 5 (55,6) 1 (50,0) 
Concluded      
≤ 10 years ago 3 (20,0) 7 (28,0) 14 (42,4) 3 (33,3) 0 (0,0) 
> 10 years ago 0 (0,0) 2 (8,0) 0 (0,0) 0 (0,0) 0 (0,0) 
Not indicating how long ago 1 (6,7) 6 (24,0) 3 (9,1) 1 (11,1) 0 (0,0) 
* There are multinational projects so the n is not equal to the sum of the frequencies in the table 
* North: Denmark, Estonia. Finland, Iceland, Ireland, Latvia, Lithuania, Norway, Sweden, UK 
West: Austria, Belgium, France, Germany, Luxembourg, The Netherlands, Switzerland 
South: Croatia, Cyprus, Greece, Italy, Malta, Portugal, Slovenia, Spain 
East: Bulgaria, Czech Republic, Hungary, Poland, Romania, Slovakia 
Other: Israel 
Note: Data presented in this table refer to a multiple-choice question. The sum of reported studies does not correspond to the total of 
answers given to the questionnaire (n=124). 
Looking at the studies which reported a national level of implementation (n=57), the results are 
similar to the ones verified before (Table 7). In fact, for all European regions the studies are mainly 
either initiated/ongoing or concluded. 
Table 7: Status of studies/projects/activities with  nationally representative samples by European-
defined region 
 European-defined region * 












Planned 1 (7,1) 1 (4,8) 2 (11,1) 0 (0,0) 0 (0,0) 
Initiated/Ongoing 8 (57,1) 9 (42,9) 5 (27,8) 6 (54,5) 1 (50,0) 
Concluded      
≤ 10 years ago 3 (21,4) 5 (23,8) 11 (61,1) 5 (45,5) 1 (50,0) 
> 10 years ago 1 (7,1) 0 (0,0) 0 (0,0) 0 (0,0) 0 (0,0) 
Not indicating how long ago 1 (7,1) 6 (28,6) 0 (0,0) 0 (0,0) 0 (0,0) 
* North: Denmark, Estonia. Finland, Iceland, Ireland, Latvia, Lithuania, Norway, Sweden, UK 
West: Austria, Belgium, France, Germany, Luxembourg, The Netherlands, Switzerland 
South: Croatia, Cyprus, Greece, Italy, Malta, Portugal, Slovenia, Spain 
East: Bulgaria, Czech Republic, Hungary, Poland, Romania, Slovakia 
Other: Israel 
Note: Data presented in this table refer to a multiple-choice question. The sum of reported studies does not correspond to the total of 
answers given to the questionnaire (n=124). 
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Attending to the design of the studies, cross-sectional surveys or longitudinal studies were found 
across the European regions (Table 8). 
Table 8: Study design by European-defined region 












Cross-sectional survey 10 (35,7) 24 (54,5) 23 (52,3) 7 (43,8) 3 (42,9) 
Case-control 3 (10,7) 1 (2,3) 9 (20,5) 1 (6,3) 1 (14,3) 
Longitudinal (cohort) 12 (42,9) 16 (36,4) 12 (27,3) 7 (43,8) 3 (42,9) 
Cross-sectional and longitudinal 3 (10,7) 1 (2,3) 0 (0,0) 0 (0,0) 0 (0,0) 
Pilot survey 0 (0,0) 1 (2,3) 0 (0,0) 0 (0,0) 0 (0,0) 
Surveillance 0 (0,0) 1 (2,3) 0 (0,0) 1 (6,3) 0 (0,0) 
* North: Denmark, Estonia. Finland, Iceland, Ireland, Latvia, Lithuania, Norway, Sweden, UK 
West: Austria, Belgium, France, Germany, Luxembourg, The Netherlands, Switzerland 
South: Croatia, Cyprus, Greece, Italy, Malta, Portugal, Slovenia, Spain 
East: Bulgaria, Czech Republic, Hungary, Poland, Romania, Slovakia 
Other: Israel 
Note: Data presented in this table refer to a multiple-choice question. The sum of reported studies does not correspond to the total of 
answers given to the questionnaire (n=124). 
The majority of the studies included a non-clinical population (Table 9). 
Table 9: Type of target population by European-defi ned region 












General population (non-clinical 
population) 
25 (89,3) 44 (100,0) 43 (97,7) 16 (100,0) 5 (71,4) 
Clinical population 3 (10,7) 0 (0,0) 1 (2,3) 0 (0,0) 2 (28,6) 
* North: Denmark, Estonia. Finland, Iceland, Ireland, Latvia, Lithuania, Norway, Sweden, UK 
West: Austria, Belgium, France, Germany, Luxembourg, The Netherlands, Switzerland 
South: Croatia, Cyprus, Greece, Italy, Malta, Portugal, Slovenia, Spain 
East: Bulgaria, Czech Republic, Hungary, Poland, Romania, Slovakia 
Other: Israel 
Note: Data presented in this table refer to a multiple-choice question. The sum of reported studies does not correspond to the total of 
answers given to the questionnaire (n=124). 
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For each of the target groups and corresponding sample sizes, the mean, median and standard 
deviation are presented in Table 10. 
Table 10: Target groups and sample size(s): Mean, m edian and standard deviation 
 Mean Median Standard deviation 
Children 1272 280 2935 
Adolescents 559 150 1099 
Mother-newborn pairs: Mother in the group 1590 296 3510 
Mother-newborn pairs: Pairs in the group 1475 270 3392 
Adults 2937 200 14096 
Elderly 485 11 1340 
An analysis by European-defined region shows that the identified studies included predominantly 
children and adults (Table 11), while the elderly are the most under-represented population sub-
group. 
Table 11: Target population by European-defined reg ion 












Newborns 9 (32,1) 13 (29,5) 9 (20,5) 11 (68,8) 2 (28,6) 
Children 16 (57,1) 26 (59,1) 24 (54,5) 14 (87,5) 4 (57,1) 
Adolescents 7 (25,0) 13 (29,5) 6 (13,6) 4 (25,0) 0 (0,0) 
Adults 19 (67,9) 18 (40,9) 24 (54,5) 9 (56,3) 5 (71,4) 
Elderly 5 (17,9) 5 (11,4) 6 (13,6) 4 (25,0) 0 (0,0) 
* North: Denmark, Estonia. Finland, Iceland, Ireland, Latvia, Lithuania, Norway, Sweden, UK 
West: Austria, Belgium, France, Germany, Luxembourg, The Netherlands, Switzerland 
South: Croatia, Cyprus, Greece, Italy, Malta, Portugal, Slovenia, Spain 
East: Bulgaria, Czech Republic, Hungary, Poland, Romania, Slovakia 
Other: Israel 
Note: Data presented in this table refer to a multiple-choice question. The sum of reported studies does not correspond to the total of 
answers given to the questionnaire (n=124). 
Almost all studies/projects/activities (97,6%) were/will be approved by an ethics commission/entity 
(Table 12). 
Table 12: Ethical approval 
 Frequency (n) Percent (%) 
No 3 2,4 
Yes 121 97,6 
Total 124 100,0 
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In case of face-to-face administered questionnaire or phone interview, nearly 70% of the 
studies/projects/activities collected / will collect data with qualified and trained personnel (Table 
13). 
Table 13: Information was/will be obtained by quali fied and trained personnel (in case of face-to-face  
administered questionnaire or phone interview) 
 Frequency (n) Percent (%) 
No 38 30,6 
Yes 86 69,4 
Total 124 100,0 
 
 EXISTING SAMPLES  
As depicted in Figure 4, cadmium was the most reported substance under study (of the nine 
prioritised substances), followed by phthalates, bisphenols and pre-/polyfluorinated compounds. To 
note that emerging chemicals and chromium VI were one of the least reported substances, and the 
anilin family was not included in any the studies. 
 
Figure 4: Groups of substances under study 
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In the North and East, the most studied substances were phthalates/DINCH, whereas in the West 
and South was cadmium Table 14. 
Table 14: Groups of substances by European-defined region 












Phthalates/DINCH 14 (56,0) 19 (43,2) 7 (16,3) 9 (56,3) 3 (60,0) 
Bisphenols 12 (48,0) 18 (40,9) 6 (14,0) 6 (37,5) 2 (40,0) 
Per-/Polyfluorinated compounds 9 (36,0) 17 (38,6) 5 (11,6) 6 (37,5) 0 (0,0) 
Flame Retardants 8 (32,0) 14 (31,8) 7 (16,3) 7 (43,8) 0 (0,0) 
Cadmium 10 (40,0) 23 (52,3) 24 (55,8) 7 (43,8) 1 (20,0) 
Chromium VI 0 (0,0) 2 (4,5) 2 (4,7) 0 (0,0) 1 (20,0) 
PAHs 8 (32,0) 14 (31,8) 5 (11,6) 5 (31,3) 2 (40,0) 
Anilin family: Anilines, MOCA 0 (0,0) 0 (0,0) 0 (0,0) 0 (0,0) 0 (0,0) 
Chemical mixtures 1 (4,0) 5 (11,4) 4 (9,3) 2 (12,5) 2 (40,0) 
Emerging chemicals 2 (8,0) 2 (4,5) 0 (0,0) 2 (12,5) 0 (0,0) 
* North: Denmark, Estonia. Finland, Iceland, Ireland, Latvia, Lithuania, Norway, Sweden, UK 
West: Austria, Belgium, France, Germany, Luxembourg, The Netherlands, Switzerland 
South: Croatia, Cyprus, Greece, Italy, Malta, Portugal, Slovenia, Spain 
East: Bulgaria, Czech Republic, Hungary, Poland, Romania, Slovakia 
Other: Israel 
Note 1: Data presented in this table refer to a multiple-choice question. The sum of reported studies does not correspond to the total of 
answers given to the questionnaire (n=124). 
Note 2: Sample base includes only studies with general population 
 
Table 15 and Table 16 present the groups of substances by European region, age group and 
status (concluded or initiated/ongoing and planned, respectively) of the studies/projects/activities 
undertaken in the general population. The reported studies are mostly initiated/ongoing, the 
majority of them had children and adults as target population groups, phthalates and cadmium as 
the main substances under study, and they were mostly conducted in the Western region of 
Europe.  
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Table 15: Groups of substances by European-defined region*, age groups and status of the study/project /activity  
    
Status of the study/project/activity     
 
 Concluded Initiated/Ongoing   
    
















































Phthalates/DINCH 1 2,6 0,2 2 2,0 0,4 - - - - - - - - - 4 4,5 0,8 5 5,6 0,9 1 2,9 0,2 5 6,9 0,9 1 25,0 0,2 19 3,6 
Bisphenols 1 2,6 0,2 3 3,0 0,6 1 1,9 0,2 2 4,9 0,4 - - - 4 4,5 0,8 4 4,5 0,8 2 5,7 0,4 3 4,2 0,6 - - - 20 3,8 
Per-/Polyfluorinated compounds 1 2,6 0,2 5 5,0 0,9 - - - 2 4,9 0,4 - - - 3 3,4 0,6 4 4,5 0,8 - - - 3 4,2 0,6 - - - 18 3,4 
Flame Retardants - - - 2 2,0 0,4 1 1,9 0,2 3 7,3 0,6 - - - 3 3,4 0,6 4 4,5 0,8 1 2,9 0,2 4 5,6 0,8 - - - 18 3,4 
Cadmium - - - 3 3,0 0,6 1 1,9 0,2 1 2,4 0,2 - - - 1 1,1 0,2 4 4,5 0,8 1 2,9 0,2 2 2,8 0,4 - - - 13 2,5 
Chromium VI - - - - - - - - - - - - - - - - - - 2 2,2 0,4 - - - - - - - - - 2 0,4 
PAHs - - - 1 1,0 0,2 - - - - - - - - - 2 2,3 0,4 2 2,2 0,4 1 2,9 0,2 4 5,6 0,8 - - - 10 1,9 
Anilin family: Anilines, MOCA - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 
Chemical mixtures - - - - - - 1 1,9 0,2 - - - - - - 1 1,1 0,2 1 1,1 0,2 1 2,9 0,2 2 2,8 0,4 - - - 6 1,1 






Phthalates/DINCH 5 12,8 0,9 7 7,0 1,3 3 5,7 0,6 3 7,3 0,6 - - - 6 6,8 1,1 6 6,7 1,1 2 5,7 0,4 5 6,9 0,9 1 25,0 0,2 38 7,2 
Bisphenols 3 7,7 0,6 7 7,0 1,3 2 3,8 0,4 3 7,3 0,6 - - - 6 6,8 1,1 5 5,6 0,9 3 8,6 0,6 3 4,2 0,6 - - - 32 6,1 
Per-/Polyfluorinated compounds 1 2,6 0,2 5 5,0 0,9 1 1,9 0,2 2 4,9 0,4 - - - 5 5,7 0,9 5 5,6 0,9 - - - 3 4,2 0,6 - - - 22 4,2 
Flame Retardants 1 2,6 0,2 3 3,0 0,6 1 1,9 0,2 3 7,3 0,6 - - - 5 5,7 0,9 4 4,5 0,8 2 5,7 0,4 4 5,6 0,8 - - - 23 4,4 
Cadmium 3 7,7 0,6 7 7,0 1,3 7 13,2 1,3 4 9,8 0,8 - - - 3 3,4 0,6 5 5,6 0,9 3 8,6 0,6 2 2,8 0,4 - - - 34 6,5 
Chromium VI - - - - - - - - - - - - - - - - - - 2 2,2 0,4 1 2,9 0,2 - - - - - - 3 0,6 
PAHs 1 2,6 0,2 3 3,0 0,6 1 1,9 0,2 1 2,4 0,2 - - - 3 3,4 0,6 4 4,5 0,8 1 2,9 0,2 4 5,6 0,8 - - - 18 3,4 
Anilin family: Anilines, MOCA - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 
Chemical mixtures - - - - - - 3 5,7 0,6 - - - - - - 1 1,1 0,2 2 2,2 0,4 1 2,9 0,2 2 2,8 0,4 1 25,0 0,2 10 1,9 








Phthalates/DINCH 1 2,6 0,2 2 2,0 0,4 - - - - - - - - - 2 2,3 0,4 2 2,2 0,4 1 2,9 0,2 1 1,4 0,2 - - - 9 1,7 
Bisphenols 1 2,6 0,2 3 3,0 0,6 1 1,9 0,2 1 2,4 0,2 - - - 2 2,3 0,4 2 2,2 0,4 2 5,7 0,4 1 1,4 0,2 - - - 13 2,5 
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Status of the study/project/activity     
 
 Concluded Initiated/Ongoing   
    










































Total  n % 
Per-/Polyfluorinated compounds 1 2,6 0,2 1 1,0 0,2 - - - - - - - - - 2 2,3 0,4 2 2,2 0,4 - - - 1 1,4 0,2 - - - 7 1,3 
Flame Retardants - - - 3 3,0 0,6 - - - 2 4,9 0,4 - - - 2 2,3 0,4 2 2,2 0,4 1 2,9 0,2 1 1,4 0,2 - - - 11 2,1 
Cadmium - - - 5 5,0 0,9 1 1,9 0,2 - - - - - - - - - 2 2,2 0,4 1 2,9 0,2 - - - - - - 9 1,7 
Chromium VI - - - - - - - - - - - - - - - - - - - - - 1 2,9 0,2 - - - - - - 1 0,2 
PAHs - - - 5 5,0 0,9 - - - - - - - - - 1 1,1 0,2 3 3,4 0,6 - - - 1 1,4 0,2 - - - 10 1,9 
Anilin family: Anilines, MOCA - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 
Chemical mixtures - - - - - - - - - - - - - - - 1 1,1 0,2 1 1,1 0,2 1 2,9 0,2 1 1,4 0,2 - - - 4 0,8 





Phthalates/DINCH 5 12,8 0,9 7 7,0 1,3 3 5,7 0,6 3 7,3 0,6 2 33,3 0,4 6 6,8 1,1 2 2,2 0,4 - - - 2 2,8 0,4 - - - 30 5,7 
Bisphenols 3 7,7 0,6 5 5,0 0,9 2 3,8 0,4 2 4,9 0,4 2 33,3 0,4 5 5,7 0,9 1 1,1 0,2 1 2,9 0,2 1 1,4 0,2 - - - 22 4,2 
Per-/Polyfluorinated compounds 1 2,6 0,2 4 4,0 0,8 2 3,8 0,4 - - - - - - 6 6,8 1,1 2 2,2 0,4 1 2,9 0,2 2 2,8 0,4 - - - 18 3,4 
Flame Retardants 3 7,7 0,6 2 2,0 0,4 3 5,7 0,6 2 4,9 0,4 - - - 3 3,4 0,6 2 2,2 0,4 - - - 2 2,8 0,4 - - - 17 3,2 
Cadmium 3 7,7 0,6 7 7,0 1,3 9 17,0 1,7 3 7,3 0,6 - - - 4 4,5 0,8 1 1,1 0,2 2 5,7 0,4 1 1,4 0,2 - - - 30 5,7 
Chromium VI - - - - - - 1 1,9 0,2 - - - - - - - - - - - - - - - - - - - - - 1 0,2 
PAHs 1 2,6 0,2 2 2,0 0,4 2 3,8 0,4 1 2,4 0,2 1 16,7 0,2 1 1,1 0,2 1 1,1 0,2 1 2,9 0,2 1 1,4 0,2 - - - 11 2,1 
Anilin family: Anilines, MOCA - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 
Chemical mixtures - - - 1 1,0 0,2 3 5,7 0,6 - - - 1 16,7 0,2 1 1,1 0,2 1 1,1 0,2 1 2,9 0,2 1 1,4 0,2 1 25,0 0,2 10 1,9 






Phthalates/DINCH 1 2,6 0,2 1 1,0 0,2 - - - - - - - - - - - - 1 1,1 0,2 - - - 1 1,4 0,2 - - - 4 0,8 
Bisphenols 1 2,6 0,2 2 2,0 0,4 1 1,9 0,2 1 2,4 0,2 - - - - - - - - - 1 2,9 0,2 - - - - - - 6 1,1 
Per-/Polyfluorinated compounds 1 2,6 0,2 - - - - - - - - - - - - - - - 1 1,1 0,2 - - - 1 1,4 0,2 - - - 3 0,6 
Flame Retardants - - - 1 1,0 0,2 - - - 2 4,9 0,4 - - - - - - 1 1,1 0,2 - - - 1 1,4 0,2 - - - 5 0,9 
Cadmium - - - 1 1,0 0,2 1 1,9 0,2 - - - - - - - - - - - - - - - 1 1,4 0,2 - - - 3 0,6 
Chromium VI - - - - - - 1 1,9 0,2 - - - - - - - - - - - - - - - - - - - - - 1 0,2 
PAHs - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 
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Status of the study/project/activity     
 
 Concluded Initiated/Ongoing   
    










































Total  n % 
Anilin family: Anilines, MOCA - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 
Chemical mixtures - - - - - - 1 1,9 0,2 - - - - - - - - - 1 1,1 0,2 1 2,9 0,2 - - - - - - 3 0,6 
Emerging chemicals - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 
  39 100 7,4 100 100 19,0 53 100 10,1 41 100 7,8 6 100 1,1 88 100 16,7 89 100 16,9 35 100 6,6 72 100 13,7 4 100 0,8 527 100 
* North: Denmark, Estonia. Finland, Iceland, Ireland, Latvia, Lithuania, Norway, Sweden, UK 
West: Austria, Belgium, France, Germany, Luxembourg, The Netherlands, Switzerland 
South: Croatia, Cyprus, Greece, Italy, Malta, Portugal, Slovenia, Spain 
East: Bulgaria, Czech Republic, Hungary, Poland, Romania, Slovakia 
Other: Israel 
Note 1: Data presented in this table refer to a multiple-choice question. The sum of reported studies does not correspond to the total of answers given to the questionnaire (n=124). 
Note 2: Sample base includes only studies with general population 
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Table 16: Planned studies according to age groups, substances under study and European-defined region*   
    
Status of the study/project/activity     
 
 Planned   




























Phthalates/DINCH - - - - - - - - - - - - - - - - - 
Bisphenols - - - - - - - - - - - - - - - - - 
Per-/Polyfluorinated compounds - - - - - - - - - - - - - - - - - 
Flame Retardants - - - - - - - - - - - - - - - - - 
Cadmium - - - - - - 1 20,0 0,2 - - - - - - 1 5,3 
Chromium VI - - - - - - - - - - - - - - - - - 
PAHs - - - - - - - - - - - - - - - - - 
Anilin family: Anilines, MOCA - - - - - - - - - - - - - - - - - 
Chemical mixtures - - - - - - - - - - - - - - - - - 






Phthalates/DINCH - - - 1 9,1 0,2 - - - - - - - - - 1 5,3 
Bisphenols - - - 1 9,1 0,2 - - - - - - - - - 1 5,3 
Per-/Polyfluorinated compounds - - - 1 9,1 0,2 - - - - - - - - - 1 5,3 
Flame Retardants - - - - - - - - - - - - - - - - - 
Cadmium - - - - - - 3 60,0 0,6 - - - - - - 3 15,8 
Chromium VI - - - - - - - - - - - - - - - - - 
PAHs - - - - - - - - - - - - - - - - - 
Anilin family: Anilines, MOCA - - - - - - - - - - - - - - - - - 
Chemical mixtures - - - 1 9,1 0,2 - - - - - - - - - 1 5,3 








Phthalates/DINCH - - - 1 9,1 0,2 - - - - - - - - - 1 5,3 
Bisphenols - - - 1 9,1 0,2 - - - - - - - - - 1 5,3 
Per-/Polyfluorinated compounds - - - 1 9,1 0,2 - - - - - - - - - 1 5,3 
Flame Retardants - - - - - - - - - - - - - - - - - 
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Status of the study/project/activity     
 
 Planned   






















Total n % 
Cadmium - - - - - - - - - - - - - - - - - 
Chromium VI - - - - - - - - - - - - - - - - - 
PAHs - - - - - - - - - - - - - - - - - 
Anilin family: Anilines, MOCA - - - - - - - - - - - - - - - - - 
Chemical mixtures - - - 1 9,1 0,2 - - - - - - - - - 1 5,3 





Phthalates/DINCH - - - - - - - - - - - - - - - - - 
Bisphenols - - - - - - - - - - - - - - - - - 
Per-/Polyfluorinated compounds - - - - - - - - - - - - - - - - - 
Flame Retardants - - - - - - - - - - - - - - - - - 
Cadmium - - - - - - 1 20,0 0,2 - - - 1 33,3 0,2 2 10,5 
Chromium VI - - - - - - - - - - - - 1 33,3 0,2 1 5,3 
PAHs - - - - - - - - - - - - 1 33,3 0,2 1 5,3 
Anilin family: Anilines, MOCA - - - - - - - - - - - - - - - - - 
Chemical mixtures - - - 1 9,1 0,2 - - - - - - - - - 1 5,3 
Emerging chemicals - - - - - - - - - - - - - - - - - 
  0 0,0 0,0 11 100 2,1 5 100 0,9 0 0,0 0,0 3 100 0,6 19 100 
* North: Denmark, Estonia. Finland, Iceland, Ireland, Latvia, Lithuania, Norway, Sweden, UK 
West: Austria, Belgium, France, Germany, Luxembourg, The Netherlands, Switzerland 
South: Croatia, Cyprus, Greece, Italy, Malta, Portugal, Slovenia, Spain 
East: Bulgaria, Czech Republic, Hungary, Poland, Romania, Slovakia 
Other: Israel 
Note 1: The data present in this table refer to multiple-choice questions. Therefore, the sum of reported studies may differ from the total of answers given to the questionnaire (n=124). 
Note 2: Sample base includes only studies with general population 
Note 3: No cases for Elderly 
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The same information is presented in Table 17 but only with studies/projects/activities having a national representativeness level. The majority of 
the studies involved children and newborns. In studies with children, the most analysed substances were cadmium, flame retardants, bisphenols 
and phthalates. For those studies with newborns, the main substances under study were flame retardants. In both cases, these studies were 
mostly conducted in Western Europe. 
Table 17: Groups of substances by European-defined region, age groups in national representative sampl es (n=32) 
    European-defined region*     
    North West South East Other Total 




















Total n % 
Newborns 
Phthalates/DINCH 2 8,7 1,2 4 5,7 2,5 1 2,5 0,6 1 3,6 0,6 - - - 8 4,9 
Bisphenols 2 8,7 1,2 3 4,3 1,8 2 5,0 1,2 1 3,6 0,6 - - - 8 4,9 
Per-/Polyfluorinated compounds 1 4,3 0,6 3 4,3 1,8 - - - 1 3,6 0,6 - - - 5 3,1 
Flame Retardants 1 4,3 0,6 4 5,7 2,5 2 5,0 1,2 4 14,3 2,5 - - - 11 6,7 
Cadmium 1 4,3 0,6 4 5,7 2,5 1 2,5 0,6 2 7,1 1,2 - - - 8 4,9 
Chromium VI - - - 2 2,9 1,2 - - - - - - - - - 2 1,2 
PAHs 1 4,3 0,6 1 1,4 0,6 1 2,5 0,6 2 7,1 1,2 - - - 5 3,1 
Anilin family: Anilines, MOCA - - - - - - - - - - - - - - - - - 
Chemical mixtures - - - - - - 2 5,0 1,2 - - - - - - 2 1,2 
Emerging chemicals - - - - - - - - - - - - - - - - - 
Children 
Phthalates/DINCH 3 13,0 1,8 7 10,0 4,3 1 2,5 0,6 1 3,6 0,6 - - - 12 7,4 
Bisphenols 3 13,0 1,8 6 8,6 3,7 2 5,0 1,2 1 3,6 0,6 - - - 12 7,4 
Per-/Polyfluorinated compounds 2 8,7 1,2 5 7,1 3,1 1 2,5 0,6 1 3,6 0,6 - - - 9 5,5 
Flame Retardants 2 8,7 1,2 4 5,7 2,5 2 5,0 1,2 4 14,3 2,5 - - - 12 7,4 
Cadmium 2 8,7 1,2 6 8,6 3,7 3 7,5 1,8 2 7,1 1,2 - - - 13 8,0 
Chromium VI - - - 2 2,9 1,2 - - - - - - - - - 2 1,2 
PAHs 2 8,7 1,2 2 2,9 1,2 1 2,5 0,6 2 7,1 1,2 - - - 7 4,3 
Anilin family: Anilines, MOCA - - - - - - - - - - - - - - - - - 
Chemical mixtures - - - 1 1,4 0,6 4 10,0 2,5 - - - 1 50,0 0,6 6 3,7 
Emerging chemicals 1 4,3 0,6 1 1,4 0,6 - - - - - - - - - 2 1,2 
Adolescents Phthalates/DINCH - - - 2 2,9 1,2 - - - - - - - - - 2 1,2 
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    European-defined region*     
    North West South East Other Total 




















Total n % 
Bisphenols - - - 2 2,9 1,2 1 2,5 0,6 - - - - - - 3 1,8 
Per-/Polyfluorinated compounds - - - 2 2,9 1,2 - - - - - - - - - 2 1,2 
Flame Retardants - - - - - - - - - 2 7,1 1,2 - - - 2 1,2 
Cadmium - - - 1 1,4 0,6 1 2,5 0,6 - - - - - - 2 1,2 
Chromium VI - - - - - - - - - - - - - - - - - 
PAHs - - - 1 1,4 0,6 - - - - - - - - - 1 0,6 
Anilin family: Anilines, MOCA - - - - - - - - - - - - - - - - - 
Chemical mixtures - - - 1 1,4 0,6 1 2,5 0,6 - - - - - - 2 1,2 
Emerging chemicals - - - 1 1,4 0,6 - - - - - - - - - 1 0,6 
Adults 
Phthalates/DINCH - - - 1 1,4 0,6 - - - - - - - - - 1 0,6 
Bisphenols - - - 1 1,4 0,6 1 2,5 0,6 - - - - - - 2 1,2 
Per-/Polyfluorinated compounds - - - - - - 2 5,0 1,2 - - - - - - 2 1,2 
Flame Retardants - - - - - - 2 5,0 1,2 2 7,1 1,2 - - - 4 2,5 
Cadmium - - - 1 1,4 0,6 2 5,0 1,2 - - - - - - 3 1,8 
Chromium VI - - - - - - - - - - - - - - - - - 
PAHs - - - - - - - - - - - - - - - - - 
Anilin family: Anilines, MOCA - - - - - - - - - - - - - - - - - 
Chemical mixtures - - - - - - 4 10,0 2,5 - - - 1 50,0 0,6 5 3,1 
Emerging chemicals - - - - - - - - - - - - - - - - - 
Elderly 
Phthalates/DINCH - - - 1 1,4 0,6 - - - - - - - - - 1 0,6 
Bisphenols - - - 1 1,4 0,6 1 2,5 0,6 - - - - - - 2 1,2 
Per-/Polyfluorinated compounds - - - - - - - - - - - - - - - - - 
Flame Retardants - - - - - - - - - 2 7,1 1,2 - - - 2 1,2 
Cadmium - - - - - - - - - - - - - - - - - 
Chromium VI - - - - - - - - - - - - - - - - - 
PAHs - - - - - - - - - - - - - - - - - 
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    European-defined region*     
    North West South East Other Total 




















Total n % 
Anilin family: Anilines, MOCA - - - - - - - - - - - - - - - - - 
Chemical mixtures - - - - - - 2 5,0 1,2 - - - - - - 2 1,2 
Emerging chemicals - - - - - - - - - - - - - - - - - 
  23 100 14,1 70 100 42,9 40 100 24,5 28 100 17,2 2 100 1,2 163 100 
* North: Denmark, Estonia. Finland, Iceland, Ireland, Latvia, Lithuania, Norway, Sweden, UK 
West: Austria, Belgium, France, Germany, Luxembourg, The Netherlands, Switzerland 
South: Croatia, Cyprus, Greece, Italy, Malta, Portugal, Slovenia, Spain 
East: Bulgaria, Czech Republic, Hungary, Poland, Romania, Slovakia 
Other: Israel 
Note: Data presented in this table refer to a multiple-choice question. The sum of reported studies does not correspond to the total of answers given to the questionnaire (n=124). 
Note 2: Sample base includes only studies with general population 
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As shown in Figure 5, blood was the most collected biological sample, followed by urine (spot 
sample – first morning) and serum. On the other hand, only one of the studies collected cell lines 
and fat/adipose tissue. Other collected samples included (among others): amniotic fluid, faeces, 
brain, kidney, liver, RNA and semen. 
 
 
Figure 5: Biological samples collected 
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The characterisation of the biological sample did not present geographical variability (Table 18).  
Table 18: Biological samples collected by European- defined region 












None - - - - - 
Blood 18 (64,3) 29 (65,9) 29 (65,9) 10 (62,5) 2 (28,6) 
Blood erythrocytes 3 (10,7) 4 (9,1) 3 (6,8) 1 (6,3) 1 (14,3) 
Plasma 14 (50,0) 15 (34,1) 10 (22,7) 5 (31,3) 2 (28,6) 
Serum 14 (50,0) 17 (38,6) 16 (36,4) 7 (43,8) 2 (28,6) 
Saliva 7 (25,0) 2 (4,5) 6 (13,6) 3 (18,8) - 
Buccal cells - 3 (6,8) 1 (2,3) 1 (6,3) - 
Nails 1 (3,6) 2 (4,5) 4 (9,1) - - 
DNA 11 (39,3) 7 (15,9) 4 (9,1) 4 (25,0) - 
Cells lines - 1 (2,3) - - - 
12-hours overnight urine 3 (10,7) - - - - 
Urine (24h) 3 (10,7) 1 (2,3) 3 (6,8) - - 
Urine (spot sample-random) 11 (39,3) 16 (36,4) 9 (20,5) 4 (25,0) 7 (100,0) 
Urine (spot sample-first morning) 15 (53,6) 20 (45,5) 21 (47,7) 11 (68,8) - 
Human milk 4 (14,3) 7 (15,9) 7 (15,9) 6 (37,5) 1 (14,3) 
Hair (chopped/lyophilised sample) 1 (3,6) 4 (9,1) 3 (6,8) 2 (12,5) - 
Hair (complete locks) 8 (28,6) 13 (29,5) 21 (47,7) 4 (25,0) - 
Fat/adipose tissue 1 (3,6) - - - - 
Placenta 1 (3,6) 3 (6,8) 1 (2,3) 2 (12,5) - 
Umbilical cord blood 5 (17,9) 12 (27,3) 6 (13,6) 6 (37,5) 1 (14,3) 
* North: Denmark, Estonia. Finland, Iceland, Ireland, Latvia, Lithuania, Norway, Sweden, UK 
West: Austria, Belgium, France, Germany, Luxembourg, The Netherlands, Switzerland 
South: Croatia, Cyprus, Greece, Italy, Malta, Portugal, Slovenia, Spain 
East: Bulgaria, Czech Republic, Hungary, Poland, Romania, Slovakia 
Other: Israel 
Note: Data presented in this table refer to a multiple-choice question. The sum of reported studies does not correspond to the total of 
answers given to the questionnaire (n=124). 
The same pattern is presented for the distribution of the biological samples by groups of 
substances (Table 19). 
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Blood 32 (76,2) 27 (95,0) 28 (80,0) 26 (78,8) 47 (85,5) 5 (100,0) 21 (75,0) 9 (64,3) 5 (83,3) 
Blood 
erythrocytes 4 (9,5) 4 (11,1) 4 (11,4) 3 (9,1) 8 (14,5) 3 (60,0) 2 (7,1) 1 (7,1) - 
Plasma 19 (45,2) 18 (50,0) 16 (45,7) 16 (48,5) 24 (43,6) 4 (80,0) 15 (53,6) 4 (28,6) 4 (66,7) 
Serum 23 (54,8) 22 (61,1) 23 (65,7) 19 (57,6) 26 (47,3) 3 (60,0) 13 (46,4) 5 (35,7) 3 (50,0) 
Saliva 5 (11,9) 4 (11,1) 3 (8,6) 5 (15,2) 6 (10,9) - 4 (14,3) 3 (21,4) 2 (33,3) 
Buccal cells 2 (4,8) 2 (5,6) 2 (5,7) 2 (6,1) 2 (3,6) - 2 (7,1) 1 (7,1) 2 (33,3) 
Nails - - 1 (2,9) 1 (3,0) 6 (10,9) - 2 (7,1) - - 
DNA 14 (33,3) 12 (33,3) 13 (37,1) 8 (24,2) 10 (18,2) 2 (40,0) 6 (21,4) 3 (21,4) 2 (33,3) 




1 (2,4) 1 (2,8) 1 (2,9) - 1 (1,8) - - - - 








22 (52,4) 19 (52,8) 18 (51,4) 17 (51,5) 33 (60,0) 2 (40,0) 18 (64,3) 5 (35,7) 4 (66,7) 









14 (33,3) 12 (33,3) 10 (28,6) 11 (33,3) 26 (47,3) 1 (20,0) 7 (25,0) 1 (7,1) - 
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tissue - - - - 1 (1,8) - - - - 
Placenta 4 (9,5) 2 (5,6) 4 (11,4) 3 (9,1) 3 (5,5) - 1 (3,6) 1 (7,1) - 
Umbilical 
cord blood 14 (33,3) 11 (30,6) 15 (42,9) 11 (33,3) 12 (21,8) 2 (40,0) 5 (17,9) 3 (21,4) 1 (16,7) 
Note 1: Data presented in this table refer to a multiple-choice question. The sum of reported studies does not correspond to the total of answers given to the questionnaire (n=124). 
Note 2: No cases for ‘None‘ biological samples neither for substances from Anilin family 
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More than half of the studies have biobanked samples (Table 20). The distribution of biobanked 
samples by European-defined region is presented in Table 21 and by groups of substances in 
Table 22. 
Table 20: Existence of biobanked samples 
 Frequency (n) Percent (%) 
No 46 37,1 
Yes 78 62,9 
Total 124 100,0 
 
Table 21: Biobanked samples by European-defined reg ion 












Biobanked samples    20 (71,4) 30 (68,2) 23 (52,3) 11 (68,8) 5 (71,4) 
* North: Denmark, Estonia. Finland, Iceland, Ireland, Latvia, Lithuania, Norway, Sweden, UK 
West: Austria, Belgium, France, Germany, Luxembourg, The Netherlands, Switzerland 
South: Croatia, Cyprus, Greece, Italy, Malta, Portugal, Slovenia, Spain 
East: Bulgaria, Czech Republic, Hungary, Poland, Romania, Slovakia 
Other: Israel 
Note: Data presented in this table refer to a multiple-choice question. The sum of reported studies does not correspond to the total of 
answers given to the questionnaire (n=124). 
 































(78,6) 8 (57,1) 5 (83,3) 
Note 1: Data presented in this table refer to a multiple-choice question. The sum of reported studies does not correspond to the total of 
answers given to the questionnaire (n=124). 
Note 2: No cases for substances from Anilin family 
 
A more detailed analysis of two of the most represented biobanked samples is presented below. 
Table 23 depicts the number of studies/projects/activities (general population) with urine samples 
(12-hours overnight urine, urine 24h, spot sample-random and spot sample-first morning) by group 
of substances, region and age group. Table 24 shows the same information for blood samples 
(blood, blood erythrocytes, plasma and serum). In both cases, the largest number of studies were 
from Western and Northern regions. Concerning the target population and substances under study, 
the focus is put on children and phthalates, respectively.
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Table 23: Urine samples by groups of substances, Eu ropean-defined region* and age groups 
        















































Total  n % 
North 
Newborns 5 5,0 1,0 5 5,6 1,0 4 7,3 0,8 3 5,4 0,6 1 1,2 0,2 - - - 2 4,0 0,4 1 3,0 0,2 1 7,7 0,2 22 4,5 
Children 11 11,0 2,3 9 10,1 1,8 6 10,9 1,2 6 10,7 1,2 6 7,1 1,2 - - - 4 8,0 0,8 1 3,0 0,2 2 15,4 0,4 45 9,2 
Adolescents 3 3,0 0,6 3 3,4 0,6 3 5,5 0,6 2 3,6 0,4 - - - - - - 1 2,0 0,2 1 3,0 0,2 1 7,7 0,2 14 2,9 
Adults 11 11,0 2,3 8 9,0 1,6 7 12,7 1,4 4 7,1 0,8 7 8,2 1,4 - - - 2 4,0 0,4 1 3,0 0,2 1 7,7 0,2 41 8,4 
Elderly 1 1,0 0,2 1 1,1 0,2 1 1,8 0,2 - - - - - - - - - - - - - - - - - - 3 0,6 
West 
Newborns 6 6,0 1,2 5 5,6 1,0 5 9,1 1,0 4 7,1 0,8 5 5,9 1,0 2 28,6 0,4 3 6,0 0,6 1 3,0 0,2 - - - 31 6,4 
Children 13 13,0 2,7 11 12,4 2,3 7 12,7 1,4 5 8,9 1,0 10 11,8 2,0 2 28,6 0,4 7 14,0 1,4 3 9,1 0,6 1 7,7 0,2 59 12,1 
Adolescents 5 5,0 1,0 6 6,7 1,2 4 7,3 0,8 5 8,9 1,0 7 8,2 1,4 - - - 8 16,0 1,6 2 6,1 0,4 1 7,7 0,2 38 7,8 
Adults 9 9,0 1,8 6 6,7 1,2 5 9,1 1,0 3 5,4 0,6 8 9,4 1,6 - - - 3 6,0 0,6 2 6,1 0,4 - - - 36 7,4 
Elderly 2 2,0 0,4 2 2,2 0,4 1 1,8 0,2 2 3,6 0,4 1 1,2 0,2 - - - - - - 1 3,0 0,2 - - - 9 1,8 
South  
Newborns 1 1,0 0,2 3 3,4 0,6 - - - 2 3,6 0,4 2 2,4 0,4 - - - 1 2,0 0,2 2 6,1 0,4 - - - 11 2,3 
Children 5 5,0 1,0 5 5,6 1,0 - - - 3 5,4 0,6 12 14,1 2,5 1 14,3 0,2 2 4,0 0,4 3 9,1 0,6 - - - 31 6,4 
Adolescents 1 1,0 0,2 3 3,4 0,6 - - - 1 1,8 0,2 1 1,2 0,2 1 14,3 0,2 - - - 1 3,0 0,2 - - - 8 1,6 
Adults 3 3,0 0,6 3 3,4 0,6 - - - 2 3,6 0,4 10 11,8 2,0 - - - 3 6,0 0,6 3 9,1 0,6 - - - 24 4,9 
Elderly - - - 2 2,2 0,4 - - - - - - - - - - - - - - - 2 6,1 0,4 - - - 4 0,8 
East 
Newborns 5 5,0 1,0 4 4,5 0,8 4 7,3 0,8 5 8,9 1,0 3 3,5 0,6 - - - 4 8,0 0,8 2 6,1 0,4 2 15,4 0,4 29 5,9 
Children 8 8,0 1,6 5 5,6 1,0 4 7,3 0,8 5 8,9 1,0 6 7,1 1,2 - - - 5 10,0 1,0 2 6,1 0,4 2 15,4 0,4 37 7,6 
Adolescents 1 1,0 0,2 2 2,2 0,4 1 1,8 0,2 1 1,8 0,2 - - - - - - 1 2,0 0,2 1 3,0 0,2 1 7,7 0,2 8 1,6 
Adults 5 5,0 1,0 3 3,4 0,6 2 3,6 0,4 2 3,6 0,4 4 4,7 0,8 - - - 2 4,0 0,4 1 3,0 0,2 1 7,7 0,2 20 4,1 
Elderly 1 1,0 0,2 1 1,1 0,2 1 1,8 0,2 1 1,8 0,2 1 1,2 0,2 - - - - - - - - - - - - 5 1,0 
Other 
Newborns 1 1,0 0,2 - - - - - - - - - - - - - - - - - - - - - - - - 1 0,2 
Children 1 1,0 0,2 - - - - - - - - - - - - - - - - - - 1 3,0 0,2 - - - 2 0,4 
Adults 2 2,0 0,4 2 2,2 0,4 - - - - - - 1 1,2 0,2 1 14,3 0,2 2 4,0 0,4 2 6,1 0,4 - - - 10 2,0 
  100 100 20,5 89 100 18,2 55 100 11,3 56 100 11,5 85 100 17,4 7 100 1,4 50 100 10,2 33 100 6,8 13 100 2,7 488 100 
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* North: Denmark, Estonia. Finland, Iceland, Ireland, Latvia, Lithuania, Norway, Sweden, UK 
West: Austria, Belgium, France, Germany, Luxembourg, The Netherlands, Switzerland 
South: Croatia, Cyprus, Greece, Italy, Malta, Portugal, Slovenia, Spain 
East: Bulgaria, Czech Republic, Hungary, Poland, Romania, Slovakia 
Other: Israel 
Note 1: Data presented in this table refer to a multiple-choice question. The sum of reported studies does not correspond to the total of answers given to the questionnaire (n=124). 
Note 2: Sample base includes only studies with general population 
Note 3: No cases for Adolescents and Elderly from Other European-defined region neither for substances from Anilin family 
 
Table 24: Blood samples by groups of substances, Eu ropean-defined region* and age groups  
        















































Total  n % 
North  
Newborns 5 6,9 1,1 5 6,2 1,1 4 6,3 0,9 3 4,7 0,7 1 1,5 0,2 - - - 2 5,4 0,5 1 3,6 0,2 1 6,7 0,2 22 5,1 
Children 8 11,1 1,8 8 9,9 1,8 6 9,4 1,4 6 9,4 1,4 3 4,6 0,7 - - - 3 8,1 0,7 1 3,6 0,2 2 13,3 0,5 37 8,5 
Adolescents 3 4,2 0,7 3 3,7 0,7 3 4,7 0,7 2 3,1 0,5 - - - - - - 1 2,7 0,2 1 3,6 0,2 1 6,7 0,2 14 3,2 
Adults 8 11,1 1,8 7 8,6 1,6 7 10,9 1,6 5 7,8 1,1 4 6,2 0,9 - - - 1 2,7 0,2 1 3,6 0,2 1 6,7 0,2 34 7,8 
Elderly 1 1,4 0,2 1 1,2 0,2 1 1,6 0,2 - - - - - - - - - - - - - - - - - - 3 0,7 
West 
Newborns 7 9,7 1,6 7 8,6 1,6 7 10,9 1,6 5 7,8 1,1 6 9,2 1,4 2 22,2 0,5 3 8,1 0,7 1 3,6 0,2 1 6,7 0,2 39 9,0 
Children 11 15,3 2,5 11 13,6 2,5 9 14,1 2,1 6 9,4 1,4 8 12,3 1,8 2 22,2 0,5 4 10,8 0,9 2 7,1 0,5 2 13,3 0,5 55 12,6 
Adolescents 5 6,9 1,1 5 6,2 1,1 4 6,3 0,9 5 7,8 1,1 7 10,8 1,6 - - - 7 18,9 1,6 2 7,1 0,5 1 6,7 0,2 36 8,3 
Adults 6 8,3 1,4 4 4,9 0,9 4 6,3 0,9 3 4,7 0,7 5 7,7 1,1 - - - 1 2,7 0,2 2 7,1 0,5 - - - 25 5,7 
Elderly 2 2,8 0,5 1 1,2 0,2 1 1,6 0,2 1 1,6 0,2 1 1,5 0,2 - - - - - - 1 3,6 0,2 - - - 7 1,6 
South  
Newborns 1 1,4 0,2 3 3,7 0,7 - - - 2 3,1 0,5 2 3,1 0,5 - - - 1 2,7 0,2 2 7,1 0,5 - - - 11 2,5 
Children 2 2,8 0,5 4 4,9 0,9 1 1,6 0,2 3 4,7 0,7 7 10,8 1,6 1 11,1 0,2 1 2,7 0,2 3 10,7 0,7 - - - 22 5,1 
Adolescents 1 1,4 0,2 3 3,7 0,7 - - - 1 1,6 0,2 2 3,1 0,5 1 11,1 0,2 - - - 1 3,6 0,2 - - - 9 2,1 
Adults - - - 2 2,5 0,5 3 4,7 0,7 3 4,7 0,7 9 13,8 2,1 1 11,1 0,2 2 5,4 0,5 3 10,7 0,7 - - - 23 5,3 
Elderly - - - 2 2,5 0,5 - - - - - - 1 1,5 0,2 1 11,1 0,2 - - - 1 3,6 0,2 - - - 5 1,1 
East Newborns 4 5,6 0,9 5 6,2 1,1 5 7,8 1,1 6 9,4 1,4 3 4,6 0,7 - - - 4 10,8 0,9 2 7,1 0,5 2 13,3 0,5 31 7,1 
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Total  n % 
Children 4 5,6 0,9 5 6,2 1,1 5 7,8 1,1 6 9,4 1,4 3 4,6 0,7 - - - 4 10,8 0,9 2 7,1 0,5 2 13,3 0,5 31 7,1 
Adolescents 1 1,4 0,2 2 2,5 0,5 1 1,6 0,2 2 3,1 0,5 - - - - - - 1 2,7 0,2 1 3,6 0,2 1 6,7 0,2 9 2,1 
Adults 2 2,8 0,5 2 2,5 0,5 2 3,1 0,5 3 4,7 0,7 1 1,5 0,2 - - - 1 2,7 0,2 1 3,6 0,2 1 6,7 0,2 13 3,0 
Elderly 1 1,4 0,2 1 1,2 0,2 1 1,6 0,2 2 3,1 0,5 1 1,5 0,2 - - - - - - - - - - - - 6 1,4 
Other  Adults - - - - - - - - - - - - 1 1,5 0,2 1 11,1 0,2 1 2,7 0,2 - - - - - - 3 0,7 
  72 100 16,6 81 100 18,6 64 100 14,7 64 100 14,7 65 100 14,9 9 100 2,1 37 100 8,5 28 100 6,4 15 100 3,4 435 100 
 
* North: Denmark, Estonia. Finland, Iceland, Ireland, Latvia, Lithuania, Norway, Sweden, UK 
West: Austria, Belgium, France, Germany, Luxembourg, The Netherlands, Switzerland 
South: Croatia, Cyprus, Greece, Italy, Malta, Portugal, Slovenia, Spain 
East: Bulgaria, Czech Republic, Hungary, Poland, Romania, Slovakia 
Other: Israel 
Note 1: Data presented in this table refer to a multiple-choice question. The sum of reported studies does not correspond to the total of answers given to the questionnaire (n=124). 
Note 2: Sample base includes only studies with general population 
Note 3: No cases for Newborns, Children, Adolescents and Elderly from Other European-defined region neither for substances from Anilin family  
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Nearly 50% of the studies allow access of the samples they have stored, with 26,6% for 
consultation and 21,0% for access and use of other researchers/organizations (Table 25). 
Table 25: Access and use of biobanked samples 
 Frequency (n) Percent (%) 
No access at all 19 15,3 
Access (only for consultation) for other 
researchers/organisations 
33 26,6 
Access and use for other researchers/ organisations 26 21,0 
Not applicable 46 37,1 
Total 124 100,0 
 
Several indicators and parameters were collected by the reported studies. Table 26 to Table 28 
summarise the results of the data collected for clinical parameters, anthropometric data, other 
biomarkers or physiological indicators, outdoor pollution and occupational exposure by European-
defined region. 
Table 26: Clinical parameters, anthropometric data and other biomarkers or physiological indicators 
by European-defined-region 












Respiratory/lung parameters 6 (21,4) 17 (38,6) 6 (13,6) 4 (25,0) 0 (0,0) 
Reproductive and/or development 
system parameters  9 (32,1) 18 (40,9) 6 (13,6) 5 (31,3) 3 (42,9) 
Neurological parameters  3 (10,7) 14 (31,8) 10 (22,7) 2 (12,5) 0 (0,0) 
Anthropometric data (objectively 
measured) 17 (60,7) 37 (84,1) 25 (56,8) 13 (81,3) 6 (85,7) 
Other biomarkers or physiological 
indicators 20 (71,4) 21 (47,7) 9 (20,5) 6 (37,5) 3 (42,9) 
* North: Denmark, Estonia. Finland, Iceland, Ireland, Latvia, Lithuania, Norway, Sweden, UK 
West: Austria, Belgium, France, Germany, Luxembourg, The Netherlands, Switzerland 
South: Croatia, Cyprus, Greece, Italy, Malta, Portugal, Slovenia, Spain 
East: Bulgaria, Czech Republic, Hungary, Poland, Romania, Slovakia 
Other: Israel 
Note: Data presented in this table refer to a multiple-choice question. The sum of reported studies does not correspond to the total of 
answers given to the questionnaire (n=124). 
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Table 27: Collected data about outdoor pollution by  European-defined region 












Data about outdoor pollution   7 (25,0) 23 (52,3) 18 (40,9) 5 (31,3) 1 (14,3) 
* North: Denmark, Estonia. Finland, Iceland, Ireland, Latvia, Lithuania, Norway, Sweden, UK 
West: Austria, Belgium, France, Germany, Luxembourg, The Netherlands, Switzerland 
South: Croatia, Cyprus, Greece, Italy, Malta, Portugal, Slovenia, Spain 
East: Bulgaria, Czech Republic, Hungary, Poland, Romania, Slovakia 
Other: Israel 
Note: Data presented in this table refer to a multiple-choice question. The sum of reported studies does not correspond to the total of 
answers given to the questionnaire (n=124). 
Table 28: Collected data about occupational exposur e by European-defined region 












Data about occupational exposure   7 (25,0) 20 (45,5) 17 (38,6) 7 (43,8) 2 (28,6) 
* North: Denmark, Estonia. Finland, Iceland, Ireland, Latvia, Lithuania, Norway, Sweden, UK 
West: Austria, Belgium, France, Germany, Luxembourg, The Netherlands, Switzerland 
South: Croatia, Cyprus, Greece, Italy, Malta, Portugal, Slovenia, Spain 
East: Bulgaria, Czech Republic, Hungary, Poland, Romania, Slovakia 
Other: Israel 
Note: Data presented in this table refer to a multiple-choice question. The sum of reported studies does not correspond to the total of 
answers given to the questionnaire (n=124). 
For the vast majority of the studies, non-biological data is partially accessible to the HBM4EU use 
(Table 29). 
Table 29: Data access to non-biological data 
 Frequency (n) Percent (%) 
No access is possible 30 24,2 
Partial access to database 80 64,5 
Access to total database 14 11,3 
Total 124 100,0 
Almost 50% of the studies declare free availability to the questionnaire used for data collection, for 
HBM4EU partners and approximately 35% provide free access to any researcher (Table 30). 
Table 30: Possibility of sharing the questionnaire used for data collection 
 Frequency (n) Percent (%) 
No 21 16,9 
Yes, it is available to any researcher 43 34,7 
Yes, only to HBM4EU partners 60 48,4 
Total 124 100,0 
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4.1.1 Questionnaire on occupational exposure 
Concerning the occupational exposure questionnaire, some of the main results are presented 
below. The answers were collected in the same period as the main questionnaire (March 28 and 
June 8, 2017), and 33 questionnaires were filled in. 
It should be noted that descriptive analysis of these data were performed by FMUL but a deeper 
analysis will be performed by DPH, UKF and FIOH, the institutions responsible for the 
development of the questionnaire. The complete database will also be available on the wiki as well 
as the statistical analysis performed by FMUL. 
Around 43% of the institutions answering the occupational exposure questionnaire were from 
Finland, followed by 12,1% from Belgium and 6,1% from Latvia and Portugal (Table 31). 
Table 31: Nationality of the respondent Institution /Organisation 
 Frequency (n) Percent (%) 
Belgium 4 12,1 
Croatia 1 3,0 
Dutch 1 3,0 
Finnish 14 42,4 
Italian 1 3,0 
Latvia 2 6,1 
Lithuanian 1 3,0 
Portuguese 2 6,1 
Slovak 1 3,0 
Spanish 1 3,0 
Switzerland 1 3,0 
Total 33 100,0 
Most of the institutions undertaking studies on occupational exposure are public or universities 
(Table 32). 
Table 32 - Type of the Institution/Organisation 
 Frequency (n) Percent (%) 
Public 19 57,6 
Private 2 6,1 
University 9 27,3 
Public & University 1 3,0 
Other 1 3,0 
No answer 1 3,0 
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In terms of study design, most of the studies on occupational exposure were cross-sectional (Table 
33). 
Table 33: Study design 
 Frequency (n) Percent (%) 
Cross-sectional study 28 84,8 
Longitudinal / Cohort study 5 15,2 
Total 33 100,0 
Nearly 30% of the studies covered only one year, but almost other 30% covered two, three and 
nine years (Table 34). 
Table 34: Number of years covered 
 Frequency (n) Percent (%) 
1 9 27,3 
2 3 9,1 
3 3 9,1 
4 1 3,0 
5 1 3,0 
7 1 3,0 
9 3 9,1 
14 2 6,1 
16 1 3,0 
17 1 3,0 
18 1 3,0 
19 1 3,0 
23 1 3,0 
No answer 5 15,2 
Total 33 100,0 
It was sought to understand how the collected data from the reported studies could be used for the 
purpose of the HBM4EU initiative. From Table 35 it can be seen that most of the data are available 
(78,8%). 
Table 35: Data use for the purpose of the HBM4EU in itiative 
 Frequency (n) Percent (%) 
No 0 0,0 
Yes 26 78,8 
No answer 7 21,2 
Total 33 100,0 
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The collected samples in occupational exposure studies are mainly from urine and blood (Table 
36). 
Table 36: Collected samples 
 Frequency (n) Percent (%) 
Urine 13 39,4 
Blood 1 3,0 
Urine and blood 4 12,1 
Urine and air 3 9,1 
Blood and air 2 6,1 
Urine, blood and air 2 6,1 
Urine, blood, air and other 3 9,1 
Other 1 3,0 
No answer 4 12,1 
Total 33 87,9 
The following table describes the information each study has gathered with regard to HBM data, 
namely concerning the type of biological sample (Table 37). 
Table 37: Type of biological sample 
 Frequency (n) Percent (%) 
Blood 3 9,1 
Blood serum 1 3,0 
Hair 1 3,0 
Urine 17 51,5 
Urine and blood 9 27,3 
Urine, blood and Hair 1 3,0 
No answer 1 3,0 
Total 33 100,0 
The time elapsed at the time of sampling since the last supposed exposure was also questioned, 
being the most frequent one the situation of <6h (Table 38). 
Table 38: Time elapsed at the time of sampling sinc e the last supposed exposure (end of the shift) 
 Frequency (n) Percent (%) 
<6h 17 51,5 
12-18h 2 6,1 
>48h 1 3,0 
6-12h & 18-24h 1 3,0 
<6h & 12-18h 1 3,0 
No answer 11 33,3 
Total 33 100,0 
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4.1.2 Level of potential evidence of the studies/pr ojects/activities 
One of the goals of this task was to define quality criteria for the studies/projects/activities, allowing 
data comparability. Following the recommendations of some of the partners, it was decided to 
change this concept and to propose instead criteria that index a level of evidence for each 
study/project/activity. As a matter of fact, it is not the quality of each study/project/activity that is in 
question (there is a pre-assumption that all projects have internal validity and, therefore, quality). 
What is relevant, for building up overall pictures about collected data and information, is how 
potentially strong is the collected (or to be collected) evidence. Level of evidence is a concept that 
is adopted by several institutions, to summarise collected knowledge (e.g., Cochrane Foundation). 
In this context, taking into consideration partners’ consultation about evidence criteria, and 
attending only to an overarching appreciation of the potentially produced (or to be produced) 
evidence by each study/project/activity, the selected variables for building up an index of potential 
level of evidence (and corresponding options of answer, i.e., level of evidence) were: 
1. Implementation level of the study (options: 1 = international/national; 0 = regional/other); 
2. Ethical approval (options: 1 = yes; 0 = no); 
3. Study design (options: 1 = longitudinal/cohort; 0 = pilot-study, cross-sectional survey, case-
control); 
4. Sample size (options: 1 = 100 or more individuals; 0 = 0 – 99 individuals); 
5. Qualified/trained interviewers (options: 1 = yes; 0 = no). 
For an overall index of potential evidence, a linear sum of these parameters was done. Therefore, 
studies/projects/activities range from 0 to 5 points in terms potential level of evidence. As can be 
seen in next table, 48,2% of the studies/projects/activities have characteristics that can be high or 
very high level of evidence. 
Table 39: Potential level of evidence * 
 Frequency (n) Percent (%) 
1 = Very low evidence 4 3,7 
2 = Low evidence 23 21.3 
3 = Rather low evidence 29 26,9 
4 = High evidence 42 38,9 
5 = Very high evidence 10 9,3 
Total 108 100,0 
*Only projects with data for all the parameters were included. 
4.1.3 Metadata available to be uploaded into IPCheM  
The developed questionnaire also intended to identify which biomarkers and other 
parameters/indicators were available, what level of access was reported as allowed and what was 
the aggregation level. 
With regard to the information collected for section 3 (Fieldwork and data collection) and 4 (Other 
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Table 40:  Percentage of studies/projects/activitie s that collect/ed information, by specific health-
related parameters and indicators 
 Frequency (n) Percent (%) 
Genetic-related data 31 25,0 
Molecular information 32 25,8 
Skin parameters 10 8,1 
Respiratory/lung parameters 30 24,2 
Skeletal parameters 6 4,8 
Renal function parameters 34 27,4 
Reproductive and/or development system parameters 41 33,1 
Immunity 11 8,9 
Neurological parameters 26 21,0 
Essential trace elements 34 27,4 
Anthropometric data (objectively measured) 89 71,8 
Other parameters and indicators 57 46,0 
Outdoor pollution 50 40,3 
Environmental noise exposure 11 8,9 
Climate 20 16,1 
Residence 105 84,7 
Indoor parameters 71 57,3 
Food intake / food habits 109 87,9 
Frequency of consumption of food produced locally 46 37,1 
Traffic exposure or mobility 59 47,6 
Participants’ personal hygiene 42 33,9 
Smoking habits 98 79,0 
Dental status 56 45,2 
Clothing / body adornments 56 45,2 
Contact with toxic substances 46 37,1 
Hobbies and holidays 64 51,6 
Other lifestyle aspects 48 38,7 
Health care utilization 26 21,0 
Family health-related history 50 40,3 
Medical history of the participant 79 63,7 
Specific stages of life 48 38,7 
Pregnancy or delivery 65 52,4 
New born / infant biometry/health 49 39,5 
Unspecified health complaints 23 18,5 
Accidents 9 7,3 
Exposure during pregnancy and/or breastfeeding 39 31,5 
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 Frequency (n) Percent (%) 
Occupational exposure 46 37,1 
Other types of exposure 37 29,8 
Medication during pregnancy, delivery or breastfeeding 37 29,8 
Medication during delivery 17 13,7 
Medication during breastfeeding 20 16,1 
Medication administered to or taken by children or adolescents 35 28,2 
Permanent or acute medication for respiratory or allergic diseases 52 41,9 
Socio-demographic and/or socio-economic factors 105 84,7 
Considering the access and use by IPCheM, the results are as follows (Table 41 and Table 42). 
Table 41: Access and use of biomarkers and other pa rameters 
 Frequency (n) Percent (%) 
No access at all 47 37,9 
Access for IPCheM* (only for consultation) 18 14,5 
Access (only for consultation) for other 
researchers/organisations 
14 11,3 
Access and use for IPCheM 23 18,5 
Access and use for other researchers/ organisations 22 17,7 
Total 124 100,0 
Table 42: Aggregation level of data of biomarkers a nd other parameters 
 Frequency (n) Percent (%) 
Metadata 26 19,5 
Aggregated data (by gender, age groups, population type, …) 46 34,6 
Filtered/generalised single measurement data with key 
parameters 
23 17,3 
Single measurement data with additional relevant parameters 38 28,6 
Total 133 100,0 
Note: Data presented in this table refer to a multiple-choice question. The sum of reported studies does not correspond to the total of 
answers given to the questionnaire (n=124). 
In addition to the results presented in the above pages, for European representative studies, more 
analysis on the data gaps will be done by VITO in WP 10 and Task 7.2. This additional work is of 
utmost importance in order to obtain a more complete perspective on the existing data gaps. For 
that, it is necessary i) to have a thorough look into the data with access to individual data and ii) to 
have defined which data shall be available to report about European representativeness. 
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4.2 Literature review 
The literature search aimed to review the available biomonitoring and exposure data regarding the 
prioritised substances. 
A unique file was produced with the information gathered from the reviewed papers for each of the 
substances indicated in the following table. An example of the synoptic table produced for one of 
the substances, in this case for cadmium, for the five first entries is presented below. The full excel 





1 Hoet P, Haufroid V, Deumer G, Dumont X, Lison D, Hantson P. Acute kidney injury following acute liver failure: Potential role of systemic cadmium mobilization? Intensive Care Med. 2012;38(3):467–73. Belgium To test the hyp thesis that a r leas of Cd during ALF may cause a redistribution of Cd from the liver to the kidneys and play a role in the occurrence of ALF-associated acute tubular kidney injury.
2 Hambach R, Lison D, D’Haese P, Weyler J, François G, De Schryver A, et al. Adverse effects of low occupational cadmium exposure on renal and oxidative stress biomarkers in solderers. Occup Environ Med. 2013;70(2):108–13. Belgium Local To ssess indicators for Cd exposure in bl od (Cd-B) and urine (Cd-U) in workers performing Ag soldering versus a non-exposed reference population; (2) to detect early subclinical renal effects in those workers by applying a set of biomarkers (ie, NAG, IAP, m-Alb, β2-MG, RBP); (3) to assess oxidative stress in the same workers by applying a set of biomarkers (ie, derivatives of determinable reactive oxygen metabolites (d-ROM)Advanced oxidation protein products (AOPP) and 8-isoprostanes; GPX; Cu/Zn SOD; 8-hydroxy-20-deoxyguanosine (8-OHdG); (4) to study the association between Cd-B, Cd-U and these biomarkers in solderers. 
3 Unkiewicz-Winiarczyk A, Gromysz-Kałkowska K, Szubartowska E. Aluminium, cadmium and lead concentration in the hair of tobacco smokers. Biol Trace Elem Res. 2009;132(1–3):41–50. Poland Local To estimate the mean cont nt of Al, Cd and Pb in the hair of people residing in similar conditions and to relate the data to smoking habit, age and sex.
4 Sánchez-Rodríguez JE, Bartolomé M, Cañas AI, Huetos O, Navarro C, Rodríguez AC, et al. Anti-smoking legislation and its effects on urinary cotinine and cadmium levels. Environ Res. 2015;136:227–33. Spain Local To analyze th impact 
5 Durand C, Sauthier N, Schwoebel V. Assessment of exposure to soils contaminated with lead, cadmium, and arsenic near a zinc smelter, Cassiopée Study, France, 2008. Environ Monit Assess. 2015;187(352).Franc Local To measure and explain 
Country/countries
(where the data were 
collected)
Reference




(Name, acronym and 
country of the research unit 




(including acronym, if any)
Main objectives




national, regional, local, 
…)
Target population
(- general population or 
clinical;













(recruitment place: school, 
hospital, registration office)
(recruitment via: GP, census data, 
health archives, mail address, door 
to door, …





(every year, once a 
year, …)
Cross-sectional age > 18 years 60 Inclusion criteria: (1) Convenience University hospital
Cross-sectional men workers performing 71 ‘exposure group’: Intentional/convenie refrigeration companies located in 
Cross-sectional students and workers of 109 students and workers Intentional Maria Curie-Sklodowska University
Longitudinal workers from the 83 workers from the Intentional annual medical check-up, Instituto Each year






D 7.1 - Report on ongoing activities and existing data and data gaps for the 1st prioritised 
substances including a list of metadata that can be uploaded in IPCheM 
Security: Public 
WP7 - Survey design and fieldwork preparation Version: 1.1 









Per-/polyfluorinated compounds 70 
Flame retardants -* 
Cadmium 46 
Chromium IV 4 
PAHs -** 
Anilin family: MOCA 8 
Total 176 
* For flame retardants, and in order to include the work that was already done for this substance, the literature search 
has some differences when compared with the ones performed for the other substances. Therefore, a list of ongoing 
projects was received, although not only covering population studies. 
** The collection of data for these substances was provided by the CGL (AUTH) and is therefore not included in the 
analysis for this report. The literature review for this task will complement the work done by the CGLs. 
For the purpose of this report, we present below the main results of the literature review 
considering the variables included as criteria for potential level of evidence for the 
studies/projects/activities in the survey. Since scientific papers do not provide a detailed 
description of the studies as much as the questionnaire, it was decided to search for this specific 
information. Only the clearly identified studies are included (n=22; not all of the papers selected for 
the literature review concerned a specific study and in that case were not included in the following 
analysis. The entire compilation of studies can be consulted on the HBM4EU wiki). 















(Please specify, if possible, 
non-biological data, 
biological samples and 
biomarkers and other 
parameters collected)
Medical histories; Cd, Pb and Zn; Al, As, - Non-biological data: medical historiesALF pat nts excreted markedly more Cd than the healthy controls and ICUcontrols. In ALF-patients, the four urinary LMWPs (RBP, b2-MG, CC16 and a1-MG) increased as a function of Cd excretion, with high correlation coefficients. The prevalence of patients excreting a high amount of LMWPs also increased with increasing Cd excretion. No relationship was found between the other elements investigated and the LMWPs, with the exception of copper, which shares close toxicokinetic similarities with Cd.
between March questionnaire; Cadmium, creatinine, - Non-biological data: renal and/or urological problems, hypertension, diabetes mellitus, intake of analgesics or non-steroidal anT-inflammatory drugs, working condiTons and smoking habitsrelatively l w Cd-B and Cd-U levels were found in the participa ing workers performing Ag soldering. Besides, significant associat ons betwee  Cd-B and Cd-U on he one side and markers of oxidative stress and renal effect on the other side were also found.the rela ively small size of the s udy population, wh h should b  put in li ht of the limited number f workers active in the Flemish refrigeration ndustry. In addition, the cro s-sectional design gives no informat on on the temporal sequence between exposure and outcome
The sampled hair Cadmium, aluminium, - Biological samples: hair 1. The levels of Al, Cd 
2007 to 2011 self-administered Cadmium, cotinine, - Non-biological data: lifestyle habits, such as smoking and smoke-exposure paVerns, body mass indexT e stricter anti- O e of thes  is that the 
September–Octob face-to-face Cadmium, lead, arsenic; - Non-biological data: sociodemographic and health informaTon (age, gender, occupaTonal acTvity, family situaTon, educaTonal level, body mass index, medical history); Pollutant exposure factors unrelated to the area of residence and cited in scienTfic literature (acTve and passive smoking, consumpTon of seafood and offal, consumpTon of alcohol and mineral water, free Tme or professional acTviTes where exposure to pollutants was possible, including contact with metal handles or the use of paint and dyes; Environmental exposure factors related to area of residence (length of residence, consumpTon of locally grown produce, drinking local well and spring water, frequency ofmopping the floor, presence of a private garden in the house, frequency of certain acTviTes in the area like gardening and hunTng, etc.); LifeTme exposure and exposure in recent daysNo case of le d poisoning was detected in Viviez, but 23 % of dults had urinary cadmium over 1 μg/g creatinine, 14 % of whom having markers of kidn y damage. Viviez adults had highe  levels of uri ary cadmium, and to a lesser ext nt, higher levels of urinary arsenic than those from Montbazens. Consumption of local produce (vegetabl s and animals) and length of resid nce in Viviez wer  associa ed with higher urinary cadmium levels, independe tly of known con ounding factors, suggesting persisting environment l xp sure t  contaminat d soil. To conclude, health risks related to cadmium exposure were identifi d i  the Viviez population living on contaminated soils. Lead and arsenic exposure did not pose health oncerns. Interventions w re proposed to reduce exposure and limit health consequenc s.The selection of the 
Main findings / 
Conclusions
Data collection
Limitations of the 
study
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Table 44: Countries where data were collected 
 Frequency (n) Percent (%) 
Belgium 2 5,4 
Croatia 1 2,7 
Denmark 8 21,6 
Finland 1 2,7 
Germany 1 2,7 
Greece 1 2,7 
Hungary 1 2,7 
Italy 1 2,7 
Netherlands 2 5,4 
Norway 7 18,9 
Poland 1 2,7 
Slovakia 1 2,7 
Spain 3 8,1 
Sweden 4 10,8 
Switzerland 1 2,7 
Ukraine 1 2,7 
United Kingdom 1 2,7 
Total 37 100,0 
Note: Data presented in this table refer to a multiple-choice question. The sum of reported studies does not correspond to the total of 
answers given to the questionnaire (n=124). 
For the implementation level, the majority of the studies (54,5%) identified with the literature review 
were regional (Table 45). 
Table 45: Study/project/activity implementation lev el 
 Frequency (n) Percent (%) 
International 3 13,6 
National 4 18,2 
Regional (province, county, etc.) 12 54,5 
Other 0 0,0 
No answer 3 13,6 
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Most of the studies identified in the literature review were concluded (Table 46). To note that no 
planned studies were identified with this approach. 
Table 46:  Status of the studies/projects/activities 
 Frequency (n) Percent (%) 
Concluded 12 54,6 
Initiated/ongoing 5 22,7 
Planned 0 0,0 
Unclear 2 9,1 
No answer 3 13,6 
Total 22 100,0 
In terms of study design, 54,6% of the studies were longitudinal and only 18,2% were cross-
sectional (Table 47). 
Table 47: Study design 
 Frequency (n) Percent (%) 
Cross-sectional 4 18,2 
Case-control 0 0,0 
Longitudinal (cohort) 12 54,6 
Cross-sectional and longitudinal 0 0,0 
Pilot study 0 0,0 
Surveillance 0 0,0 
Unclear 1 4,6 
No answer 5 22,7 
Total 22 100,0 
For each of the target groups and corresponding sample sizes, the mean, median and standard 
deviation are presented in Table 48. 
Table 48: Target groups and sample size(s): Mean, m edian and standard deviation 
 Mean Median Standard deviation 
Children 1716 1385 1580 
Adolescents - - - 
Mother-newborn pairs: Mother in the group 34961 3916 56346 
Mother-newborn pairs: Pairs in the group 19504 850 41095 
Adults 1367 951 1206 
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Only 6 of the 22 studies mapped with the literature review reported having qualified or trained 
personnel (Table 49). 
Table 49: Qualified or trained personnel 
 Frequency (n) Percent (%) 
No 0 0,0 
Yes 6 27,3 
No answer 16 72,7 
Total 22 100,0 
Almost 78% of the identified studies obtained ethical approval (Table 50). 
Table 50: Ethical approval 
 Frequency (n) Percent (%) 
No 0 0,0 
Yes 17 77,3 
No answer 5 22,7 
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4.3 Review of books of proceedings of HBM-related c onferences 
For the search in the books of proceedings, which aimed to identify non-published data in peer-
reviewed journals not captured by the online questionnaire, a total of available eight documents 
were reviewed. The complete information summarised for this search can be consulted on the 
HBM4EU wiki. Below is presented the analysis related to the index of potential level of evidence, 
selected from the questionnaire on existing surveys. A total of 58 studies was included. 
Table 51: Books of proceedings reviewed and identif ied studies/projects 
 Date Country 
Number of identified 
presentations 
ISES Interdisciplinary Approaches 
for Health and the Environment 
October 9-13 
2016 Utrecht, The Netherlands 53 
ISEH 2016: The 3rd International 
Symposium on Environment and 
Health 
ISEG 2016: The 10th International 
Symposium on Environmental 
Geochemistry Geoinformatics 
2016: The 24th International 
Conference on Geoinformatics 
August 14-20 
2016 Galway, Ireland 2 
2nd International Conference on 
Human Biomonitoring 
April 17-19 
2016 Berlin, Germany 77 
6th International Conference on 
Medical Geology 
July 26-August 
1 2015 Aveiro, Portugal 7 
7th International Workshop on 
Biomonitoring of Atmospheric 
Pollution 
June 14-19 
2015 Lisboa, Portugal 12 
8th International Symposium on 
Air Monitoring and Biomonitoring, 
France 2014 
June 15-19 
2014 Marseille, France 46 
9th International Symposium on 
Biological Monitoring in 
Occupational and Environmental 
Health 2013 
September 9–
11 2013 Manchester, UK 53 




Paris, France 15 
The distribution of countries where the data were collected / the studies were performed is 
presented in Table 52. Germany is the country with more studies identified through books of 
proceedings (n=23). 
Table 52: Countries where data were collected 
 Frequency (n) Percent (%) 
Austria 3 1,2 
Belgium 10 3,9 
Bulgaria 1 0,4 
Canada 3 1,2 
Croatia 2 0,8 
Cyprus 3 1,2 
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 Frequency (n) Percent (%) 
Czech Republic 10 3,9 
Denmark 9 3,5 
Estonia 2 0,8 
Finland 14 5,4 
France 21 8,2 
Germany 23 9,0 
Greece 10 3,9 
Hungary 3 1,2 
Iceland 3 1,2 
Ireland 2 0,8 
Israel 3 1,2 
Italy 17 6,6 
Latvia 1 0,4 
Lithuania 4 1,6 
Luxembourg 1 0,4 
Netherlands 14 5,4 
Norway 10 3,9 
Pakistan 1 0,4 
Poland 7 2,7 
Portugal 8 3,1 
Russia 2 0,8 
Scotland 1 0,4 
Servia 2 0,8 
Slovakia 7 2,7 
Slovenia 2 0,8 
Spain 17 6,6 
Sweden 15 5,7 
Switzerland 5 1,8 
United Kingdom 18 7,0 
USA 3 1,2 
Total 257 100,0 
Note: Data presented in this table refer to a multiple-choice question. The sum of reported studies does not correspond to the total of 
answers given to the questionnaire (n=124). 
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Unlike what was observed for the results of the survey and the literature review, the majority of the 
studies (46,6%) identified with the review of the books of proceedings had an international 
implementation level (Table 53). 
Table 53: Study/project/activity implementation lev el 
 Frequency (n) Percent (%) 
International 27 46,6 
National 16 27,6 
Regional (province, county, etc.) 12 20,7 
Other 1 1,7 
No answer 2 3,4 
Total 58 100,0 
 
Most of the studies identified through books of proceedings were concluded (Table 54). 
Table 54: Status of the studies/projects/activities  
 Frequency (n) Percent (%) 
Concluded 43 74,1 
Initiated/ongoing 9 15,5 
Planned 1 1,7 
Unclear 5 8,6 
No answer 0 0,0 
Total 58 100,0 
 
In terms of study design, 31,0% of the studies were cross-sectional (Table 55). 
Table 55: Study design 
 Frequency (n) Percent (%) 
Cross-sectional 18 31,0 
Case-control 1 1,7 
Longitudinal (cohort) 11 19,0 
Cross-sectional and longitudinal 1 1,7 
Pilot study 0 0,0 
Surveillance 0 0,0 
Unclear 4 6,9 
No answer 23 39,7 
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For each of the target groups and corresponding sample sizes, the mean, median and standard 
deviation are presented in Table 56. 
Table 56: Target groups and sample size(s): Mean, m edian and standard deviation 
 Mean Median Standard deviation 
Children 2115 812 4247 
Adolescents - - - 
Mother-newborn pairs: Mother in the group 3910 497 7068 
Mother-newborn pairs: Pairs in the group 2160 2160 0 
Adults 1997 1399 2102 
Elderly - - - 
Only 8 of the 58 studies mapped with the review of the books of proceedings reported having 
qualified or trained personnel (Table 57). 
Table 57: Qualified or trained personnel 
 Frequency (n) Percent (%) 
No 0 0,0 
Yes 8 13,8 
No answer 50 86,2 
Total 58 100,0 
Only 36,2% of the identified studies obtained ethical approval (Table 58). 
Table 58: Ethical approval 
 Frequency (n) Percent (%) 
No 0 0,0 
Yes 21 36,2 
No answer 37 63,8 
Total 58 100,0 
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5 Main conclusions 
In the last decades there has been a growth in scientific production in the HBM area. This was due, 
among other reasons, to the increasing use of new biomarker techniques – with focus on 
environmental exposure, susceptibility and effect – and to the effort of national authorities which 
started to apply HBM in population surveys designed to monitor exposure levels to environmental 
chemicals in the general population1. However, in a sea of information, where different studies 
focus on particular aspects and on specific substances, there is still a need to develop suitable 
methods for systematic mapping of available evidence and identification of research gaps. 
The use of a triangulation of methods for Task 7.1 – including an online survey, a review of the 
available literature via publication in peer-reviewed journals and a literature search within HBM-
related books of proceedings – enabled the creation of an inventory of concluded, ongoing or 
planned HBM studies and biobanked samples. 
As shown in the figure below, different methods provided distinct complementary information on 
the existing HBM surveys. In fact, only 18 projects were identified by all three approaches. On the 
contrary, a large number of studies were identified by one of the methods: 92 unique studies 
identified solely with the online questionnaire, 22 with the literature review and 58 with the review 
of the books of proceedings. In total, 206 different studies were identified through the three 
approaches. 
 
Figure 6 : Number of identified studies by type of approach  
Still, there was a difference between the number of answer/registers to the questionnaire or 
articles/abstracts identified through literature review/conference books  and the number of 
identified studies with each of the three approaches (Figure 7). For the reviews of the books of 
proceedings, this considerable difference is related to the fact that not all of the selected and 
analysed papers make explicit the included studies, but only vaguely comment on them. 
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Figure 7: Number of answer/registers and of identif ied studies by type of approach 
5.1 Identification of existing data and data gaps 
Overall, it was possible to draw several conclusions with regard to the existing data and data gaps 
(geographical and temporal) with the work developed for task 7.1: 
 There is an asymmetry in terms of countries/regions where the identified studies on HBM have 
been developed with Belgium (15,3%), Italy (12,1%) and Spain (8,1%) being the countries 
where the data collection occurred more frequently if only the data collected with the 
questionnaire directed to the NHCPs is considered. This does not necessarily mean that there 
is an unevenness of scientific production but might reflect an under-representation in the studies 
carried by specific countries, a trend that was verified throughout the three approaches used. 
Although maintaining the asymmetry, the results change when considering the studies identified 
using the other two approaches: for the studies of the literature review, data was mainly 
collected in Denmark (21,6%) and Norway (18,9%), while for the review of the books of 
proceedings data was predominantly collected in Germany (9,0%), France (8,2%) and United 
Kingdom (7,0%). Taking all three approaches together, Belgium and Italy appear as the 
countries with more cases (n=36).  
 Most of the reported studies identified with the questionnaire had a regional (45,5%) or national 
(39,9%) scope while studies from the literature review had mainly a regional implementation 
level (54,5%). In the case of the studies from the review of the books of proceedings, they had 
mainly an international level of implementation (46,6%). Taking all three approaches together, 
studies with regional and national implementation level are the most frequent, with 90 and 76 
cases, respectively. 
 Although the majority of the studies identified with the three approaches were already concluded 
or initiated/ongoing, a pattern consistent by European region, it was possible to map nine 
projects with the questionnaire and one with the review of the books of proceedings in their 
planning stage.  
 The majority of the work that has been developed in the HBM area relates to cross-sectional 
(46,8%) and longitudinal (37,9%) studies as shown in the results of the questionnaire. The other 
two approaches also point into this direction: 54,6% of the studies of the literature review had a 
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longitudinal design and 31% of the studies of the review of the books of proceedings was cross-
sectional. 
 Children and adults are the main target population of the studies/projects/activities identified 
through questionnaire, literature review and books of proceedings. 
 The analyses of the nine groups of substances under study revealed differences in terms of the 
number of projects dedicated to each substance (the most studied substance is cadmium, in 55 
projects, followed by phthalates in 42 of the cases and bisphenols in 36), being most marked 
the absence of studies on the anilin family reported through the questionnaire as well as very 
few studies, 5 and 6, on Cr VI and emerging chemicals, respectively. The undertaken literature 
reviews and study of the books of proceedings did not provide an additional understanding of 
this difference. 
 An analysis of data collected with the questionnaire by European-defined region reveals that in 
the North (56,0%) and East (56,3%), the most studied substances were phthalates/DINCH, 
whereas in the West (52,3%) and South (55,8%) was cadmium. 
 Considering the groups of substances distributed by European-defined region, age groups and 
status of the studies/projects/activities undertaken in the community (general population), the 
following was found: the reported studies were mostly concluded, the majority of them had 
adults and children as target population, cadmium as the main substance under study, and they 
were mostly conducted in Southern and Western regions of Europe. 
 For the studies/projects/activities reported as having a national representativeness level, the 
majority involved children and newborns. In studies with children, the most analysed substances 
were cadmium, flame retardants, bisphenols and phthalates. For those studies with newborns, 
the main substances under study were flame retardants. In both cases, these studies were 
mostly conducted in Western Europe. 
 Considering e.g. the results of the questionnaire, it was possible to verify that there is a variety 
of biological samples collected (mainly blood in 83 of the cases, serum in 53 and urine spot 
sample-first morning also in 53 of the studies), with many projects having several of those 
samples stored (15,1% of the stored samples are blood, 12,3% are serum and 11,1% are 
plasma and urine spot sample – first morning) and some of them available for access and/or 
use of other researchers/organisations. The literature review and the study of the books of 
proceedings did not provide such detailed information. 
 Analyses of the studies/projects/activities (general population) with urine samples and blood by 
group of substances, region and age groups, the largest number of studies are from Western 
and Northern regions. Concerning the target population and substances under study, the focus 
is on children and phthalates, respectively. 
 Information about several biomarkers, HBM samples, clinical parameters, anthropometric data, 
physiological indicators, outdoor pollution and occupational exposure has been collected with 
the questionnaire. 
 As for biobanked samples, a majority of the projects allow (partial) access to the database of 
non-biological data and have available for the HBM4EU partners the questionnaire used for 
data collection. 
 The concept of “quality criteria” to classify the studies/projects/activities was altered to “criteria 
that index a level of evidence” given the fact that there is a pre-assumption that all projects have 
internal validity and, therefore, quality. For building up overall pictures about collected data and 
information it is more important to know how potentially strong is the collected (or to be 
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collected) evidence. An overarching appreciation of the potentially produced (or to be produced) 
evidence by each study/project/activity found through the questionnaire revealed that almost 
half of them have characteristics that can make them of high or very high level which reveals 
the robustness of the results. 
 A list of metadata available to be uploaded into IPCheM is presented with this report and in a 
separate SPSS and Excel database, being nearly 20% of the reported data accessible for use. 
For European representative studies, a deeper data analysis of spatial and temporal data gaps 
will be done by VITO in WP 10 and Task 7.2 to obtain a deeper look into the data with access to 
individual data and to define which data shall be available to report about European 
representativeness. 
 The categorisation of the single compounds into the categories A-C is not addressed in this 
report and will be done by the CGLs under task 4.4 scoping documents. 
5.2 Strengths and limitations 
Biomonitoring data can provide much-needed information on exposure to a variety of 
environmental chemicals. However, the interpretation of existing biomonitoring data requires 
rigorous, scientific approaches to data collection, analysis, interpretation, and application. In this 
context, the use of a multi-methods approach was determinant for comprehensive gathering of 
research data and conclusions, enabling the identification of non-published studies, projects and 
activities that would be otherwise missed. 
With the consultation of the NHCPs from the countries included in the consortium through an 
online survey, in articulation with literature reviews, it was possible to identify, in a more complete 
manner, otherwise unreachable geographical and temporal data gaps in this area. To note that, for 
the majority of the analised data, the general patterns obsereved were consistent when the 
analyses were stratified by European-defined region, target population and groups of substances. 
Considering the large geographical coverage and the comprehensiveness of the collected data, we 
think that the potential of this work to inform the work to be developed by other work packages is 
wide. 
Nonetheless, we should envisage some of the limitations of such work as the one included in Task 
7.1. With regard to the questionnaire, the period for data collection was limited in time. After that, 
we kept receiving requests from different institutions to fill in the survey. This highlights the need to 
continuously update the information about HBM to ensure the sustainability of initiatives such as 
HBM4EU. The adaptation of the questionnaire into a repository continuously open might represent 
an alternative to keep an updated inventory of the work developed in the HBM realm. 
Moreover, a very diverse information was collected with the survey. Given the need to include 
more questions for other tasks/WPs, although comprehensive, the questionnaire was also very 
extensive. For this reason, it was not possible to check the obtained data from the NHCPs for 
plausibility or correctness. 
Other limitations relate to the fact that altough with a systematic map of the literature review 
process, this was done by different partners from several institutions on a given substance. As 
such, the interpretation of the data should be done with caution. Furthermore, numerous 
conferences have taken place in the last ten years but only a small part were captured in the 
review, notwithstanding the efforts to identify the several editions of a given conference. As a 
matter of fact, not all of the conferences have their books of proceedings available for consultation 
to the general public. 
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For the review of the books of proceedings, it was difficult to identify the project presented in a 
given abstract since the information was scarce or incomplete (most abstracts in the proceedings 
were only 250-300 words long). The same limitation is encountered within the literature review, 
where several papers were identified but only a small number made reference to a specific 
study/project/activity. 
Finnaly, we found some difficulties when compiling in a complete inventory the data collected 
through the three different approaches since some crucial information was missing for several 
studies/projects/activities. Further, an additional search for information in the grey literature was 
insufficient to complement the missing data: several project websites were disabled or outdated, 
others had few information not easily accessible and in cases where the information was spread 
among different website there were conflicting data available. Even so, an important basis to 
inform further research needs in this realm and to contribute to more targeted policy measures was 
laid, thus contributing to the overarching goal of the HBM4EU of generating knowledge to inform 
the safe management of chemicals and so protect human health. 
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Main questionnaire on existing surveys 
 
 
Section A: 1. GENERAL INFORMATION
Next, you will be asked regarding studies, projects or activities that were concluded (within last 10 years), ongoing or planned
(for starting up within the next 5 years), targeting any of the nine prioritised substances. Please provide information for one
study/project/activity at a time. If you have been involved in more than one, please access a new questionnaire for each
study/project/activity.
You will not have to answer the entire questionnaire. It is done in a way that you will only have to answer the parts that
specifically apply to the study/project/activity you are describing.
Please note that the questionnaire allows you to save the form at and resume it afterwards, at any moment, for completing the
missing information. Like that, you can fill it in in different moments, at your convenience, and not be obliged to complete it at
once.
A1. Identification of HBM study/project/activity name
Please indicate the name and acronym (if any) of the HBM activity. If
the name of the study/project/activity is not defined in English, please
provide an English translation of it.
Please indicate the name and acronym of the institution whenever possible.
Name
Acronym





Development of tools / guidelines / training materials
Quality Control / Quality Assurance




A3. Study/project/activity implementation level
If you want to answer "Other (Please specify)", please write your answer in the blank space (this will automatically select the option).
International
National
Regional (province, county, etc.)
Other (Please specify)
Other (Please specify)










































A6. Institution responsible for the study/project/activity implementation
Please indicate name, acronym (if any) and country of the institution
Name of the institute
Acronym
Country
A7. Type of the Institution










A9. Name of the Principal Investigator
A10. Contact person 1


























A15. Other institution(s) involved








A17. Other institution(s) involved 2








A19. Other institution(s) involved 3








A21. Other institution(s) involved 4








A23. Other institution(s) involved 5




A24. General objectives of the study/project/activity
A25. HBM specific related-objectives of the study/project/activity
A26. Status
 
Concluded (within the last 10 years)
Initiated/ongoing
Planned (for starting within the next 5 years)
A27. Beginning (or previewed starting) date of the study/project/activity
Please indicate the date of the starting up of the study/project/activity (including planning and organization steps – not considering only the
fieldwork schedule)
A28. (Previewed) Ending date of the study/project/activity 
(if applicable)
A29. Budget of the project/study/activity
Please indicate the total budget, to the nearest thousand Euros








Please indicate if the study/project/activity was/will be approved by an















A34. Internet link with information about data collection tools
Please insert an internet link or links (separated by semicolon) with information about the tools used for datta collection
Section B: 2. DESCRIPTION OF THE TARGET POPULATION AND
METHOD OF SELECTION OF PARTICIPANTS
Please indicate (checking all that apply) the target population and the sampling details of this HBM study/project/activity.
Target groups and respective sample size(s)
Please consider the following target groups: children, adolescents, mother-newborn pairs, adults, elderly, other specific population
(smokers, workers, disabled, ...). Next, for each group (if applicable), you will be asked about age limits and size of the sample.
Inclusion criteria
Please check all that apply in the following options
 
Exclusion criteria
Please check all that apply in the following options 
 
Inclusion criteria of control group
Exclusion criteria of control group
Consent procedures








B2. Type of target population
 





Lower limit of age
Upper limit of age
Sample size (number of participants)
B4. Adolescents
Lower limit of age
Upper limit of age
Sample size (number of participants)
B5. Mother-newborn pairs
Lower limit of mother's age
Upper limit of age mother's age
Lower limit of newborn's age
Upper limit of newborn's age
Number of mothers in the group
Number of pairs in the group
B6. Adults
Lower limit of age
Upper limit of age
Sample size (number of participants)
B7. Elderly
Lower limit of age
Upper limit of age
Sample size (number of participants)





B10. Other specific population specified above
Lower limit of age
Upper limit of age
Sample size (number of participants)






































































































































Stratified (e.g., by sex, age groups, educational level, regions, etc.)
Other (Please specify)
Other (Please specify)
B39. Please, provide a short description of your sampling
scheme (sampling units, stratification procedure, etc.)






Health or other type of professionals’ list
Other type of population register
Health archives
Participants from another study (e.g. a health examination study)
Other (Please specify)
Other (Please specify)
B41. Recruitment contact 
Through general practitioner (GP) doctors (inviting patients)
Through paediatricians (inviting patients)
Through gynaecologists (inviting patients)
Through other medical doctors (inviting patients)
Through midwives (inviting patients)
Through nurses (inviting patients)




Internet (social networks, …)
Door to door
Street contact
Direct contact (e.g., waiting room, hair dressers, …)
Other (Please specify)
Other (Please specify)





B43. At what level (which universe/population – e.g., at national level, at
regional level, …)? 







Until the number of participants/samples are recruited/collected
Other (Please specify
Other (Please specify
B45. Type of consent form
Participants’ written informed consent




B46. Scope of the informed consent
Participants gave informed content for usage of data only within the context of this
study/project/activity
Participants gave broader consent (data can be used for other studies, projects, activities)
Other details (Please specify)
Other details (Please specify)









Main individual results (participation feedback)
Newsletter to participants
Educational package on Environment and/or Health
Medical examination
Additional health monitoring
Medical advice and help
Other (Please specify)
Other (Please specify)
B48. If you slected "financial compensation" above, please specify the type
of incentive (e.g., reimbursement of travel expenses, before or after
participation, amount, …)
Section C: 3. FIELDWORK AND DATA COLLECTION
Please indicate (checking all that apply) the fieldwork details and the methods used to obtain data.
Period of data collection
C1. Beginning date
C2. Ending date
C3. Mode of data collection
Face-to-face interviews (including biological sample collection, anthropometric measurements, …)
Face-to-face interviews (neither with biological sample collection nor anthropometric measurements,
…)
Telephone interview
Computer-Assisted Telephone Interview (CATI)





C4.  In case of face-to-face administered questionnaire or phone





C5. In case of face-to-face data collection, which is/was/will be the place
where the interview is/was conducted?
At participants’ home
At an examination centre
At a mobile lab
In a hospital/maternity
In a clinic
In a primary health centre











Yes, it is available to any researcher
Yes, only to HBM4EU partners













Urine (spot sample - random)









C8. Group/s of substances under study
Please indicate (checking all that apply) the group/s of substances studied.
Phthalates /DINCH (Please specify, including if possible the CAS-number)
Bisphenols (Please specify, including if possible the CAS-number)
Per-/Polyfluorinated compounds (Please specify, including if possible the CAS-number)
Flame Retardants (Please specify, including if possible the CAS-number)
Cadmium
Chromium VI
PAHs (Please specify, including if possible the CAS-number)
Anilin family: Anilines, MOCA (Please specify, including if possible the CAS-number)
Chemicals mixtures (Please specify, including if possible the CAS-number)
Emerging chemicals (Please specify, including if possible the CAS-number)
Other (Please specify, including if possible the CAS-number)





Number of analysed samples:
Number of samples below LOD:








Number of analysed samples:
Number of samples below LOD:
Number of samples below LOQ:
Exposure range:
Analytical method:





Number of analysed samples:
Number of samples below LOD:
Number of samples below LOQ:
Exposure range:
Analytical method:





Number of analysed samples:
Number of samples below LOD:








Number of analysed samples:
Number of samples below LOD:
Number of samples below LOQ:
Exposure range:
Analytical method:





Number of analysed samples:
Number of samples below LOD:








Number of analysed samples:
Number of samples below LOD:
Number of samples below LOQ:
Exposure range:
Analytical method:





Number of analysed samples:
Number of samples below LOD:
Number of samples below LOQ:
Exposure range:
Analytical method:





Number of analysed samples:
Number of samples below LOD:
Number of samples below LOQ:
Exposure range:
Analytical method:





Number of analysed samples:
Number of samples below LOD:
Number of samples below LOQ:
Exposure range:
Analytical method:





Number of analysed samples:
Number of samples below LOD:
Number of samples below LOQ:
Exposure range:
Analytical method:










































































C31. Wich data was collected regarding respiratory/lung parameters?
Diary of lung symptoms







































C37. Does the study/project/activity collect data regarding reproductive




C38. Sexual maturation and function
Testicular volume in boys































C43. Wich data was collected regarding immunity?
Immune system effects
Innate Immunity activity
Acquired Immunity activity - Humoral
Acquired Immunity activity - Cell mediated
Acquired Immunity activity - Clinical expressions





Other (Please specify) 
Other (Please specify)
C45. Wich data was collected regarding cell-mediated immunity?
T cell response
Other (Please specify) 
Other (Please specify)
C46. Wich data was collected regarding clinical expressions immunity?
Sensitivity
Allergic reaction
Other (Please specify) 
Other (Please specify)




















C50. Behavioural and other neurological assessments






















C53. Does the study/project/activity collect anthropometric data? (Not












C55. Does the study/project/activity collect data regarding other





























C57. Individual recruitment procedure
Please describe the individual recruitment procedure (e.g.: Invitation letter, reminder letter, confirmation letter, sending of sample vessels, personal
visit for interview)
Section D: 4. OTHER DATA
Please indicate (checking all that apply) items such as outdoor pollution, climate, etc., addressed within this HBM
study/project/activity.ENVIRONMENTAL DATA
LIFESTYLE

































D4. Airborne nanoparticle identification
Trace elements / minerals
Other (Please specify)
Other (Please specify)


































D10. Which data was collected regarding outdoor climate?




















Number of years living in this residence
Number of hours in the residence (working days)
Number of persons living in the household
Number of siblings
Year of construction of the building
Urban/rural
Pollution sources near residence
Other (Please specify)
Other (Please specify)





Type of dwelling (e.g., apartment, house, …)

































































Dust from vacuum cleaner
Deposited dust in the household
Other (Please specify)
Other (Please specify)





















Food Frequency Questionnaire (FFQ)
Other method of assessment (Please specify)
Other method of assessment (Please specify)









D24. Which data was collected regarding about traffic exposure or
mobility?









D26. Which data was collected regarding the participants’ personal
hygiene?
Oral hygiene
Frequency of washing hands
Frequency of shower
Use of cosmetics
Use of tanning beds
Other (Please specify)
Other (Please specify)



















Active smokers in the family
Active smokers at working place
Daily Average duration of exposure
Other (Please specify)
Other (Please specify)













































D38. Hobbies and holidays
Time spent away from the place of residence











D40.  Which data was collected regarding other lifestyle aspects?



















D45. Other family members?
Other than grandparents, parents or siblings
Please specify









































































































































Premature rupture of membranes









D59. Which data was collected regarding pregnancy or delivery?
Health before and during pregnancy












D60. Which data was collected regarding foetal ultrasound?
Body proportions
Placental function
Organ development (brain, heart, kidney, …)
Other (Please specify)
Other (Please specify)



















D63. Please specify the moment of measurement of the APGAR score






































D71. Which data was collected regarding pregnancy and delivery?






D72. Which data was collected regarding breastfeeding?
Duration of breastfeeding














Occupational exposure to Phthalates / DINCH
Occupational exposure to Bisphenols
Occupational exposure to Per-/Polyfluorinated compounds
Occupational exposure to Flame Retardants
Occupational exposure to Cadmium
Occupational exposure to Chromium VI
Occupational exposure to PAHs
Occupational exposure to Anilin family: Anilines, MOCA
Occupational exposure to Chemicals mixtures
Occupational exposure to Emerging chemicals
Other (Please specify)
Other (Please specify)






Number of cigarettes, cigars or pipes smoked in the house




D77. Does the study/project/activity collect data about medication during


















D81. Other (Please specify)
D82. Does the study/project/activity collect data about medication




D83. Which data was collected regarding medication administered to or
taken by children or adolescents?
History of medication of child
Antibiotics by the infant
Antibiotics by the child
Drug use of the adolescent
Other (Please specify)
Other (Please specify)
D84. Does the study/project/activity collect data about permanent or acute




D85. Which data was collected regarding permanent or acute medication























Presence of extended family in the house
Other (Please specify)
Other (Please specify)







Educational level of parents
Educational level of children
School achievements of child attending school
Other (Please specify)
Other (Please specify)







Please specify any additional data not covered in the above questions
Section E: 5. QUALITY CONTROL PROCEDURES




National external Quality Assessment Schemes
E1. Pre-analytical Quality Assurance/Quality Control (QA/QC)
Standard Operating Procedures
Trained fieldworkers
Control of background contamination in the sampling material
Control of the transport conditions
Control of background contamination in the conservation material
Identification/traceability of the samples
Criteria for acceptation/rejection of the samples
Use of field blanks
Setting the conditions for sample storage
Other (Please specify)
Other (Please specify)
E2. Identification of critical phases
Quality control samples






Internal proficiency testing (blind samples)
Reporting of analytical data
Other (Please specify)
Other (Please specify)
E3. Quality control procedures - Internal quality control procedures
Routine checking of equipment
Routine calibration of equipment
Routine checking of culture media
Routine checking of water




E4. Quality control procedures - Standard operating procedures
Sample preparation
Analytical methods
Storage and retention of records and materials
Other (Please specify)
Other (Please specify)




Use of reference materials
Training according to detailed manual
Use of standard laboratory / uniform methods
Waste disposal
Use of commercial standards of precision and accuracy
Other (Please specify)
Other (Please specify)
E6. Quality control procedures - Intra-laboratory tests
Sampling instruments
Sample measurements
E7. Quality control procedures - Other data collected
E8. Other inter / intra laboratory testing
Calibration according to manufacturer’s instructions
Inter-laboratory assessment for dioxin-activity
Field duplicates
Field blanks
Field visits of supervisors
















Duplicate analysis, through different methods
Inter-laboratory comparison exercises




Inspection of non-accredited laboratories
Accredited laboratory
Accredited for certain analysis






















E15. Specify other national external quality assessment schemes
Section F: 6. DATA ANALYSIS































Multiple logistic regression analysis
Other (Please specify)
Other (Please specify)
F7. Other type of analyses (Please specify)
Section G: 7. DATA PROTECTION, AVAILABILITY AND CONDITIONS OF
ACCESS AND USE
Please indicate (checking all that apply) the conditions for data protection and availability of data and samples for this HBM
study/project/activity.DATA PROTECTION
Methods to protect personal data
NON-BIOLOGICAL DATA - CONDITIONS OF ACCESS AND USE
BIOLOGICAL SAMPLES - AVAILABILITY AND CONDITIONS OF ACCESS AND USE (for exposure research
and/or effect biomarker identification)
BIOMARKERS AND OTHER PARAMETERS - CONDITIONS OF ACCESS AND USE











G3. At data storage
Databases protection
Deleted/destroyed at the end of the study
G4. At data storage - databases protection 




G5. At data storage - Deleted/destroyed at the end of the study
When? (Please specify)




Data available to other members of consortium





No access is possible
Partial access to database
Access to total database
G8. Please indicate the type of access
Direct online access - Please indicate website
By request - Please indicate how to apply the request




G10. Type of biological samples / matrix 
Blood
Blood erythrocytes










Urine (spot sample - random)








G11. Please specify the other biological sample mentioned above
G12. Please download, fill out and upload the excel sheet bellow and
continue with the following questions.
Click to download the excel sheet
Please fill out the excel with information regarding: sample type/matrix, number of available samples, type of supplement, type of sample
container, volume of sample container, material of sample container, cleaning of sample tubes before use, sample labeling, storage duration and
storage conditions.
You should provide information on those topics for one substance per line. For example, if you select blood on the first column of the first line,
with should provide the rest of the information regarding that sample in the columns of the first line.
G13.  Access and use of biobanked samples
 
No access at all
Access (only for consultation) for other researchers/organizations
Access and use for other researchers/organizations
G14. Access to analytical standards to detect biomarkers
 
No access at all
Access for other researchers/organizations
G15. Access and use of biomarkers and other parameters
IPCheM : the Information Platform for Chemical Monitoring is a single access point at EU level for discovering chemical monitoring data
collections with one module containing HBM data
 
No access at all
Access for IPCheM* (only for consultation)
Access (only for consultation) for other researchers/organizations
Access and use for IPCheM
Access and use for other researchers/organizations
G16. Aggregation level of data 
Metadata
Aggregated data (Please specify: by gender, age groups, population type, …)
Filtered/generalized single measurement data with key parameters
Single measurement data with additional relevant parameters
G17. Licence of use (Please specify)
Please provide a description or a reference to the Licence (i.e. type of limitations, if any, to use the resource) adopted by data owner/provider to
use and re-use the data available
G18. Access conditions
Please summarise the restriction (if any) in data access (e.g. access restricted only to EY Commission and EU agencies, …)
G19. Text for acknowledgement /disclaimer
Please specify a text for acknowledgement/disclaimer which should be reported when using the data
Section H: 8. COMMUNICATION
Please indicate (checking all that apply) communication elements of this HBM study/project/activity.
Reporting results to Public Authority, to general public, to scientific community
Public debate




H2. Please indicate the Public Autority(s) to whom the results where
reported 
EU authorities - Please indicate frequency
National authorities - Please indicate frequency
Federal authorities - Please indicate frequency
Local authorities - Please indicate frequency
Other - Please specify and indicate frequency




H4. Please indicate how results were reported to the study's participants
Personalized Reports
Individual results compared with health guideline values
Participant referred to appropriate help if problem was identified





















H8. Please indicate how the results were reported to the scientific
community
Published through report form
Results published in book of proceedings









H9. Please indicate the report form where the results were reported
H10. Relevant publications (Pubmed and/or other scientific databases
engines)
Please indicate a “www.pubmed.com” (or other scientific databases engine) link to some of the study/project/activity most relevant publications (if
such exist) that covers health and HBM outcomes in a broadest sense




H12. Please indicate how the results were reported to the general public




Meeting in local inhabitants
Public debate at the end of project
Other (Please specify)
Other (Please specify)













H16. Consequences of external communication
Public awareness
Separation between research and policy
Screening tests for segments of population
Increase in visits to specialized MD
Increase in visits to laboratories
Legislation improved
Statement from public authority
Greater incentive to participate
Clean-up of contaminated areas
Other (Please specify)
Other (Please specify)
H17. Would you be willing to provide some examples of material used to




Section I: 9. OBSTACLES, SHORTCOMINGS AND DIFFICULTIES
Please indicate (checking all that apply) obstacles, shortcomings and difficulties faced in this HBM study/project/activity.
Difficulties in samples’ collection
I1. General constraints and difficulties
Financial (Please specify)




I2. Collection of blood samples (Please specify)
Fear of pain (from participant)
Concern about consequences (from participants’ perspective)
Time-demand (for participants)
Non-interest (from participants)
Other difficulty (Please specify)
Other difficulty (Please specify)
I3. Collection of fat samples (Please specify)
Fear of pain (from participant)
Concern about consequences (from participants’ perspective)
Time-demand (for participants)
Non-interest (from participants)
Other difficulty (Please specify)
Other difficulty (Please specify)
I4. Physical examinations (Please specify)
Fear of pain (from participant)
Concern about consequences (from participants’ perspective)
Time-demand (for participants)
Non-interest (from participants)
Other difficulty (Please specify)
Other difficulty (Please specify)
I5. Other type of samples’ collection (Please specify) 
Fear of pain (from participant)
Concern about consequences (from participants’ perspective)
Time-demand (for participants)
Non-interest (from participants)
Other difficulty (Please specify)
Other difficulty (Please specify)





I7. Regarding low participation level please specify
For migrants
For lower social classes
For single working mothers
For other group of participants (Please specify)
For other group of participants (Please specify)




Other (Please specify) 
Other (Please specify)
I9. Which of the following strategies you consider to be relevant for
increasing response rate
Focusing the sampling on groups with expected higher participation rate
Use of new and more direct/personal means of approaching people
Financial or other incentives
Cooperation with other studies, with governmental bodies
Participatory research ("citizen science")
Recruitment bias (Please specify)
Recruitment bias (Please specify)
I10. Other identified problems
Logistics
Team leadership
Burden of data collection
Lack of international guidelines
Lack of international standardisation
Nomenclature problems
High volume of collected information
No access to data
Other (Please specify)
Other (Please specify)
I11. Please specify the problems with logistics
I12. Please specify the problems with team leadership
Section J: 10. ADDITIONAL INFORMATION
J1. Please add any relevant information collected that was not covered by
the questionnaire.




This project has received funding from the European Union’s 
Horizon 2020 research and innovation programme under grant 
agreement No 733032. 














QUESTIONNAIRE ON OCCUPATIONAL EXPOSURE 
 
Within the scope of the European Human Biomonitoring Initiative (HBM4EU) and the work that 
has been developed for Work package 7 – Survey design and fieldwork preparation, the 
Universitá Degli Studi Di Napoli, the Constantine The Philosopher University In Nitra, and the 
Finnish Study of Occupational Health, in collaboration with the Faculty of Medicine of the 
University of Lisbon (FMUL), are creating an inventory of studies targeting occupational 




Because you are, or have been, actively involved in the fields (or related fields) of "Human 
biomonitoring" and “Occupational exposure” in your country/institution and in studies 
building the background of the HBM4EU project, we would appreciate if you could provide us 
information on the existence and availability of data pertaining to work-related exposure. 
 
We need to collect and analyse these data up till the end of April. Therefore, may we kindly invite 
you to complete the following form no later than by April 10, 2017. 
 
We also ask you to forward this form (using the following link http://hbm4eu.info/) to all 
persons/institutions that are active in the field of "Human biomonitoring" and “Occupational 
exposure” in Europe. 
 
Thank you for your collaboration! 
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Section 1 Proponent Institution/Organisation of the study 
 
1.1 Name of the Institution/Organisation:  
 
1.2 Nationality:  
 
1.3 Type of the Institution/Organisation: 
Public Private University Other
 
 
1.3.1 If other please specify  
 






Section 2 Characteristics of data 
 
2.1 Type of study (i.e. existing database, single study, other) 
 
2.2 Time frame or years covered 
 
2.3 Country and geographical area 
 










Next, if applicable, please give substance- specific answers from Section 3 to Section 6 or modify 
the Sections accordingly. 
 
Section 3 Study population 
 
Please give substance-specific answers when necessary. 
 
3.1 Occupationally exposed subjects (please provide information on age, gender, …) 
 
 













3.3.1 Selection of participants 
The whole unit
 
Random sample of the unit
 




Random sample of the enterprise
 

















Section 4 Characteristics of the study population 
 
Please give substance-specific answers when necessary. 
 
4.1 The characteristics of the study population were obtained by means of: 





4.1.1 If other please specify  
 
4.2 In the case of face to face or phone interview and administered questionnaire the information 














4.3.1 If other please specify  
 
 
4.4 Availability of data related to: 
Please give substance-specific answers when necessary. 
4.4.1 Age       
Yes No
 
4.4.2 Sex       
Yes No
 





4.4.4 Home location and related characteristics  
Yes No
 
4.4.4.1 Urban or rural    
Yes No
 
4.4.4.2 Industrial plants, incinerators or  
Yes No
 
landfill sites in the surroundings of house   
4.4.4.3 Vehicular Traffic Density   
Yes No
 
4.4.5 Presence of prosthesis or dental alloys  
Yes No
 
4.4.6 Smoking status     
Yes No
 
4.4.7 Alcohol consumption     
Yes No
 
4.4.8 Coffee consumption     
Yes No
 
4.4.9 Dietary habits  (mixed, vegetarian, vegan)  
Yes No
 
4.4.10 Physical exercise     
Yes No
 
4.4.11 Use of pharmaceuticals    
Yes No
 
4.4.12 Recreational activities or hobbies   
Yes No
 









Section 5 Occupational exposures 
 
Please give substance-specific answers when necessary. 
 
5.1 Type of industry (i.e. chemical, construction, pharmaceutical, cosmetics, health care, other) 
 
 
5.2 NACE Classifications 
 
 
5.3 Brief description of working cycle and chemicals/substances produced, used or handled: 
 
 
5.4 Availability of data related to: 
 
5.4.1 Working tasks/activities performed    
Yes No
 
by subjects enrolled in the study 
5.4.2 Length of work shift     
Yes No
 
5.4.3 Type of work shifts (i.e. fixed or rotational)  
Yes No
 
5.4.4 Occupational history     
Yes No
 
5.4.5 Use of personal protective equipment   
Yes No
 
5.4.6 Environmental monitoring (air samples from workplace) 
Yes No
 











Section 6 HBM data 
 
Please give substance-specific answers when necessary. 
 
6.1 Type of biological sample 
 
 
6.2 Investigated chemicals 
 
 
6.3 Investigated metabolites 
 
 
6.4 Analytical method: 
 
 
6.5 Time of sampling (i.e. pre-shift, end-shift, end-shift end week, other) 
 
 
6.6 At the time of sampling how much time has elapsed since the last supposed exposure (end of the 
shift)? 
< 6h 6-12h 12-18h 18-24h 24-48h > 48h
 
 


















7.4 Analysis method 
 








7.7 Additional comments 
 
 
Thank you for your collaboration! 
 
CONTACTS 
Institute of Environmental Health (ISAMB), Faculty of Medicine, University of Lisbon (FMUL) 
Av. Professor Egas Moniz, 1649-028 Lisboa 




This project has received funding from the European Union’s 
Horizon 2020 research and innovation programme under grant 
agreement No 733032. 











STATISTICAL ANALYSIS PLAN 
~ Questionnaire on existing HBM surveys ~ 
 
This document summarizes the plan for the statistical analysis of the data collected with the questionnaire on existing HBM surveys developed for Work 
package 7 – Survey design and fieldwork preparation. This questionnaire aimed to map concluded (within last 10 years), ongoing or planned (for starting up 
within the next five years) studies, projects and activities related to the nine prioritised substances. The main goal is to identify data gaps (including spatial 
and temporal gaps). 
In the following table, the strategy for reporting univariate statistics is discussed for each variable. Besides the aggregated report, variables that will allow the 
characterization of the surveys will be available in Access format. Like that, it will be possible to consult all necessary descriptive details per study, project or 
activity, with an easy-to-navigate form of variables selection. 
The table is structured in five columns: 
 Variable name: The name of the variable in the database 
 Label: The description of the variable (correspondes to the label of each variable on the databases 
 Question: The original question that appeared in the questionnaire 
 Values and codes: The options each variable can assume in the databases 
 Analysis: The planned statistical analysis to follow for each variable 
 
 
VARIABLE NAME LABEL QUESTION VALUES AND CODES ANALYSIS 
id Response ID    
submitdate Date of submission    
1. GENERAL INFORMATION 




q1.1.acronym Acronym of the study/project/activity 
q1.2.1 Study/project/activity type: Research project 
Human biomonitoring 
(HBM) type 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 





q1.2.3 Study/project/activity type: Policy / Legislation 
q1.2.4 
Study/project/activity type: Development of 
tools / guidelines / training materials 
q1.2.5 
Study/project/activity type: Quality Control / 
Quality Assurance 
q1.2.6 
Study/project/activity type: Improving Health 
Services delivery infrastructure 
q1.2.7 Study/project/activity type: Health promotion 
q1.2.other Study/project/activity type: Other 
q1.3.1 




No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q1.3.2 
Implementation level of the 
study/project/activity: National 
q1.3.3 
Implementation level of the 
study/project/activity: Regional (province, 
county, etc.) 
 
VARIABLE NAME LABEL QUESTION VALUES AND CODES ANALYSIS 
q1.3.other 
Implementation level of the 
study/project/activity: Other 
q1.4.1 Country/countries of data collection: Austria 
Country/countries where 
data were/are/will be 
collected 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
 
The variable representing the open 
category “other” will be recoded into 
extra values and analysed apart 
(descriptive analysis – frequency table) 
q1.4.2 Country/countries of data collection: Belgium 
q1.4.3 Country/countries of data collection: Bulgaria 
q1.4.4 Country/countries of data collection: Croatia 
q1.4.5 Country/countries of data collection: Cyprus 
q1.4.6 
Country/countries of data collection: Czech 
Republic 
q1.4.7 Country/countries of data collection: Denmark 
q1.4.8 Country/countries of data collection: Estonia 
q1.4.9 Country/countries of data collection: Finland 
q1.4.10 Country/countries of data collection: France 
q1.4.11 Country/countries of data collection: Germany 
q1.4.12 Country/countries of data collection: Greece 
q1.4.13 Country/countries of data collection: Hungary 
q1.4.14 Country/countries of data collection: Ireland 
q1.4.15 Country/countries of data collection: Italy 
q1.4.16 Country/countries of data collection: Latvia 
q1.4.17 Country/countries of data collection: Lithuania 
q1.4.18 
Country/countries of data collection: 
Luxembourg 
 
VARIABLE NAME LABEL QUESTION VALUES AND CODES ANALYSIS 
q1.4.19 Country/countries of data collection: Malta 
q1.4.20 
Country/countries of data collection: 
Netherlands 
q1.4.21 Country/countries of data collection: Poland 
q1.4.22 Country/countries of data collection: Portugal 
q1.4.23 Country/countries of data collection: Romania 
q1.4.24 Country/countries of data collection: Slovakia 
q1.4.25 Country/countries of data collection: Slovenia 
q1.4.26 Country/countries of data collection: Spain 
q1.4.27 Country/countries of data collection: Sweden 
q1.4.28 
Country/countries of data collection: United 
Kingdom 
q1.4.other Country/countries of data collection: Other 
q1.5.1 Language of data collection 
Language of data 
collection 
1 – Dutch 
2 – English 
3 – French 
4 – German 
5 – Italian 
6 – Portuguese 
7 – Spanish 
8 – Other 
For this single-answer format question, a 
frequency table will be produced. 
 
Open category will be recoded into extra 
values 
q1.5.other Language of data collection: Other 
q1.6.name 
Name of the institution responsible for the 





Acronym of the institution responsible for the 
study/project/activity implementation 
 
VARIABLE NAME LABEL QUESTION VALUES AND CODES ANALYSIS 
q1.6.country 
Country of the institution responsible for the 
study/project/activity implementation 
q1.7.1 
Type of the institution responsible for the 
study/project/activity implementation 
Type of the Institution 
1 – Public 
2 – Private 
3 – Other 
For this single-answer format question, a 
frequency table will be produced 
 
Open category will be recoded into extra 
values. 
q1.7.other 
Type of the institution responsible for the 
study/project/activity implementation: Other 
q1.8 Type of public institution 
What type of public 
institution? 
1 – University 
2 – Other type of public 
institution 
For this single-answer format question, a 
frequency table will be produced 
q1.9 Name of the Principal Investigator 
Name of the Principal 
Investigator 
  
q1.10.1.name Name of the contact person 1 
Contact person 1   
q1.10.1.affiliation Affiliation of the contact person 1 
q1.10.1.address Address of the contact person 1 
q1.10.1.phone Phone of the contact person 1 
q1.10.1.email Email of the contact person 1 
q1.10.2 Do you wish to add another contact person? 
Do you wish to add 
another contact person? 
No – 0 
Yes – 1 
 
q1.10.3.name Name of the contact person 2 
Contact person 2   
q1.10.3.affiliation Affiliation of the contact person 2 
q1.10-3.address Address of the contact person 2 
q1.10.3.phone Phone of the contact person 2 
q1.10.3.email Email of the contact person 2 
q1.10.4 Do you wish to add another contact person? 
Do you wish to add 
another contact person? 
No – 0 
Yes – 1 
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q1.10.5.name Name of the contact person 3 
Contact person 3   
q1.10.5.affiliation Affiliation of the contact person 3 
q1.10.5.address Address of the contact person 3 
q1.10.5.phone Phone of the contact person 3 
q1.10.5.email Email of the contact person 3 
q1.11.1.name Name of other institution(s) involved 1 
Other institution(s) 
involved 1 
  q1.11.1.acronym Acronym of other institution(s) involved 1 
q1.11.1.country Country of other institution(s) involved 1 
q1.11.2 Do you wish to add another institution? 
Do you wish to add 
another institution? 
No – 0 
Yes – 1 
 
q1.11.3.name Name of other institution(s) involved 2 
Other institution(s) 
involved 2 
  q1.11.3.acronym Acronym of other institution(s) involved 2 
q1.11.3.country Country of other institution(s) involved 2 
q1.11.4 Do you wish to add another institution? 
Do you wish to add 
another institution? 
No – 0 
Yes – 1 
 
q1.11.5.name Name of other institution(s) involved 3 
Other institution(s) 
involved 3 
  q1.11.5.acronym Acronym of other institution(s) involved 3 
q1.11.5.country Country of other institution(s) involved 3 
q1.11.6 Do you wish to add another institution? 
Do you wish to add 
another institution? 
No – 0 
Yes – 1 
 
q1.11.7.name Name of other institution(s) involved 4 
Other institution(s) 
involved 4 
  q1.11.7.acronym Acronym of other institution(s) involved 4 
q1.11.7.country Country of other institution(s) involved 4 
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q1.11.8 Do you wish to add another institution? 
Do you wish to add 
another institution? 
No – 0 
Yes – 1 
 
q1.11.9.name Name of other institution(s) involved 5 
Other institution(s) 
involved 5 
  q1.11.9.acronym Acronym of other institution(s) involved 5 
q1.11.9.country Country of other institution(s) involved 5 
q1.12.1 General objectives of the study/project/activity 




HBM specific related-objectives of the 
study/project/activity 
HBM specific related-
objectives of the 
study/project/activity 
  
q1.13 Status of the study/project/activity Status 
1 – Concluded (within 
the last 10 years) 
2 – Initiated/ongoing 
3 – Planned (for starting 
within the next 5 years) 
For this single-answer format question, a 
frequency table will be produced 
q1.14 
Beginning (or previewed starting) date of the 
study/project/activity 
Beginning (or previewed 




(Previewed) Ending date of the 
study/project/activity 




Budget of the project/study/activity (to the 
nearest thousand Euros) 
Budget of the 
project/study/activity 
 
Budget values will be recoded into 
intervals and reported in a frequency 
table. Also, descriptives will be reported 
(mean, median, standard deviation) 
q1.17.1.nameacronym 
Name (and acronym) of the entity which funded 
the study/project/activity 1 
Name (and acronym, if 
any) of the entity/entities 




Name (and acronym) of the entity which funded 
the study/project/activity 2 
 
VARIABLE NAME LABEL QUESTION VALUES AND CODES ANALYSIS 
q1.17.3.nameacronym 
Name (and acronym) of the entity which funded 
the study/project/activity 3 
q1.17.4.nameacronym 
Name (and acronym) of the entity which funded 
the study/project/activity 4 
q1.17.5.nameacronym 
Name (and acronym) of the entity which funded 
the study/project/activity 5 
q1.18 Ethical approval of the study/project/activity Ethical approval 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q1.18.1 Ethical approval by whom: Institutional policy 
By whom?   
q1.18.2 Ethical approval by whom: Ethics committee 
q1.18.3 
Ethical approval by whom: Deontology 
committee 
q1.18.other Ethical approval by whom: Other 
q1.18.name Name of the contact person for ethic documents 
Please insert information 




Affiliation of the contact person for ethic 
documents 
q1.18.address 
Address of the contact person for ethic 
documents 
q1.18.phone 
Phone of the contact person for ethic 
documents 
q1.18.email Email of the contact person for ethic documents 
q1.19.link 
Internet link with information about data 
collection tools 
Internet link with 
information about data 
collection tools 
  
2. DESCRIPTION OF THE TARGET POPULATION AND METHOD OF SELECTION OF PARTICIPANTS 
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q2.1.1 Study design 
Study design 
1 – Cross-sectional 
survey 
2 – Case-control 
3 – Longitudinal 
(cohort) 
4 – Other 
For this question, a frequency table will 
be produced. 
 
Open category will be recoded into extra 
values 
q2.1.other Study design: Other 
q2.2.1 Type of target population 
Type of target population 
1 – General population 
(non-clinical 
population) 
2 – Clinical population 
3 – Other 
For this question, a frequency table will 
be produced. 
 
Open category will be recoded into extra 
values 
q2.2.other Type of target population: Other 
q2.3.1.1 
Target groups and sample size(s): Children - 
Lower limit of age 
Children  
Age values will be recoded into age 
intervals and a frequency table will be 
produced. 
 
Regarding sample size, descriptives will 
be reported (mean, median and standard 
deviation), as well as frequency of 
recorded sample intervals 
q2.3.1.2 
Target groups and sample size(s): Children - 
Upper limit of age 
q2.3.1.3 
Target groups and sample size(s): Children - 
Sample size/number of participants 
q2.3.2.1 
Target groups and sample size(s): Adolescents - 
Lower limit of age 
Adolescents  
Age values will be recoded into age 
intervals and a frequency table will be 
produced. 
 
Regarding sample size, descriptives will 
be reported (mean, median and standard 
deviation), as well as frequency of 
recorded sample intervals 
q2.3.2.2 
Target groups and sample size(s): Adolescents - 
Upper limit of age 
q2.3.2.3 
Target groups and sample size(s): Adolescents - 
Sample size/number of participants 
q2.3.3.1 
Target groups and sample size(s): Mother-
newborn pairs - Lower limit of mother's age Mother-newborn pairs  
Age values will be recoded into age 
intervals and a frequency table will be 
produced. q2.3.3.2 Target groups and sample size(s): Mother-
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newborn pairs - Upper limit of mother's age  
Regarding sample size, descriptives will 
be reported (mean, median and standard 
deviation), as well as frequency of 
recorded sample intervals 
q2.3.3.3 
Target groups and sample size(s): Mother-
newborn pairs - Lower limit of newborn's age 
q2.3.3.4 
Target groups and sample size(s): Mother-
newborn pairs - Upper limit of newborn's age 
q2.3.3.5 
Target groups and sample size(s): Mother-
newborn pairs - Number of mothers in the 
group 
q2.3.3.6 
Target groups and sample size(s): Mother-
newborn pairs - Number of pairs in the group 
q2.3.4.1 
Target groups and sample size(s): Adults - Lower 
limit of age 
Adults  
Age values will be recoded into age 
intervals and a frequency table will be 
produced. 
 
Regarding sample size, descriptives will 
be reported (mean, median and standard 
deviation), as well as frequency of 
recorded sample intervals 
q2.3.4.2 
Target groups and sample size(s): Adults - Upper 
limit of age 
q2.3.4.3 
Target groups and sample size(s): Adults - 
Sample size/number of participants 
q2.3.5.1 
Target groups and sample size(s): Elderly - Lower 
limit of age 
Elderly  
Age values will be recoded into age 
intervals and a frequency table will be 
produced. 
 
Regarding sample size, descriptives will 
be reported (mean, median and standard 
deviation), as well as frequency of 
recorded sample intervals 
q2.3.5.2 
Target groups and sample size(s): Elderly - Upper 
limit of age 
q2.3.5.3 
Target groups and sample size(s): Elderly - 
Sample size/number of participants 
q2.3.6.1 
Target groups and sample size(s): Other specific 
population? 
Other specific population? 
(smokers, workers, 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
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q2.3.6.2.other 




Open anwers concerning “other specific 
population” will be recoded (content 
analysis) and reported in a frequency 
table.  
 
Age values will be recoded into age 
intervals and a frequency table will be 
produced. 
 
Regarding sample size, descriptives will 
be reported (mean, median and standard 
deviation), as well as frequency of 
recorded sample intervals 
q2.3.6.3 
Target groups and sample size(s): Other specific 
population - Lower limit of age 
q2.3.6.4 
Target groups and sample size(s): Other specific 
population - Upper limit of age 
q2.3.6.5 
Target groups and sample size(s): Other specific 
population - Sample size/number of participants 
q2.4 Gender of the participants Gender of the participants 
1 – Women  
2 – Men 
3 – Both 
For this single-answer format question, a 
frequency table will be produced 
q2.5.1.1 Inclusion criteria: Gender 
Gender 
No – 0 
Yes – 1 
For this question, a frequency table will 
be produced. 
 
The specification (open-answer 
component of the question) will be 
analysed (content analysis) and 
frequencies will also be reported. 
q2.5.1.description Inclusion criteria: Gender - Description 
q2.5.2.1 Inclusion criteria: Age 
Age 
No – 0 
Yes – 1 
For this question, a frequency table will 
be produced. 
 
The specification (open-answer 
component of the question) will be 
analysed (content analysis) and 
frequencies will also be reported. 
q2.5.2.description Inclusion criteria: Age - Description 
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q2.5.3.1 Inclusion criteria: Geographical Unit 
Geographical Unit (e.g., 
NUTS II) 
No – 0 
Yes – 1 
For this question, a frequency table will 
be produced. 
 
The specification (open-answer 
component of the question) will be 
analysed (content analysis) and 
frequencies will also be reported. 
q2.5.3.description Inclusion criteria: Geographical Unit - Description 
q2.5.4.1 Inclusion criteria: Health condition 
Health condition 
No – 0 
Yes – 1 
For this question, a frequency table will 
be produced. 
 
The specification (open-answer 
component of the question) will be 
analysed (content analysis) and 
frequencies will also be reported. 
q2.5.4.description Inclusion criteria: Health condition - Description 
q2.5.5.1 Inclusion criteria: Specific exposure 
Specific exposure 
No – 0 
Yes – 1 
For this question, a frequency table will 
be produced. 
 
The specification (open-answer 
component of the question) will be 
analysed (content analysis) and 
frequencies will also be reported. 
q2.5.5.description Inclusion criteria: Specific exposure - Description 
q2.5.6.1 Other inclusion criteria 
Other inclusion criteria 
No – 0 
Yes – 1 
For this question, a frequency table will 
be produced. 
 
The specification (open-answer 
component of the question) will be 
analysed (content analysis) and 
frequencies will also be reported. 
q2.5.6.description Other inclusion criteria - Description 
q2.6.1.1 Exclusion criteria: Gender 
Gender 
No – 0 
Yes – 1 
For this question, a frequency table will 
be produced. 
 q2.6.1.description Exclusion criteria: Gender - Description 
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The specification (open-answer 
component of the question) will be 
analysed (content analysis) and 
frequencies will also be reported. 
q2.6.2.1 Exclusion criteria: Age 
Age 
No – 0 
Yes – 1 
For this question, a frequency table will 
be produced. 
 
The specification (open-answer 
component of the question) will be 
analysed (content analysis) and 
frequencies will also be reported. 
q2.6.2.description Exclusion criteria: Age - Description 
q2.6.3.1 Exclusion criteria: Geographical Unit 
Geographical Unit (e.g., 
NUTS II) 
No – 0 
Yes – 1 
For this question, a frequency table will 
be produced. 
 
The specification (open-answer 
component of the question) will be 
analysed (content analysis) and 
frequencies will also be reported. 
q2.6.3.description 
Exclusion criteria: Geographical Unit – 
Description 
q2.6.4.1 Exclusion criteria: Health condition 
Health condition 
No – 0 
Yes – 1 
For this question, a frequency table will 
be produced. 
 
The specification (open-answer 
component of the question) will be 
analysed (content analysis) and 
frequencies will also be reported. 
q2.6.4.description Exclusion criteria: Health condition - Description 
q2.6.5.1 Exclusion criteria: Specific exposure 
Specific exposure 
No – 0 
Yes – 1 
For this question, a frequency table will 
be produced. 
 
The specification (open-answer 
component of the question) will be 
analysed (content analysis) and 
q2.6.5.description Exclusion criteria: Specific exposure - Description 
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frequencies will also be reported. 
q2.6.6.1 Other exclusion criteria 
Other exclusion criteria 
No – 0 
Yes – 1 
For this question, a frequency table will 
be produced. 
 
The specification (open-answer 
component of the question) will be 
analysed (content analysis) and 
frequencies will also be reported. 
q2.6.6.description Other exclusion criteria - Description 
q2.7 Presence of control group Control group 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q2.8 Control group: Size Size of the control group  
For this question, sanple size values will 
be recoded into intervals and reported in 
a frequency table. Also, descriptives will 
be reported (mean, median and standard 
deviation) 
q2.9.1.1 Control group: Inclusion criteria - Gender 
Gender 
No – 0 
Yes – 1 
For this question, a frequency table will 
be produced. 
 
The specification (open-answer 
component of the question) will be 
analysed (content analysis) and 
frequencies will also be reported. 
q2.9.1.description 
Control group: Inclusion criteria - Gender - 
Description 
q2.9.2.1 Control group: Inclusion criteria - Age 
Age 
No – 0 
Yes – 1 
For this question, a frequency table will 
be produced. 
 
The specification (open-answer 
component of the question) will be 
analysed (content analysis) and 
frequencies will also be reported. 
q2.9.2.description 
Control group: Inclusion criteria - Age - 
Description 
q2.9.3.1 Control group: Inclusion criteria - Geographical Geographical Unit (e.g., No – 0 For this question, a frequency table will 
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Unit NUTS II) Yes – 1 be produced. 
 
The specification (open-answer 
component of the question) will be 
analysed (content analysis) and 
frequencies will also be reported. 
q2.9.3.description 
Control group: Inclusion criteria - Geographical 
Unit - Description 
q2.9.4.1 
Control group: Inclusion criteria - Health 
condition 
Health condition 
No – 0 
Yes – 1 
For this question, a frequency table will 
be produced. 
 
The specification (open-answer 
component of the question) will be 
analysed (content analysis) and 
frequencies will also be reported. 
q2.9.4.description 
Control group: Inclusion criteria - Health 
condition - Description 
q2.9.5.1 
Control group: Inclusion criteria - Specific 
exposure 
Specific exposure 
No – 0 
Yes – 1 
For this question, a frequency table will 
be produced. 
 
The specification (open-answer 
component of the question) will be 
analysed (content analysis) and 
frequencies will also be reported. 
q2.9.5.description 
Control group: Inclusion criteria - Specific 
exposure - Description 
q2.9.6.1 Control group: Other inclusion criteria 
Other inclusion criteria 
No – 0 
Yes – 1 
For this question, a frequency table will 
be produced. 
 
The specification (open-answer 
component of the question) will be 
analysed (content analysis) and 
frequencies will also be reported. 
q2.9.6.description 
Control group: Other inclusion criteria - 
Description 
q2.10.1.1 Control group: Exclusion criteria - Gender 
Gender 
No – 0 
Yes – 1 
For this question, a frequency table will 
be produced. 
 
The specification (open-answer 
q2.10.1.description 
Control group: Exclusion criteria - Gender - 
Description 
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component of the question) will be 
analysed (content analysis) and 
frequencies will also be reported. 
q2.10.2.1 Control group: Exclusion criteria - Age 
Age 
No – 0 
Yes – 1 
For this question, a frequency table will 
be produced. 
 
The specification (open-answer 
component of the question) will be 
analysed (content analysis) and 
frequencies will also be reported. 
q2.10.2.description 
Control group: Exclusion criteria - Age - 
Description 
q2.10.3.1 
Control group: Exclusion criteria - Geographical 
Unit 
Geographical Unit (e.g., 
NUTS II) 
No – 0 
Yes – 1 
For this question, a frequency table will 
be produced. 
 
The specification (open-answer 
component of the question) will be 
analysed (content analysis) and 
frequencies will also be reported. 
q2.10.3.description 
Control group: Exclusion criteria - Geographical 
Unit - Description 
q2.10.4.1 
Control group: Exclusion criteria - Health 
condition 
Health condition 
No – 0 
Yes – 1 
For this question, a frequency table will 
be produced. 
 
The specification (open-answer 
component of the question) will be 
analysed (content analysis) and 
frequencies will also be reported. 
q2.10.4.description 
Control group: Exclusion criteria - Health 
condition - Description 
q2.10.5.1 
Control group: Exclusion criteria - Specific 
exposure 
Specific exposure 
No – 0 
Yes – 1 
For this question, a frequency table will 
be produced. 
 
The specification (open-answer 
component of the question) will be 
analysed (content analysis) and 
frequencies will also be reported. 
q2.10.5.description 
Control group: Exclusion criteria - Specific 
exposure - Description 
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q2.10.6.1 Control group: Other exclusion criteria 
Other exclusion criteria 
No – 0 
Yes – 1 
For this question, a frequency table will 
be produced. 
 
The specification (open-answer 
component of the question) will be 
analysed (content analysis) and 
frequencies will also be reported. 
q2.10.6.description 
Control group: Other exclusion criteria - 
Description 
q2.11.1 Sampling method: Random selection 
Sampling method 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q2.11.2 Sampling method: Convenience/intentional 
q2.11.3 Sampling method: Stratified 
q2.11.other Sampling method: Other 
q2.12.description Short description of sampling scheme 
Please provide a short 




Recruitment/sampling frame (origin of 
participant addresses): Census data 
Recruitment/sampling 
frame (origin of participant 
addresses) 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q2.13.2 
Recruitment/sampling frame (origin of 
participant addresses): Electoral register 
q2.13.3 
Recruitment/sampling frame (origin of 
participant addresses): School (class) lists 
q2.13.4 
Recruitment/sampling frame (origin of 
participant addresses): Health centre list 
q2.13.5 
Recruitment/sampling frame (origin of 
participant addresses): Hospital patients list 
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q2.13.6 
Recruitment/sampling frame (origin of 
participant addresses): Health or other type of 
professionals’ list 
q2.13.7 
Recruitment/sampling frame (origin of 
participant addresses): Other type of population 
register 
q2.13.8 
Recruitment/sampling frame (origin of 
participant addresses): Health archives 
q2.13.9 
Recruitment/sampling frame (origin of 
participant addresses): Participants from another 
study 
q2.13.other 
Recruitment/sampling frame (origin of 
participant addresses): Other 
q2.14.1 
Recruitment contact: Through general 
practitioner (GP) doctors 
Recruitment contact 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q2.14.2 Recruitment contact: Through paediatricians 
q2.14.3 Recruitment contact: Through gynaecologists 
q2.14.4 
Recruitment contact: Through other medical 
doctors 
q2.14.5 Recruitment contact: Through midwives 
q2.14.6 Recruitment contact: Through nurses 
q2.14.7 Recruitment contact: Mass Media Call/Invitation 
q2.14.8 Recruitment contact: Mail address (letter) 
q2.14.9 Recruitment contact: Telephone contact 
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q2.14.10 Recruitment contact: E-mail invitation 
q2.14.11 Recruitment contact: Internet 
q2.14.12 Recruitment contact: Door to door 
q2.14.13 Recruitment contact: Street contact 
q2.14.14 Recruitment contact: Direct contact 
q2.14.other Recruitment contact: Other 
q2.15 Is it a representative sample? 
Is it a representativeness 
sample (regarding any kind 
of universe/population?) 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q2.15.1.description Representative sample: Level 
At what level (which 
universe/population – e.g., 
at national level, at 
regional level, …)? 
  
q2.16.1 
Time schedule (frequency) of the 
study/project/activity: Only once 
Time schedule (frequency) 
of this 
study/project/activity 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q2.16.2 
Time schedule (frequency) of the 
study/project/activity: Once a year 
q2.16.3 
Time schedule (frequency) of the 
study/project/activity: Every 2 years 
q2.16.4 
Time schedule (frequency) of the 
study/project/activity: Every 3 years 
q2.16.5 
Time schedule (frequency) of the 
study/project/activity: Every 4 years 
q2.16.6 
Time schedule (frequency) of the 
study/project/activity: Every 5 years 
q2.16.7 Time schedule (frequency) of the 
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study/project/activity: Until the number of 
participants/samples are recruited/collected 
q2.16.other 
Time schedule (frequency) of the 
study/project/activity: Other 
q2.17.1 
Type of consent form: Participants’ written 
informed consent 
Type of consent form 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q2.17.2 
Type of consent form: Parents’ written informed 
consent 
q2.17.3 Type of consent form: Oral informed consent 
q2.17.other Type of consent form: Other 
q2.18.1 
Scope of the informed consent: Participants gave 
informed content for usage of data only within 
the context of this study/project/activity 
Scope of the informed 
consent 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q2.18.2 
Scope of the informed consent: Participants gave 
broader consent (data can be used for other 
studies/projects/activities) 
q2.18.other Scope of the informed consent: Other 
q2.19.1 Incentives for participants: No encouragement 
Incentives for participants 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q2.19.2 Incentives for participants: Reminder letter 
q2.19.3 Incentives for participants: Small gifts/presents 
q2.19.4 
Incentives for participants: Financial 
compensation 
q2.19.5 Incentives for participants: Greetings cards 
q2.19.6 Incentives for participants: Birthday cards 
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q2.19.7 
Incentives for participants: Expensive presents 
(lottery) 
q2.19.8 Incentives for participants: Main collective results 
q2.19.9 
Incentives for participants: Main individual 
results (participation feedback) 
q2.19.10 
Incentives for participants: Newsletter to 
participants 
q2.19.11 
Incentives for participants: Educational package 
on Environment and/or Health 
q2.19.12 Incentives for participants: Medical examination 
q2.19.13 
Incentives for participants: Additional health 
monitoring 
q2.19.14 
Incentives for participants: Medical advice and 
help 
q2.19.other Incentives for participants: Other 
q2.19.4.1.description 
Incentives for participants: Type of financial 
compensation 
If you have selected 
"financial compensation" 
above, please specify the 
type 
of incentive (e.g., 
reimbursement of travel 
expenses, before or after 
participation, amount, …) 
 
The open-answer will be analysed 
(content analysis) and frequencies will 
also be reported 
3. FIELDWORK AND DATA COLLECTION 
q3.1 Beginning date of data collection Beginning date   
q3.2 Ending date of data collection Ending date   
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q3.3.1 
Mode of data collection: Face-to-face interviews 
(including biological sample collection, 
anthropometric measurements, …) 
Mode of data collection 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q3.3.2 
Mode of data collection: Face-to-face interviews 
(neither with biological sample collection nor 
anthropometric measurements, …) 
q3.3.3 Mode of data collection: Telephone interview 
q3.3.4 
Mode of data collection: Computer-Assisted 
Telephone Interview (CATI) 
q3.3.5 
Mode of data collection: Computer-Assisted 
Personal Interview (CAPI) 
q3.3.6 
Mode of data collection: Self-administered 
questionnaire (paper) 
q3.3.7 
Mode of data collection: Self-administered 
questionnaire (online) 
q3.3.other Mode of data collection: Other 
q3.4 
For face-to-face administered questionnaire or 
phone interview, information obtained by 
qualified and trained personnel 
In case of face-to-face 
administered questionnaire 
or phone interview, the 
information was/will be 
obtained by qualified and 
trained personnel? 
0 – No 
1 – Yes 
2 – No answer 
For this single-answer format question, a 
frequency table will be produced 
q3.5.1 
In case of face-to-face data collection, place 
where the interview is/was conducted: At 
participants’ home 
In case of face-to-face data 
collection, which 
is/was/will be the place 
where the interview is/was 
conducted? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for q3.5.2 
In case of face-to-face data collection, place 
where the interview is/was conducted: At an 
 
VARIABLE NAME LABEL QUESTION VALUES AND CODES ANALYSIS 
examination centre descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q3.5.3 
In case of face-to-face data collection, place 
where the interview is/was conducted: At a 
mobile lab 
q3.5.4 
In case of face-to-face data collection, place 
where the interview is/was conducted: In a 
hospital/maternity 
q3.5.5 
In case of face-to-face data collection, place 
where the interview is/was conducted: In a clinic 
q3.5.6 
In case of face-to-face data collection, place 
where the interview is/was conducted: In a 
primary health centre 
q3.5.7 
In case of face-to-face data collection, place 
where the interview is/was conducted: In a 
nursing home 
q3.5.8 
In case of face-to-face data collection, place 
where the interview is/was conducted: At 
kindergarten 
q3.5.9 
In case of face-to-face data collection, place 
where the interview is/was conducted: At 
(vocational) school 
q3.5.10 
In case of face-to-face data collection, place 
where the interview is/was conducted: In a 
lactarium 
q3.5.11 
In case of face-to-face data collection, place 
where the interview is/was conducted: At 
workplace 
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q3.5.other 
In case of face-to-face data collection, place 
where the interview is/was conducted: Other 
q3.6 
In case of using a questionnaire for data 
collection, is it possible to share this 
questionnaire? 
In case of using a 
questionnaire for data 
collection, is it possible to 
share this questionnaire? 
1 – No 
2 – Yes, it is available to 
any researcher 
3 – Yes, only to 
HBM4EU partners 
For this single-answer format question, a 
frequency table will be produced 
q3.7.1 Biological samples collected: None 
Biological samples 
collected 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q3.7.2 Biological samples collected: Blood 
q3.7.3 Biological samples collected: Blood erythrocytes 
q3.7.4 Biological samples collected: Plasma 
q3.7.5 Biological samples collected: Serum 
q3.7.6 Biological samples collected: Saliva 
q3.7.7 Biological samples collected: Buccal cells 
q3.7.8 Biological samples collected: Nails 
q3.7.9 Biological samples collected: DNA 
q3.7.10 Biological samples collected: Cells lines 
q3.7.11 
Biological samples collected: 12-hours overnight 
urine 
q3.7.12 Biological samples collected: Urine (24h) 
q3.7.13 
Biological samples collected: Urine (spot sample-
random) 
q3.7.14 
Biological samples collected: Urine (spot sample-
first morning) 
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q3.7.15 Biological samples collected: Human milk 
q3.7.16 
Biological samples collected: Hair 
(chopped/lyophilised sample) 
q3.7.17 
Biological samples collected: Hair (complete 
locks) 
q3.7.18 Biological samples collected: Fat/adipose tissue 
q3.7.19 Biological samples collected: Placenta 
q3.7.20 
Biological samples collected: Umbilical cord 
blood 
q3.7.other Biological samples collected: Other 
q3.8.1.1 
Group/s of substances under study: 
Phthalates/DINCH Group/s of substances 
under study: 
Phthalates/DINCH 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.1.comment 
Group/s of substances under study: Comment 
(including CAS-number) 
  
q3.8.2.1 Group/s of substances under study: Bisphenols 
Group/s of substances 
under study: Bisphenols 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.2.comment 




Group/s of substances under study: Per-
/Polyfluorinated compounds 




No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.3.comment 




Group/s of substances under study: Flame 
Retardants 
Group/s of substances 
under study: Flame 
Retardants 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.4.comment Group/s of substances under study: Comment   
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(including CAS-number) 
q3.8.5.1 Group/s of substances under study: Cadmium Group/s of substances 
under study: Cadmium 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.5.comment Group/s of substances under study: Comment   
q3.8.6.1 
Group/s of substances under study: Chromium 
VI Group/s of substances 
under study: Chromium VI 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.6.comment Group/s of substances under study: Comment   
q3.8.7.1 Group/s of substances under study: PAHs 
Group/s of substances 
under study: PAHs 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.7.comment 




Group/s of substances under study: Anilin family: 
Anilines, MOCA Group/s of substances 
under study: Anilin family: 
Anilines, MOCA 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.8.comment 




Group/s of substances under study: Chemical 
mixtures Group/s of substances 
under study: Chemical 
mixtures 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.9.comment 




Group/s of substances under study: Emerging 
chemicals Group/s of substances 
under study: Emerging 
chemicals 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.10.comment 
Group/s of substances under study: Comment 
(including CAS-number) 
  
q3.8.11.1 Group/s of substances under study: Other Group/s of substances 
under study: Other 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.11.comment Group/s of substances under study: Comment   
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(including CAS-number) 
q3.8.1.1.1 Phthalates/DINCH: Matrix Regarding phthalates 
/DINCH: Matrix 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.1.1.1.comment Phthalates/DINCH: Comment   
q3.8.1.1.2 Phthalates/DINCH: Unit of measurement Regarding phthalates 
/DINCH: Unit of 
measurement 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.1.1.2.comment Phthalates/DINCH: Comment   
q3.8.1.1.3 Phthalates/DINCH: LOD Regarding phthalates 
/DINCH: LOD 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.1.1.3.comment Phthalates/DINCH: Comment   
q3.8.1.1.4 Phthalates/DINCH: LOQ Regarding phthalates 
/DINCH: LOQ 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.1.1.4.comment Phthalates/DINCH: Comment   
q3.8.1.1.5 Phthalates/DINCH: Number of analysed samples Regarding phthalates 
/DINCH: Number of 
analysed samples 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.1.1.5.comment Phthalates/DINCH: Comment   
q3.8.1.1.6 
Phthalates/DINCH: Number of samples below 
LOD 
Regarding phthalates 
/DINCH: Number of 
samples below LOD 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.1.1.6.comment Phthalates/DINCH: Comment   
q3.8.1.1.7 
Phthalates/DINCH: Number of samples below 
LOQ 
Regarding phthalates 
/DINCH: Number of 
samples below LOQ 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.1.1.7.comment Phthalates/DINCH: Comment   
q3.8.1.1.8 Phthalates/DINCH: Exposure range Regarding phthalates 
/DINCH: Exposure range 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.1.1.8.comment Phthalates/DINCH: Comment   
q3.8.1.1.9 Phthalates/DINCH: Analytical method Regarding phthalates No – 0 For this yes-no answer format question, 
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/DINCH: Analytical method Yes – 1 a frequency table will be produced 
q3.8.1.1.9.comment Phthalates/DINCH: Comment   
q3.8.2.1.1 Bisphenols: Matrix Regarding bisphenols: 
Matrix 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.2.1.1.comment Bisphenols: Comment   
q3.8.2.1.2 Bisphenols: Unit of measurement Regarding bisphenols: Unit 
of measurement 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.2.1.2.comment Bisphenols: Comment   
q3.8.2.1.3 Bisphenols: LOD 
Regarding bisphenols: LOD 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.2.1.3.comment Bisphenols: Comment   
q3.8.2.1.4 Bisphenols: LOQ 
Regarding bisphenols: LOQ 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.2.1.4.comment Bisphenols: Comment   
q3.8.2.1.5 Bisphenols: Number of analysed samples Regarding bisphenols: 
Number of analysed 
samples 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.2.1.5.comment Bisphenols: Comment   
q3.8.2.1.6 Bisphenols: Number of samples below LOD Regarding bisphenols: 
Number of samples below 
LOD 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.2.1.6.comment Bisphenols: Comment   
q3.8.2.1.7 Bisphenols: Number of samples below LOQ Regarding bisphenols: 
Number of samples below 
LOQ 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.2.1.7.comment Bisphenols: Comment   
q3.8.2.1.8 Bisphenols: Exposure range Regarding bisphenols: 
Exposure range 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.2.1.8.comment Bisphenols: Comment   
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q3.8.2.1.9 Bisphenols: Analytical method Regarding bisphenols: 
Analytical method 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.2.1.9.comment Bisphenols: Comment   
q3.8.3.1.1 Per-/Polyfluorinated compounds: Matrix Regarding per-
/Polyfluorinated 
compounds: Matrix 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.3.1.1.comment Per-/Polyfluorinated compounds: Comment   
q3.8.3.1.2 




compounds: Unit of 
measurement 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.3.1.2.comment Per-/Polyfluorinated compounds: Comment   
q3.8.3.1.3 Per-/Polyfluorinated compounds: LOD Regarding per-
/Polyfluorinated 
compounds: LOD 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.3.1.3.comment Per-/Polyfluorinated compounds: Comment   
q3.8.3.1.4 Per-/Polyfluorinated compounds: LOQ Regarding per-
/Polyfluorinated 
compounds: LOQ 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.3.1.4.comment Per-/Polyfluorinated compounds: Comment   
q3.8.3.1.5 




compounds: Number of 
analysed samples 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.3.1.5.comment Per-/Polyfluorinated compounds: Comment   
q3.8.3.1.6 
Per-/Polyfluorinated compounds: Number of 
samples below LOD 
Regarding per-
/Polyfluorinated 
compounds: Number of 
samples below LOD 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.3.1.6.comment Per-/Polyfluorinated compounds: Comment   
q3.8.3.1.7 
Per-/Polyfluorinated compounds: Number of 
samples below LOQ 
Regarding per-
/Polyfluorinated 
compounds: Number of 
samples below LOQ 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.3.1.7.comment Per-/Polyfluorinated compounds: Comment   
q3.8.3.1.8 Per-/Polyfluorinated compounds: Exposure Regarding per- No – 0 For this yes-no answer format question, 
 




Yes – 1 a frequency table will be produced 
q3.8.3.1.8.comment Per-/Polyfluorinated compounds: Comment   
q3.8.3.1.9 






No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.3.1.9.comment Per-/Polyfluorinated compounds: Comment   
q3.8.4.1.1 Flame retardants: Matrix Regarding flame 
retardants: Matrix 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.4.1.1.comment Flame retardants: Comment   
q3.8.4.1.2 Flame retardants: Unit of measurement Regarding flame 
retardants: Unit of 
measurement 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.4.1.2.comment Flame retardants: Comment   
q3.8.4.1.3 Flame retardants: LOD Regarding flame 
retardants: LOD 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.4.1.3.comment Flame retardants: Comment   
q3.8.4.1.4 Flame retardants: LOQ Regarding flame 
retardants: LOQ 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.4.1.4.comment Flame retardants: Comment   
q3.8.4.1.5 Flame retardants: Number of analysed samples Regarding flame 
retardants: Number of 
analysed samples 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.4.1.5.comment Flame retardants: Comment   
q3.8.4.1.6 
Flame retardants: Number of samples below 
LOD 
Regarding flame 
retardants: Number of 
samples below LOD 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.4.1.6.comment Flame retardants: Comment   
q3.8.4.1.7 
Flame retardants: Number of samples below 
LOQ 
Regarding flame 
retardants: Number of 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
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q3.8.4.1.7.comment Flame retardants: Comment samples below LOQ   
q3.8.4.1.8 Flame retardants: Exposure range Regarding flame 
retardants: Exposure range 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.4.1.8.comment Flame retardants: Comment   
q3.8.4.1.9 Flame retardants: Analytical method Regarding flame 
retardants: Analytical 
method 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.4.1.9.comment Flame retardants: Comment   
q3.8.5.1.1 Cadmium: Matrix Regarding cadmium: 
Matrix 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.5.1.1.comment Cadmium: Comment   
q3.8.5.1.2 Cadmium: Unit of measurement Regarding cadmium: Unit 
of measurement 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.5.1.2.comment Cadmium: Comment   
q3.8.5.1.3 Cadmium: LOD 
Regarding cadmium: LOD 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.5.1.3.comment Cadmium: Comment   
q3.8.5.1.4 Cadmium: LOQ 
Regarding cadmium: LOQ 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.5.1.4.comment Cadmium: Comment   
q3.8.5.1.5 Cadmium: Number of analysed samples Regarding cadmium: 
Number of analysed 
samples 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.5.1.5.comment Cadmium: Comment   
q3.8.5.1.6 Cadmium: Number of samples below LOD Regarding cadmium: 
Number of samples below 
LOD 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.5.1.6.comment Cadmium: Comment   
q3.8.5.1.7 Cadmium: Number of samples below LOQ 
Regarding cadmium: 
Number of samples below 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
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q3.8.5.1.7.comment Cadmium: Comment LOQ   
q3.8.5.1.8 Cadmium: Exposure range Regarding cadmium: 
Exposure range 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.5.1.8.comment Cadmium: Comment   
q3.8.5.1.9 Cadmium: Analytical method Regarding cadmium: 
Analytical method 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.5.1.9.comment Cadmium: Comment   
q3.8.6.1.1 Chromium VI: Matrix Regarding chromium VI: 
Matrix 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.6.1.1.comment Chromium VI: Comment   
q3.8.6.1.2 Chromium VI: Unit of measurement Regarding chromium VI: 
Unit of measurement 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.6.1.2.comment Chromium VI: Comment   
q3.8.6.1.3 Chromium VI: LOD Regarding chromium VI: 
LOD 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.6.1.3.comment Chromium VI: Comment   
q3.8.6.1.4 Chromium VI: LOQ Regarding chromium VI: 
LOQ 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.6.1.4.comment Chromium VI: Comment   
q3.8.6.1.5 Chromium VI: Number of analysed samples Regarding chromium VI: 
Number of analysed 
samples 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.6.1.5.comment Chromium VI: Comment   
q3.8.6.1.6 Chromium VI: Number of samples below LOD Regarding chromium VI: 
Number of samples below 
LOD 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.6.1.6.comment Chromium VI: Comment   
q3.8.6.1.7 Chromium VI: Number of samples below LOQ 
Regarding chromium VI: 
Number of samples below 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
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q3.8.6.1.7.comment Chromium VI: Comment LOQ   
q3.8.6.1.8 Chromium VI: Exposure range Regarding chromium VI: 
Exposure range 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.6.1.8.comment Chromium VI: Comment   
q3.8.6.1.9 Chromium VI: Analytical method Regarding chromium VI: 
Analytical method 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.6.1.9.comment Chromium VI: Comment   
q3.8.7.1.1 PAHs: Matrix 
Regarding PAHs: Matrix 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.7.1.1.comment PAHs: Comment   
q3.8.7.1.2 PAHs: Unit of measurement Regarding PAHs: Unit of 
measurement 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.7.1.2.comment PAHs: Comment   
q3.8.7.1.3 PAHs: LOD 
Regarding PAHs: LOD 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.7.1.3.comment PAHs: Comment   
q3.8.7.1.4 PAHs: LOQ 
Regarding PAHs: LOQ 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.7.1.4.comment PAHs: Comment   
q3.8.7.1.5 PAHs: Number of analysed samples Regarding PAHs: Number 
of analysed samples 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.7.1.5.comment PAHs: Comment   
q3.8.7.1.6 PAHs: Number of samples below LOD Regarding PAHs: Number 
of samples below LOD 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.7.1.6.comment PAHs: Comment   
q3.8.7.1.7 PAHs: Number of samples below LOQ 
Regarding PAHs: Number 
of samples below LOQ 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
 
VARIABLE NAME LABEL QUESTION VALUES AND CODES ANALYSIS 
q3.8.7.1.7.comment PAHs: Comment   
q3.8.7.1.8 PAHs: Exposure range Regarding PAHs: Exposure 
range 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.7.1.8.comment PAHs: Comment   
q3.8.7.1.9 PAHs: Analytical method Regarding PAHs: Analytical 
method 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.7.1.9.comment PAHs: Comment   
q3.8.8.1.1 Anilin family - Anilines, MOCA: Matrix Regarding Anilin family: 
Anilines, MOCA: Matrix 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.8.1.1.comment Anilin family - Anilines, MOCA: Comment   
q3.8.8.1.2 
Anilin family - Anilines, MOCA: Unit of 
measurement 
Regarding Anilin family: 
Anilines, MOCA: Unit of 
measurement 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.8.1.2.comment Anilin family - Anilines, MOCA: Comment   
q3.8.8.1.3 Anilin family - Anilines, MOCA: LOD Regarding Anilin family: 
Anilines, MOCA: LOD 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.8.1.3.comment Anilin family - Anilines, MOCA: Comment   
q3.8.8.1.4 Anilin family - Anilines, MOCA: LOQ Regarding Anilin family: 
Anilines, MOCA: LOQ 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.8.1.4.comment Anilin family - Anilines, MOCA: Comment   
q3.8.8.1.5 
Anilin family - Anilines, MOCA: Number of 
analysed samples 
Regarding Anilin family: 
Anilines, MOCA: Number 
of analysed samples 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.8.1.5.comment Anilin family - Anilines, MOCA: Comment   
q3.8.8.1.6 
Anilin family - Anilines, MOCA: Number of 
samples below LOD 
Regarding Anilin family: 
Anilines, MOCA: Number 
of samples below LOD 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.8.1.6.comment Anilin family - Anilines, MOCA: Comment   
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q3.8.8.1.7 
Anilin family - Anilines, MOCA: Number of 
samples below LOQ 
Regarding Anilin family: 
Anilines, MOCA: Number 
of samples below LOQ 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.8.1.7.comment Anilin family - Anilines, MOCA: Comment   
q3.8.8.1.8 Anilin family - Anilines, MOCA: Exposure range Regarding Anilin family: 
Anilines, MOCA: Exposure 
range 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.8.1.8.comment Anilin family - Anilines, MOCA: Comment   
q3.8.8.1.9 
Anilin family - Anilines, MOCA: Analytical 
method 
Regarding Anilin family: 
Anilines, MOCA: Analytical 
method 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.8.1.9.comment Anilin family - Anilines, MOCA: Comment   
q3.8.9.1.1 Chemical mixtures: Matrix Regarding chemicals 
mixtures: Matrix 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.9.1.1.comment Chemical mixtures: Comment   
q3.8.9.1.2 Chemical mixtures: Unit of measurement Regarding chemicals 
mixtures: Unit of 
measurement 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.9.1.2.comment Chemical mixtures: Comment   
q3.8.9.1.3 Chemical mixtures: LOD Regarding chemicals 
mixtures: LOD 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.9.1.3.comment Chemical mixtures: Comment   
q3.8.9.1.4 Chemical mixtures: LOQ Regarding chemicals 
mixtures: LOQ 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.9.1.4.comment Chemical mixtures: Comment   
q3.8.9.1.5 Chemical mixtures: Number of analysed samples Regarding chemicals 
mixtures: Number of 
analysed samples 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.9.1.5.comment Chemical mixtures: Comment   
q3.8.9.1.6 
Chemical mixtures: Number of samples below 
LOD 
Regarding chemicals 
mixtures: Number of 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
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q3.8.9.1.6.comment Chemical mixtures: Comment samples below LOD   
q3.8.9.1.7 
Chemical mixtures: Number of samples below 
LOQ 
Regarding chemicals 
mixtures: Number of 
samples below LOQ 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.9.1.7.comment Chemical mixtures: Comment   
q3.8.9.1.8 Chemical mixtures: Exposure range Regarding chemicals 
mixtures: Exposure range 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.9.1.8.comment Chemical mixtures: Comment   
q3.8.9.1.9 Chemical mixtures: Analytical method Regarding chemicals 
mixtures: Analytical 
method 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.9.1.9.comment Chemical mixtures: Comment   
q3.8.10.1.1 Emerging chemicals: Matrix Regarding emerging 
chemicals: Matrix 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.10.1.1.comment Emerging chemicals: Comment   
q3.8.10.1.2 Emerging chemicals: Unit of measurement Regarding emerging 
chemicals: Unit of 
measurement 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.10.1.2.comment Emerging chemicals: Comment   
q3.8.10.1.3 Emerging chemicals: LOD Regarding emerging 
chemicals: LOD 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.10.1.3.comment Emerging chemicals: Comment   
q3.8.10.1.4 Emerging chemicals: LOQ Regarding emerging 
chemicals: LOQ 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.10.1.4.comment Emerging chemicals: Comment   
q3.8.10.1.5 
Emerging chemicals: Number of analysed 
samples 
Regarding emerging 
chemicals: Number of 
analysed samples 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.10.1.5.comment Emerging chemicals: Comment   
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q3.8.10.1.6 
Emerging chemicals: Number of samples below 
LOD 
Regarding emerging 
chemicals: Number of 
samples below LOD 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.10.1.6.comment Emerging chemicals: Comment   
q3.8.10.1.7 
Emerging chemicals: Number of samples below 
LOQ 
Regarding emerging 
chemicals: Number of 
samples below LOQ 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.10.1.7.comment Emerging chemicals: Comment   
q3.8.10.1.8 Emerging chemicals: Exposure range Regarding emerging 
chemicals: Exposure range 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.10.1.8.comment Emerging chemicals: Comment   
q3.8.10.1.9 Emerging chemicals: Analytical method Regarding emerging 
chemicals: Analytical 
method 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.10.1.9.comment Emerging chemicals: Comment   
q3.8.11.1.1 Other substances: Matrix Regarding other substance: 
Matrix 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.11.1.1.comment Other substances: Comment   
q3.8.11.1.2 Other substances: Unit of measurement Regarding other substance: 
Unit of measurement 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.11.1.2.comment Other substances: Comment   
q3.8.11.1.3 Other substances: LOD Regarding other substance: 
LOD 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.11.1.3.comment Other substances: Comment   
q3.8.11.1.4 Other substances: LOQ Regarding other substance: 
LOQ 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.11.1.4.comment Other substances: Comment   
q3.8.11.1.5 Other substances: Number of analysed samples 
Regarding other substance: 
Number of analysed 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
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q3.8.11.1.5.comment Other substances: Comment samples   
q3.8.11.1.6 
Other substances: Number of samples below 
LOD 
Regarding other substance: 
Number of samples below 
LOD 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.11.1.6.comment Other substances: Comment   
q3.8.11.1.7 
Other substances: Number of samples below 
LOQ 
Regarding other substance: 
Number of samples below 
LOQ 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.11.1.7.comment Other substances: Comment   
q3.8.11.1.8 Other substances: Exposure range Regarding other substance: 
Exposure range 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.11.1.8.comment Other substances: Comment   
q3.8.11.1.9 Other substances: Analytical method Regarding other 
substances: Analytical 
method 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.8.11.1.9.comment Other substances: Comment   
q3.9 






No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.9.1.1 
Genetic-related data: Specific polymorphism - 
GSTM1 
Which data were collected 
regarding specific 
polymorphisms? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q3.9.1.2 
Genetic-related data: Specific polymorphism - 
GSTM3 
q3.9.1.3 
Genetic-related data: Specific polymorphism - 
GSTT1 
q3.9.1.4 
Genetic-related data: Specific polymorphism - 
GSTP1 
q3.9.1.5 Genetic-related data: Specific polymorphism - 
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NAT2 
q3.9.1.6 
Genetic-related data: Specific polymorphism - 
EPHX 
q3.9.1.7 
Genetic-related data: Specific polymorphism - 
XRCC1 
q3.9.1.8 
Genetic-related data: Specific polymorphism - 
XRCC3 
q3.9.1.9 
Genetic-related data: Specific polymorphism - 
XPD 
q3.9.1.10 
Genetic-related data: Specific polymorphism - 
XPA 
q3.9.1.11 
Genetic-related data: Specific polymorphism - 
TDG 
q3.9.1.12 
Genetic-related data: Specific polymorphism - 
ALAD 
q3.9.1.other 
Genetic-related data: Specific polymorphism - 
Other 
q3.9.2.1 
Genetic-related data: DNA damage - Single 
strand breaks 
Which data were collected 
regarding DNA Damage? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q3.9.2.2 
Genetic-related data: DNA damage - Double 
strand breaks 
q3.9.2.3 
Genetic-related data: DNA damage - DNA strand 
cross links 
q3.9.2.4 
Genetic-related data: DNA damage - DNA 
adducts 
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q3.9.2.5 
Genetic-related data: DNA damage - DNA base 
changes 
q3.9.2.other Genetic-related data: DNA damage - Other 
q3.9.3.1 Genetic-related data: DNA repair - Apoptosis 
Which data were collected 
regarding DNA Repair? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q3.9.3.2 
Genetic-related data: DNA repair - Excision 
repair 
q3.9.3.3 
Genetic-related data: DNA repair - Double-
strand break repair 
q3.9.3.other Genetic-related data: DNA repair - Other 
q3.9.4.1 Genetic-related data: Gene mutations - HPRT 
Which data were collected 
regarding gene mutations? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q3.9.4.2 
Genetic-related data: Gene mutations - 
Glycophorin A 
q3.9.4.other Genetic-related data: Gene mutations - Other 
q3.9.5.1 
Genetic-related data: Chromosomal alterations - 
Chromosomal aberrations 
Which data were collected 
regarding chromosomal 
alterations? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q3.9.5.2 
Genetic-related data: Chromosomal alterations - 
Micronuclei 
q3.9.5.3 
Genetic-related data: Chromosomal alterations - 
Numerical chromosome changes 
q3.9.5.4 
Genetic-related data: Chromosomal alterations - 
Sister chromatid exchange 
q3.9.5.5 Genetic-related data: Chromosomal alterations - 
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Reciprocal translocations 
q3.9.5.other 
Genetic-related data: Chromosomal alterations - 
Other 
q3.10 
Does the study/project/activity collect data 
regarding molecular information? 
Does the 
study/project/activity 
collect data regarding 
molecular information? 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.10.1 Molecular information: Genetic 
Which data were collected 
regarding molecular 
information? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q3.10.2 Molecular information: Epigenetic 
q3.10.3 Molecular information: Proteins 
q3.10.4 Molecular information: Metabolites 
q3.10.other Molecular information: Other 
q3.11 
Does the study/project/activity collect data 
about skin parameters? 
Does the 
study/project/activity 
collect data about skin 
parameters? 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.11.1 Skin parameters data: Skin examination 
Which data were collected 
regarding skin parameters? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q3.11.2 Skin parameters data: RAST 
q3.11.3 Skin parameters data: SPT 
q3.11.4 Skin parameters data: Epicutane test 
q3.11.other Skin parameters data: Other 
q3.12 
Does the study/project/activity collect data 
about respiratory/lung parameters? 
Does the 
study/project/activity 
collect data about 
respiratory/lung 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
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parameters? 
q3.12.1 
Respiratory/lung parameters data: Diary of lung 
symptoms 
Which data were collected 
regarding respiratory/lung 
parameters? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q3.12.2 
Respiratory/lung parameters data: Complement 
C3c in serum 
q3.12.3 Respiratory/lung parameters data: Spirometry 
q3.12.4 
Respiratory/lung parameters data: Lung function 
test 
q3.12.other Respiratory/lung parameters data: Other 
q3.12.4.1 
Respiratory/lung parameters data: Lung function 
test - VFC 
Which data were collected 
regarding specific lung 
function test? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q3.12.4.2 
Respiratory/lung parameters data: Lung function 
test - FEV1 
q3.12.4.3 
Respiratory/lung parameters data: Lung function 
test - PEF 
q3.12.4.4 
Respiratory/lung parameters data: Lung function 
test - MEF50 
q3.12.4.5 
Respiratory/lung parameters data: Lung function 
test - Bronchial hyperactivity 
q3.12.4.other 
Respiratory/lung parameters data: Lung function 
test - Other 
q3.13 
Does the study/project/activity collect data 
about skeletal parameters? 
Does the 
study/project/activity 
collect data about skeletal 
parameters? 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.13.1 Skeletal parameters data: Osteocalcin Which data were collected No – 0 This set of variables represents a 
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q3.13.2 Skeletal parameters data: Bone density regarding skeletal 
parameters? 
Yes – 1 multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q3.13.other Skeletal parameters data: Other 
q3.14 
Does the study/project/activity collect data 
regarding renal function parameters? 
Does the 
study/project/activity 
collect data regarding renal 
function parameters? 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.14.1 
Renal function parameters data: Urinary total 
protein 
Which data were collected 
regarding renal function 
parameters? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q3.14.2 Renal function parameters data: Albumin 
q3.14.3 
Renal function parameters data: Alpha-1-
microglobuline 
q3.14.4 
Renal function parameters data: Urinary β2-
microglobulin 
q3.14.5 
Renal function parameters data: HMW- and 
LMW-proteins 
q3.14.6 Renal function parameters data: Creatinine value 
q3.14.7 
Renal function parameters data: Retinol binding 
protein 
q3.14.8 Renal function parameters data: NAG in urine 
q3.14.9 Renal function parameters data: 8-ALA 
q3.14.other Renal function parameters data: Other 
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q3.15 
Does the study/project/activity collect data 








No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.15.1.1 
Reproductive and/or development system 
parameters data: Sexual maturation and function 
- Testicular volume in boys 
Which data were collected 
regarding sexual 
maturation and function? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q3.15.1.2 
Reproductive and/or development system 
parameters data: Sexual maturation and function 
- Age at menarche in girls 
q3.15.1.3 
Reproductive and/or development system 
parameters data: Sexual maturation and function 
- Puberty stage (Marshall-Tanner) 
q3.15.1.4 
Reproductive and/or development system 
parameters data: Sexual maturation and function 
- Sex hormones 
q3.15.1.5 
Reproductive and/or development system 
parameters data: Sexual maturation and function 
- Thyroid hormones 
q3.15.1.6 
Reproductive and/or development system 
parameters data: Sexual maturation and function 
- Libido 
q3.15.1.7 
Reproductive and/or development system 
parameters data: Sexual maturation and function 
- Semen analysis 
q3.15.1.other Reproductive and/or development system 
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parameters data: Sexual maturation and function 
- Other 
q3.15.2.1 
Reproductive and/or development system 
parameters data: Pregnancy and lactation - Milk 
Quantity/Quality 
Which data were collected 
regarding pregnancy and 
lactation? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q3.15.2.2 
Reproductive and/or development system 
parameters data: Pregnancy and lactation - 
Thyroid markers 
q3.15.2.other 
Reproductive and/or development system 
parameters data: Pregnancy and lactation - 
Other 
q3.15.3.1 
Reproductive and/or development system 
parameters data: Newborn - Birth weight 
Which data were collected 
regarding newborn? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q3.15.3.2 
Reproductive and/or development system 
parameters data: Newborn - APGAR score 
q3.15.3.3 
Reproductive and/or development system 
parameters data: Newborn - Digit ratio 
q3.15.3.other 
Reproductive and/or development system 
parameters data: Newborn - Other 
q3.15.4.1 
Reproductive and/or development system 
parameters data: Development - Griffith’s testing 
Which data were collected 
regarding development? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q3.15.4.2 
Reproductive and/or development system 
parameters data: Development - 
Neuropathological parameters 
q3.15.4.3 
Reproductive and/or development system 
parameters data: Development - 
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Neuropsychological parameters 
q3.15.4.4 
Reproductive and/or development system 
parameters data: Development - 
Neurophysiological parameters 
q3.15.4.5 
Reproductive and/or development system 
parameters data: Development - Growth 
retardation 
q3.15.4.other 
Reproductive and/or development system 
parameters data: Development - Other 
q3.16 




collect data regarding 
immunity? 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.16.1 Immunity data: Immune system effects 
Which data were collected 
regarding acquired 
immunity activity? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q3.16.2 Immunity data: Innate Immunity activity 
q3.16.3 
Immunity data: Acquired Immunity activity - 
Humoral 
q3.16.4 
Immunity data: Acquired Immunity activity - Cell 
mediated 
q3.16.5 
Immunity data: Acquired Immunity activity - 
Clinical expressions 
q3.16.3.1 
Immunity data: Acquired Immunity activity - 
Humoral: IgM 
Which data were collected 
regarding humoral 
immunity? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
q3.16.3.2 
Immunity data: Acquired Immunity activity - 
Humoral: Antigen specific 
q3.16.3.3 Immunity data: Acquired Immunity activity - 
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Humoral: Cytokine release/activity frequency table will be produced for this 
multiple-choice-set. 
q3.16.3.4 
Immunity data: Acquired Immunity activity - 
Humoral: Co-receptors 
q3.16.3.other 
Immunity data: Acquired Immunity activity - 
Humoral: Other 
q3.16.4.1 
Immunity data: Acquired Immunity activity - Cell 
mediated: T cell response 
Which data were collected 
regarding cell-mediated 
immunity? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q3.16.4.other 
Immunity data: Acquired Immunity activity - Cell 
mediated: Other 
q3.16.5.1 
Immunity data: Acquired Immunity activity - 
Clinical expressions: Sensitivity 
Which data were collected 
regarding clinical 
expressions immunity? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q3.16.5.2 
Immunity data: Acquired Immunity activity - 
Clinical expressions: Allergic reaction 
q3.16.5.other 
Immunity data: Acquired Immunity activity - 
Clinical expressions: Other 
q3.17 
Does the study/project/activity collect data 
regarding neurological parameters? 
Does the 
study/project/activity 
collect data regarding 
neurological parameters? 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.17.1.1 
Neurological parameters data: Morphological - 
Neuropathological Which morphological data 
were collected? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple q3.17.1.2 
Neurological parameters data: Morphological - 
Gross anatomical 
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q3.17.1.3 
Neurological parameters data: Morphological - 
Immunocytochemical 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. q3.17.1.other 
Neurological parameters data: Morphological - 
Other 
q3.17.2.1 
Neurological parameters data: Physiological and 
biochemical - BrainStem Response Audiometry 
Which physiological and 
biochemical data were 
collected? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q3.17.2.2 
Neurological parameters data: Physiological and 
biochemical - EEG 
q3.17.2.3 
Neurological parameters data: Physiological and 
biochemical - Brain mapping 
q3.17.2.4 
Neurological parameters data: Physiological and 
biochemical - Neurotransmitters 
q3.17.2.5 
Neurological parameters data: Physiological and 
biochemical - Cell integrity 
q3.17.2.6 
Neurological parameters data: Physiological and 
biochemical - Enzyme/Protein activity 
q3.17.2.other 
Neurological parameters data: Physiological and 
biochemical - Other 
q3.17.3.1 
Neurological parameters data: Behavioural and 
other neurological assessments - Neurological 
Evaluation Scale (NES) tests 
Which data were collected 
regarding behavioural and 
other neurological 
assessments? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q3.17.3.2 
Neurological parameters data: Behavioural and 
other neurological assessments - 
Neuropsychological evaluation 
q3.17.3.3 
Neurological parameters data: Behavioural and 
other neurological assessments - Neuro-
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cognitive development 
q3.17.3.4 
Neurological parameters data: Behavioural and 
other neurological assessments - Motor 
development 
q3.17.3.other 
Neurological parameters data: Behavioural and 
other neurological assessments - Other 
q3.18 
Does the study/project/activity collect data 
regarding essential trace elements? 
Does the 
study/project/activity 
collect data regarding 
essential trace elements? 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.18.1 Essential trace elements data: K 
Which data were collected 
regarding essential trace 
elements? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q3.18.2 Essential trace elements data: Na 
q3.18.3 Essential trace elements data: Ca 
q3.18.4 Essential trace elements data: Mg 
q3.18.5 Essential trace elements data: Cu 
q3.18.6 Essential trace elements data: Zn 
q3.18.7 Essential trace elements data: Fe 
q3.18.8 Essential trace elements data: Mn 
q3.18.other Essential trace elements data: Other 
q3.19 
Does the study/project/activity collect 




data? (Not subjective data 
but objectively measured, 
instead) 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.19.1 Anthropometric data: Height Which anthropometric data No – 0 This set of variables represents a 
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q3.19.2 Anthropometric data: Weight were collected? Yes – 1 multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q3.19.3 Anthropometric data: Waist 
q3.19.4 Anthropometric data: Hip 
q3.19.5 Anthropometric data: Skin fold 
q3.19.other Anthropometric data: Other 
q3.20 
Does the study/project/activity collect data 




collect data regarding 
other biomarkers or 
physiological indicators? 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q3.20.1 
Other biomarkers or physiological indicators 
data: Oxidative damage 
Which data were collected 
regarding biomarkers or 
physiological indicators? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q3.20.2 
Other biomarkers or physiological indicators 
data: Blood pressure 
q3.20.3 
Other biomarkers or physiological indicators 
data: Heart rate 
q3.20.4 
Other biomarkers or physiological indicators 
data: Status of the thyroid gland 
q3.20.5 
Other biomarkers or physiological indicators 
data: Glucose tolerance 
q3.20.6 
Other biomarkers or physiological indicators 
data: Fasting glycaemia 
q3.20.7 
Other biomarkers or physiological indicators 
data: Glycated haemoglobin 
q3.20.8 Other biomarkers or physiological indicators 
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data: Immunophenotyping 
q3.20.9 
Other biomarkers or physiological indicators 
data: HDL cholesterol 
q3.20.10 
Other biomarkers or physiological indicators 
data: LDL cholesterol 
q3.20.11 
Other biomarkers or physiological indicators 
data: Total cholesterol 
q3.20.12 
Other biomarkers or physiological indicators 
data: Serum triglycerides 
q3.20.13 
Other biomarkers or physiological indicators 
data: Bone density 
q3.20.14 
Other biomarkers or physiological indicators 
data: Iron status 
q3.20.15 
Other biomarkers or physiological indicators 
data: Vitamin levels 
q3.20.16 
Other biomarkers or physiological indicators 
data: Haematocrit 
q3.20.17 
Other biomarkers or physiological indicators 
data: Specific metabolising genes 
q3.20.18 
Other biomarkers or physiological indicators 
data: Haemoglobin 
q3.20.19 
Other biomarkers or physiological indicators 
data: Growth factors 
q3.20.20 
Other biomarkers or physiological indicators 
data: Hearing assessment 
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q3.20.21 
Other biomarkers or physiological indicators 
data: Visual accuracy 
q3.20.other 
Other biomarkers or physiological indicators 
data: Other 
q3.21.description Individual recruitment procedures 




4. OTHER DATA 
q4.1.1 
ENVIRONMENTAL DATA Does the 




collect data about outdoor 
pollution? 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q4.1.1.1.1 
ENVIRONMENTAL DATA Outdoor pollution data: 
Air pollutants - Amount of reactive oxygen 
species 
Which data were collected 
regarding air pollutants? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q4.1.1.1.2 
ENVIRONMENTAL DATA Outdoor pollution data: 
Air pollutants - Transition metal content 
q4.1.1.1.3 
ENVIRONMENTAL DATA Outdoor pollution data: 
Air pollutants - LPS content 
q4.1.1.1.4 
ENVIRONMENTAL DATA Outdoor pollution data: 
Air pollutants - Biological pollutants 
q4.1.1.1.5 
ENVIRONMENTAL DATA Outdoor pollution data: 
Air pollutants - PM 2,5 
q4.1.1.1.6 
ENVIRONMENTAL DATA Outdoor pollution data: 
Air pollutants - PM 10 
q4.1.1.1.7 
ENVIRONMENTAL DATA Outdoor pollution data: 
Air pollutants - Black smoke 
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q4.1.1.1.8 
ENVIRONMENTAL DATA Outdoor pollution data: 
Air pollutants - NO2 
q4.1.1.1.9 
ENVIRONMENTAL DATA Outdoor pollution data: 
Air pollutants - Nox 
q4.1.1.1.10 
ENVIRONMENTAL DATA Outdoor pollution data: 
Air pollutants - SO2 
q4.1.1.1.11 
ENVIRONMENTAL DATA Outdoor pollution data: 
Air pollutants - Carbon monoxide (CO) 
q4.1.1.1.12 
ENVIRONMENTAL DATA Outdoor pollution data: 
Air pollutants - Ozone (O3) 
q4.1.1.1.13 
ENVIRONMENTAL DATA Outdoor pollution data: 
Air pollutants - Benzene 
q4.1.1.1.14 
ENVIRONMENTAL DATA Outdoor pollution data: 
Air pollutants - Toluene 
q4.1.1.1.15 
ENVIRONMENTAL DATA Outdoor pollution data: 
Air pollutants - Xylenes 
q4.1.1.1.16 
ENVIRONMENTAL DATA Outdoor pollution data: 
Air pollutants - Pesticides 
q4.1.1.1.17 
ENVIRONMENTAL DATA Outdoor pollution data: 
Air pollutants - Biocides 
q4.1.1.1.other 
ENVIRONMENTAL DATA Outdoor pollution data: 
Air pollutants - Other 
q4.1.1.2.1 
ENVIRONMENTAL DATA Outdoor pollution data: 
Airborne nanoparticle identification - Trace 
elements/minerals 
Which data were collected 
regarding airborne 
nanoparticle identification? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
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q4.1.1.2.other 
ENVIRONMENTAL DATA Outdoor pollution data: 
Airborne nanoparticle identification - Other 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q4.1.1.2.1.1 
ENVIRONMENTAL DATA Outdoor pollution data: 
Airborne nanoparticle identification - Trace 
elements/minerals: Arsenic 
Which data were collected 
regarding trace 
elements/minerals? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q4.1.1.2.1.2 
ENVIRONMENTAL DATA Outdoor pollution data: 
Airborne nanoparticle identification - Trace 
elements/minerals: Boron 
q4.1.1.2.1.3 
ENVIRONMENTAL DATA Outdoor pollution data: 
Airborne nanoparticle identification - Trace 
elements/minerals: Bronze 
q4.1.1.2.1.4 
ENVIRONMENTAL DATA Outdoor pollution data: 
Airborne nanoparticle identification - Trace 
elements/minerals: Cadmium 
q4.1.1.2.1.5 
ENVIRONMENTAL DATA Outdoor pollution data: 
Airborne nanoparticle identification - Trace 
elements/minerals: Chromium 
q4.1.1.2.1.6 
ENVIRONMENTAL DATA Outdoor pollution data: 
Airborne nanoparticle identification - Trace 
elements/minerals: Copper 
q4.1.1.2.1.7 
ENVIRONMENTAL DATA Outdoor pollution data: 
Airborne nanoparticle identification - Trace 
elements/minerals: Iron 
q4.1.1.2.1.8 
ENVIRONMENTAL DATA Outdoor pollution data: 
Airborne nanoparticle identification - Trace 
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elements/minerals: Lead 
q4.1.1.2.1.9 
ENVIRONMENTAL DATA Outdoor pollution data: 
Airborne nanoparticle identification - Trace 
elements/minerals: Magnesium 
q4.1.1.2.1.10 
ENVIRONMENTAL DATA Outdoor pollution data: 
Airborne nanoparticle identification - Trace 
elements/minerals: Phosphorus 
q4.1.1.2.1.11 
ENVIRONMENTAL DATA Outdoor pollution data: 
Airborne nanoparticle identification - Trace 
elements/minerals: Selenium 
q4.1.1.2.1.12 
ENVIRONMENTAL DATA Outdoor pollution data: 
Airborne nanoparticle identification - Trace 
elements/minerals: Zinc 
q4.1.1.2.1.other 
ENVIRONMENTAL DATA Outdoor pollution data: 
Airborne nanoparticle identification - Trace 
elements/minerals: Other 
q4.1.1.3.1 
ENVIRONMENTAL DATA Outdoor pollution data: 
Soil pollution - Metals Which data were collected 
regarding soil pollution: 
Metals? 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q4.1.1.3.1.comment 
ENVIRONMENTAL DATA Outdoor pollution data: 
Soil pollution - Metals: Comment 
  
q4.1.1.3.2 
ENVIRONMENTAL DATA Outdoor pollution data: 
Soil pollution - Biocides Which data were collected 
regarding soil pollution: 
Biocides? 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q4.1.1.3.2.comment 
ENVIRONMENTAL DATA Outdoor pollution data: 
Soil pollution - Biocides: Comment 
  
q4.1.1.3.3 
ENVIRONMENTAL DATA Outdoor pollution data: 
Soil pollution - Pesticides 
Which data were collected 
regarding soil pollution: 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
 
VARIABLE NAME LABEL QUESTION VALUES AND CODES ANALYSIS 
q4.1.1.3.3.comment 
ENVIRONMENTAL DATA Outdoor pollution data: 




ENVIRONMENTAL DATA Outdoor pollution data: 
Soil pollution - Other Which data were collected 
regarding soil pollution: 
Other? 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q4.1.1.3.4.comment 
ENVIRONMENTAL DATA Outdoor pollution data: 
Soil pollution - Other: Comment 
  
q4.1.1.4 
ENVIRONMENTAL DATA Outdoor pollution data: 
Environmental noise exposure 
Which data were collected 
regarding environmental 
noise exposure? 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q4.1.1.5.1 
ENVIRONMENTAL DATA Outdoor pollution data: 
Ratio of heavy metals assessment in - Plants 
Which data were collected 
regarding ratio of heavy 
metals assessment? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q4.1.1.5.2 
ENVIRONMENTAL DATA Outdoor pollution data: 
Ratio of heavy metals assessment in - Water 
q4.1.1.5.3 
ENVIRONMENTAL DATA Outdoor pollution data: 
Ratio of heavy metals assessment in - Wild life 
q4.1.1.5.other 
ENVIRONMENTAL DATA Outdoor pollution data: 
Ratio of heavy metals assessment in - Other 
q4.1.2 
ENVIRONMENTAL DATA Does the 
study/project/activity collect data about climate? 
Does the 
study/project/activity 
collect data about climate? 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q4.1.2.1 
ENVIRONMENTAL DATA Outdoor climate data: 
Temperature (maximum, minimum, …) 
Which data were collected 
regarding outdoor climate? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
q4.1.2.2 
ENVIRONMENTAL DATA Outdoor climate data: 
Humidity 
q4.1.2.3 
ENVIRONMENTAL DATA Outdoor climate data: 
Pressure 
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q4.1.2.4 




ENVIRONMENTAL DATA Outdoor climate data: 
Cloudiness 
q4.1.2.6 
ENVIRONMENTAL DATA Outdoor climate data: 
Sun exposure 
q4.1.2.7 
ENVIRONMENTAL DATA Outdoor climate data: 
Snow fall (depth of snow on the ground) 
q4.1.2.8 
ENVIRONMENTAL DATA Outdoor climate data: 
Frost 
q4.1.2.9 
ENVIRONMENTAL DATA Outdoor climate data: 
Wind chill 
q4.1.2.other 
ENVIRONMENTAL DATA Outdoor climate data: 
Other 
q4.1.3 
ENVIRONMENTAL DATA Does the 




collect general information 
on residence? 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q4.1.3.1 
ENVIRONMENTAL DATA General information on 
residence: Address 
Which data were collected 
regarding general 
information on residence? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q4.1.3.2 
ENVIRONMENTAL DATA General information on 
residence: Place of residence 
q4.1.3.3 
ENVIRONMENTAL DATA General information on 
residence: Number of years living in this 
residence 
q4.1.3.4 ENVIRONMENTAL DATA General information on 
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residence: Number of hours in the residence 
(working days) 
q4.1.3.5 
ENVIRONMENTAL DATA General information on 
residence: Number of persons living in the 
household 
q4.1.3.6 
ENVIRONMENTAL DATA General information on 
residence: Number of siblings 
q4.1.3.7 
ENVIRONMENTAL DATA General information on 
residence: Year of construction of the building 
q4.1.3.8 
ENVIRONMENTAL DATA General information on 
residence: Urban/rural 
q4.1.3.9 
ENVIRONMENTAL DATA General information on 
residence: Pollution sources near residence 
q4.1.3.other 
ENVIRONMENTAL DATA General information on 
residence: Other 
q4.1.4 
ENVIRONMENTAL DATA Does the 




collect data about indoor 
parameters? 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q4.1.4.1.1 
ENVIRONMENTAL DATA Indoor parameters: 
Housing characteristics - Type of dwelling (e.g., 
apartment, house, …) 
Which data were collected 
regarding housing 
characteristics? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q4.1.4.1.2 
ENVIRONMENTAL DATA Indoor parameters: 
Housing characteristics - Accommodation 
crowding (e.g., number of persons per bedroom) 
q4.1.4.1.3 
ENVIRONMENTAL DATA Indoor parameters: 
Housing characteristics - Heating appliances 
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q4.1.4.1.4 
ENVIRONMENTAL DATA Indoor parameters: 
Housing characteristics - Cooking appliances 
q4.1.4.1.5 
ENVIRONMENTAL DATA Indoor parameters: 
Housing characteristics - Ventilation 
q4.1.4.1.6 
ENVIRONMENTAL DATA Indoor parameters: 
Housing characteristics - Ceiling covering 
q4.1.4.1.7 
ENVIRONMENTAL DATA Indoor parameters: 
Housing characteristics - Wall covering 
q4.1.4.1.8 
ENVIRONMENTAL DATA Indoor parameters: 
Housing characteristics - Floor covering 
q4.1.4.1.9 
ENVIRONMENTAL DATA Indoor parameters: 
Housing characteristics - Indoor smoking 
q4.1.4.1.10 
ENVIRONMENTAL DATA Indoor parameters: 
Housing characteristics - Home dampness 
q4.1.4.1.11 
ENVIRONMENTAL DATA Indoor parameters: 
Housing characteristics - Pet ownership 
q4.1.4.1.12 
ENVIRONMENTAL DATA Indoor parameters: 
Housing characteristics - Garden belonging to 
the house 
q4.1.4.1.13 
ENVIRONMENTAL DATA Indoor parameters: 
Housing characteristics - Use of pesticides 
q4.1.4.1.14 
ENVIRONMENTAL DATA Indoor parameters: 
Housing characteristics - Use of biocides 
q4.1.4.1.other 
ENVIRONMENTAL DATA Indoor parameters: 
Housing characteristics - Other 
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q4.1.4.2.1 
ENVIRONMENTAL DATA Indoor parameters: 
Household drinking water parameters - 
Aluminium 
Which data were collected 
regarding household 
drinking water parameters? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q4.1.4.2.2 
ENVIRONMENTAL DATA Indoor parameters: 
Household drinking water parameters - Arsenic 
q4.1.4.2.3 
ENVIRONMENTAL DATA Indoor parameters: 
Household drinking water parameters - Barium 
q4.1.4.2.4 
ENVIRONMENTAL DATA Indoor parameters: 
Household drinking water parameters - Boron 
q4.1.4.2.5 
ENVIRONMENTAL DATA Indoor parameters: 
Household drinking water parameters - 
Cadmium 
q4.1.4.2.6 
ENVIRONMENTAL DATA Indoor parameters: 
Household drinking water parameters - Calcium 
q4.1.4.2.7 
ENVIRONMENTAL DATA Indoor parameters: 
Household drinking water parameters - Chloride 
q4.1.4.2.8 
ENVIRONMENTAL DATA Indoor parameters: 
Household drinking water parameters - Copper 
q4.1.4.2.9 
ENVIRONMENTAL DATA Indoor parameters: 
Household drinking water parameters - Iron 
q4.1.4.2.10 
ENVIRONMENTAL DATA Indoor parameters: 
Household drinking water parameters - Lead 
q4.1.4.2.11 
ENVIRONMENTAL DATA Indoor parameters: 
Household drinking water parameters - 
Magnesium 
q4.1.4.2.12 ENVIRONMENTAL DATA Indoor parameters: 
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Household drinking water parameters - 
Manganese 
q4.1.4.2.13 
ENVIRONMENTAL DATA Indoor parameters: 
Household drinking water parameters - Nickel 
q4.1.4.2.14 
ENVIRONMENTAL DATA Indoor parameters: 
Household drinking water parameters - Nitrate 
q4.1.4.2.15 
ENVIRONMENTAL DATA Indoor parameters: 
Household drinking water parameters - 
Phosphorus 
q4.1.4.2.16 
ENVIRONMENTAL DATA Indoor parameters: 
Household drinking water parameters - 
Potassium 
q4.1.4.2.17 
ENVIRONMENTAL DATA Indoor parameters: 
Household drinking water parameters - 
Selenium 
q4.1.4.2.18 
ENVIRONMENTAL DATA Indoor parameters: 
Household drinking water parameters - Sodium 
q4.1.4.2.19 
ENVIRONMENTAL DATA Indoor parameters: 
Household drinking water parameters - 
Strontium 
q4.1.4.2.20 
ENVIRONMENTAL DATA Indoor parameters: 
Household drinking water parameters - Sulphate 
q4.1.4.2.21 
ENVIRONMENTAL DATA Indoor parameters: 
Household drinking water parameters - Zinc 
q4.1.4.2.other 
ENVIRONMENTAL DATA Indoor parameters: 
Household drinking water parameters - Other 
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q4.1.4.3.1 
ENVIRONMENTAL DATA Indoor parameters: 
Household air quality - Relative humidity 
Which data were collected 
regarding household air 
quality? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q4.1.4.3.2 
ENVIRONMENTAL DATA Indoor parameters: 
Household air quality - Temperature 
q4.1.4.3.3 
ENVIRONMENTAL DATA Indoor parameters: 
Household air quality - PM 2,5 
q4.1.4.3.4 
ENVIRONMENTAL DATA Indoor parameters: 
Household air quality - PM 10 
q4.1.4.3.5 
ENVIRONMENTAL DATA Indoor parameters: 
Household air quality - NO 
q4.1.4.3.6 
ENVIRONMENTAL DATA Indoor parameters: 
Household air quality - NO2 
q4.1.4.3.7 
ENVIRONMENTAL DATA Indoor parameters: 
Household air quality - Nox 
q4.1.4.3.8 
ENVIRONMENTAL DATA Indoor parameters: 
Household air quality - CO 
q4.1.4.3.9 
ENVIRONMENTAL DATA Indoor parameters: 
Household air quality - SO2 
q4.1.4.3.10 
ENVIRONMENTAL DATA Indoor parameters: 
Household air quality - Carbonyl 
q4.1.4.3.11 
ENVIRONMENTAL DATA Indoor parameters: 
Household air quality - Fungal contamination 
q4.1.4.3.12 
ENVIRONMENTAL DATA Indoor parameters: 
Household air quality - Mould burden 
q4.1.4.3.13 ENVIRONMENTAL DATA Indoor parameters: 
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Household air quality - VOC 
q4.1.4.3.14 
ENVIRONMENTAL DATA Indoor parameters: 
Household air quality - MVOC 
q4.1.4.3.15 
ENVIRONMENTAL DATA Indoor parameters: 
Household air quality - PCBs 
q4.1.4.3.16 
ENVIRONMENTAL DATA Indoor parameters: 
Household air quality - Coarse particles 
q4.1.4.3.17 
ENVIRONMENTAL DATA Indoor parameters: 
Household air quality - Environmental tobacco 
smoke 
q4.1.4.3.other 
ENVIRONMENTAL DATA Indoor parameters: 
Household air quality - Other 
q4.1.4.4.1 
ENVIRONMENTAL DATA Indoor parameters: 
House dust - Mite levels 
Which data were collected 
regarding house dust? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q4.1.4.4.2 
ENVIRONMENTAL DATA Indoor parameters: 
House dust - Mould spores 
q4.1.4.4.3 
ENVIRONMENTAL DATA Indoor parameters: 
House dust - Fungal contamination 
q4.1.4.4.4 
ENVIRONMENTAL DATA Indoor parameters: 
House dust - Pentachlorphenol 
q4.1.4.4.5 
ENVIRONMENTAL DATA Indoor parameters: 
House dust - Pyrethroides 
q4.1.4.4.6 
ENVIRONMENTAL DATA Indoor parameters: 
House dust - Dust from vacuum cleaner 
q4.1.4.4.7 ENVIRONMENTAL DATA Indoor parameters: 
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House dust - Deposited dust in the household 
q4.1.4.4.other 
ENVIRONMENTAL DATA Indoor parameters: 
House dust - Other 
q4.1.4.4.6.1 
ENVIRONMENTAL DATA Indoor parameters: 
House dust - Dust from vacuum cleaner: 
Biocides/pesticides 
Which data were collected 
regarding dust from 
vacuum cleaner? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q4.1.4.4.6.2 
ENVIRONMENTAL DATA Indoor parameters: 
House dust - Dust from vacuum cleaner: 
Plasticisers 
q4.1.4.4.6.3 
ENVIRONMENTAL DATA Indoor parameters: 
House dust - Dust from vacuum cleaner: Metals 
q4.1.4.4.6.other 
ENVIRONMENTAL DATA Indoor parameters: 
House dust - Dust from vacuum cleaner: Other 
q4.1.4.4.7.1 
ENVIRONMENTAL DATA Indoor parameters: 
House dust - Deposited dust in the household: 
Biocides/pesticides 
Which data were collected 
regarding deposited dust 
in the household? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q4.1.4.4.7.2 
ENVIRONMENTAL DATA Indoor parameters: 
House dust - Deposited dust in the household: 
Plasticisers 
q4.1.4.4.7.3 
ENVIRONMENTAL DATA Indoor parameters: 
House dust - Deposited dust in the household: 
Metals 
q4.1.4.4.7.other 
ENVIRONMENTAL DATA Indoor parameters: 
House dust - Deposited dust in the household: 
Other 
q4.2.1 LIFESTYLE Does the study/project/activity collect 
Does the 
study/project/activity 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
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data about food intake / food habits? collect data about food 
intake / food habits? 
q4.2.1.1.1 
LIFESTYLE Food intake / food habits: Type of 
food habits’ assessment method - 24h recall 
Which data were collected 
regarding type of food 
habits’ assessment 
method? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q4.2.1.1.2 
LIFESTYLE Food intake / food habits: Type of 
food habits’ assessment method - Total diet 
register 
q4.2.1.1.3 
LIFESTYLE Food intake / food habits: Type of 
food habits’ assessment method - Observation 
q4.2.1.1.4 
LIFESTYLE Food intake / food habits: Type of 
food habits’ assessment method - Food 
Frequency Questionnaire (FFQ) 
q4.2.1.1.other 
LIFESTYLE Food intake / food habits: Type of 
food habits’ assessment method - Other 
q4.2.1.2 
LIFESTYLE Food intake / food habits: Frequency 
of consumption of food produced locally 
Which data were collected 
regarding frequency of 
consumption of food 
produced locally? 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q4.2.2 
LIFESTYLE Does the study/project/activity collect 
data about traffic exposure or mobility? 
Does the 
study/project/activity 
collect data about traffic 
exposure or mobility? 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q4.2.2.1 
LIFESTYLE Traffic exposure or mobility: Time 
spent in traffic 
Which data were collected 
regarding about traffic 
exposure or mobility? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
q4.2.2.2 
LIFESTYLE Traffic exposure or mobility: Near road 
exposure 
q4.2.2.other LIFESTYLE Traffic exposure or mobility: Other 
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multiple-choice-set. 
q4.2.3 
LIFESTYLE Does the study/project/activity collect 
data about participants’ personal hygiene? 
Does the 
study/project/activity 
collect data about 
participants’ personal 
hygiene? 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q4.2.3.1 
LIFESTYLE Participants’ personal hygiene: Oral 
hygiene 
Which data were collected 
regarding the participants’ 
personal hygiene? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q4.2.3.2 
LIFESTYLE Participants’ personal hygiene: 
Frequency of washing hands 
q4.2.3.3 
LIFESTYLE Participants’ personal hygiene: 
Frequency of shower 
q4.2.3.4 
LIFESTYLE Participants’ personal hygiene: Use of 
cosmetics 
q4.2.3.5 
LIFESTYLE Participants’ personal hygiene: Use of 
tanning beds 
q4.2.3.other LIFESTYLE Participants’ personal hygiene: Other 
q4.2.4 
LIFESTYLE Does the study/project/activity collect 
data about smoking habits? 
Does the 
study/project/activity 
collect data about smoking 
habits? 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q4.2.4.1.1 
LIFESTYLE Smoking habits: Smoker - Active 
smoker 
Smoker 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
q4.2.4.1.2 
LIFESTYLE Smoking habits: Smoker - Former 
smoker 
q4.2.4.1.3 LIFESTYLE Smoking habits: Smoker - Starting age 
q4.2.4.1.4 LIFESTYLE Smoking habits: Smoker - Amount 
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q4.2.4.1.5 LIFESTYLE Smoking habits: Smoker - Frequency multiple-choice-set. 
q4.2.4.1.6 
LIFESTYLE Smoking habits: Smoker - Smoking 
during pregnancy 
q4.2.4.1.7 
LIFESTYLE Smoking habits: Smoker - 
Measurement of nicotine metabolites (e.g., 
cotinine) 
q4.2.4.1.other LIFESTYLE Smoking habits: Smoker - Other 
q4.2.4.2 LIFESTYLE Smoking habits: Non-smoker Non-smoker 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q4.2.4.3.1 
LIFESTYLE Smoking habits: Passive smoking - 
Active smokers in the family 
Passive smoking 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q4.2.4.3.2 
LIFESTYLE Smoking habits: Passive smoking - 
Active smokers at working place 
q4.2.4.3.3 
LIFESTYLE Smoking habits: Passive smoking - 
Daily average duration of exposure 
q4.2.4.3.other 
LIFESTYLE Smoking habits: Passive smoking - 
Other 
q4.2.5 
LIFESTYLE Does the study/project/activity collect 
data about dental status? 
Does the 
study/project/activity 
collect data about dental 
status? 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q4.2.5.1.1 
LIFESTYLE Dental status: Teeth decay’s 
prevention or treatment - Teeth sealants use 
Which data were collected 
regarding teeth decay’s 
prevention or treatment? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
q4.2.5.1.2 
LIFESTYLE Dental status: Teeth decay’s 
prevention or treatment - Amalgam fillings 
q4.2.5.1.3 LIFESTYLE Dental status: Teeth decay’s 
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prevention or treatment - Crowns frequency table will be produced for this 
multiple-choice-set. 
q4.2.5.1.4 
LIFESTYLE Dental status: Teeth decay’s 
prevention or treatment - Use of braces 
q4.2.5.1.other 
LIFESTYLE Dental status: Teeth decay’s 
prevention or treatment - Other 
q4.2.6 
LIFESTYLE Does the study/project/activity collect 
data about clothing / body adornments? 
Does the 
study/project/activity 
collect data about clothing 
/ body adornments? 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q4.2.6.1 
LIFESTYLE Clothing / body adornments: Leather 
clothing 
Which data were collected 
regarding clothing / body 
adornments? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q4.2.6.2 LIFESTYLE Clothing / body adornments: Piercing 
q4.2.6.3 LIFESTYLE Clothing / body adornments: Tattoos 
q4.2.6.4 LIFESTYLE Clothing / body adornments: Jewellery 
q4.2.6.other LIFESTYLE Clothing / body adornments: Other 
q4.2.7 
LIFESTYLE Does the study/project/activity collect 
data about contact with toxic substances? 
Does the 
study/project/activity 
collect data about contact 
with toxic substances? 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q4.2.7.1 LIFESTYLE Contact with toxic substances: Where 
Which data were collected 
regarding contact with 
toxic substances? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q4.2.7.2 LIFESTYLE Contact with toxic substances: Type 
q4.2.7.3 
LIFESTYLE Contact with toxic substances: 
Frequency 
q4.2.7.4 
LIFESTYLE Contact with toxic substances: 
Duration 
q4.2.7.5 LIFESTYLE Contact with toxic substances: 
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Amount 
q4.2.7.other LIFESTYLE Contact with toxic substances: Other 
q4.2.8 
LIFESTYLE Does the study/project/activity collect 
data about hobbies and holidays? 
Does the 
study/project/activity 
collect data about hobbies 
and holidays? 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q4.2.8.1 
LIFESTYLE Hobbies and holidays: Time spent 
away from the place of residence 
Which data were collected 
regarding hobbies and 
holidays? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q4.2.8.2 
LIFESTYLE Hobbies and holidays: History of 
holidays away from the city 
q4.2.8.3 
LIFESTYLE Hobbies and holidays: Time spent 
outdoors/indoors 
q4.2.8.4 LIFESTYLE Hobbies and holidays: Hobbies 
q4.2.8.5 LIFESTYLE Hobbies and holidays: Physical activity 
q4.2.8.other LIFESTYLE Hobbies and holidays: Other 
q4.2.9 
LIFESTYLE Does the study/project/activity collect 
data about other lifestyle aspects? 
Does the 
study/project/activity 
collect data about other 
lifestyle aspects? 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q4.2.9.1.description 
LIFESTYLE Data collected about other lifestyle 
aspects 
Which data were collected 
regarding other lifestyle 
aspects? 
 
For this question, content analysis will be 
done and results will be reported in a 
frequency table 
q4.3.1 
HEALTH/DISEASES RELATED DATA Does the 




collect data about health 
care utilization? 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q4.3.1.1 
HEALTH/DISEASES RELATED DATA Health care 
utilization: Doctors’ visits 
Which data were collected 
regarding health care 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
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q4.3.1.2 
HEALTH/DISEASES RELATED DATA Health care 
utilization: Previous hospital admissions 
utilization?  
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q4.3.1.other 
HEALTH/DISEASES RELATED DATA Health care 
utilization: Other 
q4.3.2 
HEALTH/DISEASES RELATED DATA Does the 




collect data about family 
health-related history? 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q4.3.2.1 
HEALTH/DISEASES RELATED DATA Family 
health-related history: Grandparents 
Which data were collected 
regarding family members? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q4.3.2.2 
HEALTH/DISEASES RELATED DATA Family 
health-related history: Parents 
q4.3.2.3 
HEALTH/DISEASES RELATED DATA Family 
health-related history: Siblings 
q4.3.2.4 
HEALTH/DISEASES RELATED DATA Family 
health-related history: Other family members Which data were collected 
regarding other family 
members? 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q4.3.2.4.otherspecify 
HEALTH/DISEASES RELATED DATA Family 




HEALTH/DISEASES RELATED DATA 




which information was 
collected? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
q4.3.2.1.2 
HEALTH/DISEASES RELATED DATA 
Grandparents' health-related history: 
Phenylketonuria 
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q4.3.2.1.3 
HEALTH/DISEASES RELATED DATA 
Grandparents' health-related history: Tay-Sachs 
frequency table will be produced for this 
multiple-choice-set. 
q4.3.2.1.4 
HEALTH/DISEASES RELATED DATA 
Grandparents' health-related history: Albinism 
q4.3.2.1.5 
HEALTH/DISEASES RELATED DATA 
Grandparents' health-related history: 
Thalassemia 
q4.3.2.1.6 
HEALTH/DISEASES RELATED DATA 
Grandparents' health-related history: Malignancy 
q4.3.2.1.7 
HEALTH/DISEASES RELATED DATA 
Grandparents' health-related history: Respiratory 
disease 
q4.3.2.1.8 
HEALTH/DISEASES RELATED DATA 
Grandparents' health-related history: Allergies 
q4.3.2.1.9 
HEALTH/DISEASES RELATED DATA 
Grandparents' health-related history: 
Cardiovascular diseases 
q4.3.2.1.10 
HEALTH/DISEASES RELATED DATA 
Grandparents' health-related history: Diabetes 
q4.3.2.1.11 
HEALTH/DISEASES RELATED DATA 
Grandparents' health-related history: Infectious 
diseases 
q4.3.2.1.12 
HEALTH/DISEASES RELATED DATA 
Grandparents' health-related history: 
Neurodegenerative diseases 
q4.3.2.1.other HEALTH/DISEASES RELATED DATA 
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Grandparents' health-related history: Other 
q4.3.2.2.1 
HEALTH/DISEASES RELATED DATA Parents' 
health-related history: Cystic fibrosis 
Regarding parents' health-
related history, which 
information was collected? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q4.3.2.2.2 
HEALTH/DISEASES RELATED DATA Parents' 
health-related history: Phenylketonuria 
q4.3.2.2.3 
HEALTH/DISEASES RELATED DATA Parents' 
health-related history: Tay-Sachs 
q4.3.2.2.4 
HEALTH/DISEASES RELATED DATA Parents' 
health-related history: Albinism 
q4.3.2.2.5 
HEALTH/DISEASES RELATED DATA Parents' 
health-related history: Thalassemia 
q4.3.2.2.6 
HEALTH/DISEASES RELATED DATA Parents' 
health-related history: Malignancy 
q4.3.2.2.7 
HEALTH/DISEASES RELATED DATA Parents' 
health-related history: Respiratory disease 
q4.3.2.2.8 
HEALTH/DISEASES RELATED DATA Parents' 
health-related history: Allergies 
q4.3.2.2.9 
HEALTH/DISEASES RELATED DATA Parents' 
health-related history: Cardiovascular diseases 
q4.3.2.2.10 
HEALTH/DISEASES RELATED DATA Parents' 
health-related history: Diabetes 
q4.3.2.2.11 
HEALTH/DISEASES RELATED DATA Parents' 
health-related history: Infectious diseases 
q4.3.2.2.12 
HEALTH/DISEASES RELATED DATA Parents' 
health-related history: Neurodegenerative 
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diseases 
q4.3.2.2.other 
HEALTH/DISEASES RELATED DATA Parents' 
health-related history: Other 
q4.3.2.3.1 
HEALTH/DISEASES RELATED DATA Siblings' 
health-related history: Cystic fibrosis 
Regarding siblings' health-
related history, which 
information was collected? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q4.3.2.3.2 
HEALTH/DISEASES RELATED DATA Siblings' 
health-related history: Phenylketonuria 
q4.3.2.3.3 
HEALTH/DISEASES RELATED DATA Siblings' 
health-related history: Tay-Sachs 
q4.3.2.3.4 
HEALTH/DISEASES RELATED DATA Siblings' 
health-related history: Albinism 
q4.3.2.3.5 
HEALTH/DISEASES RELATED DATA Siblings' 
health-related history: Thalassemia 
q4.3.2.3.6 
HEALTH/DISEASES RELATED DATA Siblings' 
health-related history: Malignancy 
q4.3.2.3.7 
HEALTH/DISEASES RELATED DATA Siblings' 
health-related history: Respiratory disease 
q4.3.2.3.8 
HEALTH/DISEASES RELATED DATA Siblings' 
health-related history: Allergies 
q4.3.2.3.9 
HEALTH/DISEASES RELATED DATA Siblings' 
health-related history: Cardiovascular diseases 
q4.3.2.3.10 
HEALTH/DISEASES RELATED DATA Siblings' 
health-related history: Diabetes 
q4.3.2.3.11 
HEALTH/DISEASES RELATED DATA Siblings' 
health-related history: Infectious diseases 
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q4.3.2.3.12 
HEALTH/DISEASES RELATED DATA Siblings' 
health-related history: Neurodegenerative 
diseases 
q4.3.2.3.other 
HEALTH/DISEASES RELATED DATA Siblings' 
health-related history: Other 
q4.3.2.4.1 
HEALTH/DISEASES RELATED DATA Other family 
members' health-related history: Cystic fibrosis 
Regarding other family 
members health-related 
history, which information 
was collected? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q4.3.2.4.2 
HEALTH/DISEASES RELATED DATA Other family 
members' health-related history: 
Phenylketonuria 
q4.3.2.4.3 
HEALTH/DISEASES RELATED DATA Other family 
members' health-related history: Tay-Sachs 
q4.3.2.4.4 
HEALTH/DISEASES RELATED DATA Other family 
members' health-related history: Albinism 
q4.3.2.4.5 
HEALTH/DISEASES RELATED DATA Other family 
members' health-related history: Thalassemia 
q4.3.2.4.6 
HEALTH/DISEASES RELATED DATA Other family 
members' health-related history: Malignancy 
q4.3.2.4.7 
HEALTH/DISEASES RELATED DATA Other family 
members' health-related history: Respiratory 
disease 
q4.3.2.4.8 
HEALTH/DISEASES RELATED DATA Other family 
members' health-related history: Allergies 
q4.3.2.4.9 
HEALTH/DISEASES RELATED DATA Other family 
members' health-related history: Cardiovascular 
diseases 
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q4.3.2.4.10 
HEALTH/DISEASES RELATED DATA Other family 
members' health-related history: Diabetes 
q4.3.2.4.11 
HEALTH/DISEASES RELATED DATA Other family 
members' health-related history: Infectious 
diseases 
q4.3.2.4.12 
HEALTH/DISEASES RELATED DATA Other family 
members' health-related history: 
Neurodegenerative diseases 
q4.3.2.4.other 
HEALTH/DISEASES RELATED DATA Other family 
members' health-related history: Other 
q4.3.3 
HEALTH/DISEASES RELATED DATA Does the 
study/project/activity collect data about medical 
history of the participant? 
Does the 
study/project/activity 
collect data about medical 
history of the participant? 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q4.3.3.1.1 
HEALTH/DISEASES RELATED DATA Medical 
history of the participant: Participants' health-
related history - Genetic disease 
Regarding participants' 
health-related history, 
which information was 
collected? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q4.3.3.1.2 
HEALTH/DISEASES RELATED DATA Medical 
history of the participant: Participants' health-
related history - Infectious disease 
q4.3.3.1.3 
HEALTH/DISEASES RELATED DATA Medical 
history of the participant: Participants' health-
related history - Cardiovascular disease 
q4.3.3.1.4 
HEALTH/DISEASES RELATED DATA Medical 
history of the participant: Participants' health-
related history - Respiratory disease 
q4.3.3.1.5 HEALTH/DISEASES RELATED DATA Medical 
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history of the participant: Participants' health-
related history - Malignantdisease 
q4.3.3.1.6 
HEALTH/DISEASES RELATED DATA Medical 
history of the participant: Participants' health-
related history - Menstrual disorders 
q4.3.3.1.7 
HEALTH/DISEASES RELATED DATA Medical 
history of the participant: Participants' health-
related history - Mental/psychiatric disorder 
q4.3.3.1.8 
HEALTH/DISEASES RELATED DATA Medical 
history of the participant: Participants' health-
related history - Neurodegenerative disease 
q4.3.3.1.9 
HEALTH/DISEASES RELATED DATA Medical 
history of the participant: Participants' health-
related history - Airway diseases 
q4.3.3.1.10 
HEALTH/DISEASES RELATED DATA Medical 
history of the participant: Participants' health-
related history - Allergies 
q4.3.3.1.11 
HEALTH/DISEASES RELATED DATA Medical 
history of the participant: Participants' health-
related history - Ear diseases 
q4.3.3.1.12 
HEALTH/DISEASES RELATED DATA Medical 
history of the participant: Participants' health-
related history - Hearing problems 
q4.3.3.1.13 
HEALTH/DISEASES RELATED DATA Medical 
history of the participant: Participants' health-
related history - Urinary infections 
q4.3.3.1.14 HEALTH/DISEASES RELATED DATA Medical 
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history of the participant: Participants' health-
related history - Other renal disorders 
q4.3.3.1.15 
HEALTH/DISEASES RELATED DATA Medical 
history of the participant: Participants' health-
related history - Auto-immune disorders 
q4.3.3.1.16 
HEALTH/DISEASES RELATED DATA Medical 
history of the participant: Participants' health-
related history - Acute infections 
q4.3.3.1.17 
HEALTH/DISEASES RELATED DATA Medical 
history of the participant: Participants' health-
related history - Cancer 
q4.3.3.1.18 
HEALTH/DISEASES RELATED DATA Medical 
history of the participant: Participants' health-
related history - Reproductive/reproduction 
diseases/disorders 
q4.3.3.1.other 
HEALTH/DISEASES RELATED DATA Medical 
history of the participant: Participants' health-
related history - Other 
q4.3.3.1.1.1 
HEALTH/DISEASES RELATED DATA Medical 
history of the participant: Participants' health-
related history - Genetic disease: Cystic fibrosis 
Which data were collected 
regarding genetic disease? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q4.3.3.1.1.2 
HEALTH/DISEASES RELATED DATA Medical 
history of the participant: Participants' health-
related history - Genetic disease: 
Phenylketonuria 
q4.3.3.1.1.3 
HEALTH/DISEASES RELATED DATA Medical 
history of the participant: Participants' health-
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related history - Genetic disease: Tay-Sachs 
q4.3.3.1.1.4 
HEALTH/DISEASES RELATED DATA Medical 
history of the participant: Participants' health-
related history - Genetic disease: Albinism 
q4.3.3.1.1.5 
HEALTH/DISEASES RELATED DATA Medical 
history of the participant: Participants' health-
related history - Genetic disease: Thalassemia 
q4.3.3.1.1.other 
HEALTH/DISEASES RELATED DATA Medical 
history of the participant: Participants' health-
related history - Genetic disease: Other 
q4.3.3.1.8.1 
HEALTH/DISEASES RELATED DATA Medical 
history of the participant: Participants' health-
related history - Neurodegenerative disease: 
Alzheimer’s disease 




No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q4.3.3.1.8.2 
HEALTH/DISEASES RELATED DATA Medical 
history of the participant: Participants' health-
related history - Neurodegenerative disease: 
Parkinson’s disease 
q4.3.3.1.8.3 
HEALTH/DISEASES RELATED DATA Medical 
history of the participant: Participants' health-
related history - Neurodegenerative disease: 
Huntington’s disease 
q4.3.3.1.8.4 
HEALTH/DISEASES RELATED DATA Medical 
history of the participant: Participants' health-
related history - Neurodegenerative disease: 
Amyotrophic lateral sclerosis 
q4.3.3.1.8.other HEALTH/DISEASES RELATED DATA Medical 
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history of the participant: Participants' health-
related history - Neurodegenerative disease: 
Other 
q4.3.3.1.9.1 
HEALTH/DISEASES RELATED DATA Medical 
history of the participant: Participants' health-
related history - Airway diseases - Bronchitis 
Which data were collected 
regarding airway diseases? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q4.3.3.1.9.2 
HEALTH/DISEASES RELATED DATA Medical 
history of the participant: Participants' health-
related history - Airway diseases - Asthma 
q4.3.3.1.9.3 
HEALTH/DISEASES RELATED DATA Medical 
history of the participant: Participants' health-
related history - Airway diseases - COPD 
q4.3.3.1.9.other 
HEALTH/DISEASES RELATED DATA Medical 
history of the participant: Participants' health-
related history - Airway diseases - Other 
q4.3.3.1.10.1 
HEALTH/DISEASES RELATED DATA Medical 
history of the participant: Participants' health-
related history - Allergies: Allergic rhinitis 
Which data were collected 
regarding allergies? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q4.3.3.1.10.2 
HEALTH/DISEASES RELATED DATA Medical 
history of the participant: Participants' health-
related history - Allergies: Atopic dermatitis 
q4.3.3.1.10.3 
HEALTH/DISEASES RELATED DATA Medical 
history of the participant: Participants' health-
related history - Allergies: Eczema 
q4.3.3.1.10.4 
HEALTH/DISEASES RELATED DATA Medical 
history of the participant: Participants' health-
related history - Allergies: Hay fever 
 
VARIABLE NAME LABEL QUESTION VALUES AND CODES ANALYSIS 
q4.3.3.1.10.other 
HEALTH/DISEASES RELATED DATA Medical 
history of the participant: Participants' health-
related history - Allergies: Other 
q4.3.4 
HEALTH/DISEASES RELATED DATA Does the 
study/project/activity collect data about specific 
stages of life? 
Does the 
study/project/activity 
collect data about specific 
stages of life? 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q4.3.4.1 
HEALTH/DISEASES RELATED DATA Specific 
stages of life: Newborn disorders 
Which data were collected 
regarding specific stages of 
life? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q4.3.4.2 
HEALTH/DISEASES RELATED DATA Specific 
stages of life: Perinatal problems 
q4.3.4.3 
HEALTH/DISEASES RELATED DATA Specific 
stages of life: Low birth weight 
q4.3.4.4 
HEALTH/DISEASES RELATED DATA Specific 
stages of life: APGAR score 
q4.3.4.5 
HEALTH/DISEASES RELATED DATA Specific 
stages of life: Congenital malformations 
q4.3.4.6 
HEALTH/DISEASES RELATED DATA Specific 
stages of life: Infant or childhood development 
disorders 
q4.3.4.7 
HEALTH/DISEASES RELATED DATA Specific 
stages of life: Gestational age 
q4.3.4.8 
HEALTH/DISEASES RELATED DATA Specific 
stages of life: Conception difficulties 
q4.3.4.9 
HEALTH/DISEASES RELATED DATA Specific 
stages of life: Miscarriage 
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q4.3.4.10 
HEALTH/DISEASES RELATED DATA Specific 
stages of life: Induced abortion 
q4.3.4.11 
HEALTH/DISEASES RELATED DATA Specific 
stages of life: Foetal death 
q4.3.4.12 
HEALTH/DISEASES RELATED DATA Specific 
stages of life: Labour complications 
q4.3.4.13 
HEALTH/DISEASES RELATED DATA Specific 
stages of life: Premature rupture of membranes 
q4.3.4.14 
HEALTH/DISEASES RELATED DATA Specific 
stages of life: Other pregnancy complications 
q4.3.4.15 
HEALTH/DISEASES RELATED DATA Specific 
stages of life: Premenopause-related data 
q4.3.4.16 
HEALTH/DISEASES RELATED DATA Specific 
stages of life: Menopause-related data 
q4.3.4.17 
HEALTH/DISEASES RELATED DATA Specific 
stages of life: Postmenopause related data 
q4.3.5 
HEALTH/DISEASES RELATED DATA Does the 
study/project/activity collect data about 
pregnancy or delivery? 
Does the 
study/project/activity 
collect data about 
pregnancy or delivery? 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q4.3.5.1 
HEALTH/DISEASES RELATED DATA Pregnancy or 
delivery: Health before and during pregnancy 
Which data were collected 
regarding pregnancy or 
delivery? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
q4.3.5.2 
HEALTH/DISEASES RELATED DATA Pregnancy or 
delivery: Health before and during birth 
q4.3.5.3 
HEALTH/DISEASES RELATED DATA Pregnancy or 
delivery: Maternal smoking 
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q4.3.5.4 




HEALTH/DISEASES RELATED DATA Pregnancy or 
delivery: Duration of pregnancy 
q4.3.5.6 
HEALTH/DISEASES RELATED DATA Pregnancy or 
delivery: Parity 
q4.3.5.7 
HEALTH/DISEASES RELATED DATA Pregnancy or 
delivery: Previous voluntary abortions 
q4.3.5.8 
HEALTH/DISEASES RELATED DATA Pregnancy or 
delivery: Previous miscarriages 
q4.3.5.9 
HEALTH/DISEASES RELATED DATA Pregnancy or 
delivery: Twins 
q4.3.5.10 
HEALTH/DISEASES RELATED DATA Pregnancy or 
delivery: Foetal ultrasound 
q4.3.5.11 
HEALTH/DISEASES RELATED DATA Pregnancy or 
delivery: Follow-up after delivery 
q4.3.5.other 
HEALTH/DISEASES RELATED DATA Pregnancy or 
delivery: Other 
q4.3.5.10.1 
HEALTH/DISEASES RELATED DATA Pregnancy or 
delivery: Foetal ultrasound - Body proportions 
Which data were collected 
regarding foetal 
ultrasound? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q4.3.5.10.2 
HEALTH/DISEASES RELATED DATA Pregnancy or 
delivery: Foetal ultrasound - Placental function 
q4.3.5.10.3 
HEALTH/DISEASES RELATED DATA Pregnancy or 
delivery: Foetal ultrasound - Organ development 
(brain, heart, kidney, …) 
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q4.3.5.10.other 
HEALTH/DISEASES RELATED DATA Pregnancy or 
delivery: Foetal ultrasound - Other 
q4.3.6 
HEALTH/DISEASES RELATED DATA Does the 
study/project/activity collect data about new 
born / infant biometry/health? 
Does the 
study/project/activity 
collect data about new 
born / infant 
biometry/health? 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q4.3.6.1 
HEALTH/DISEASES RELATED DATA New born / 
infant biometry/health - Sex 
Which data were collected 
regarding new born / 
infant biometry/health? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q4.3.6.2 
HEALTH/DISEASES RELATED DATA New born / 
infant biometry/health - Weight 
q4.3.6.3 
HEALTH/DISEASES RELATED DATA New born / 
infant biometry/health - Length 
q4.3.6.4 
HEALTH/DISEASES RELATED DATA New born / 
infant biometry/health - Health status 
q4.3.6.5 
HEALTH/DISEASES RELATED DATA New born / 
infant biometry/health - APGAR score 
q4.3.6.6 
HEALTH/DISEASES RELATED DATA New born / 
infant biometry/health - Perinatal complications 
q4.3.6.7 
HEALTH/DISEASES RELATED DATA New born / 
infant biometry/health - Neonatal respiratory 
problems 
q4.3.6.8 
HEALTH/DISEASES RELATED DATA New born / 
infant biometry/health - Birth defects 
q4.3.6.9 
HEALTH/DISEASES RELATED DATA New born / 
infant biometry/health - Hospital admissions 
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q4.3.6.10 
HEALTH/DISEASES RELATED DATA New born / 
infant biometry/health - Medication 
q4.3.6.other 
HEALTH/DISEASES RELATED DATA New born / 
infant biometry/health - Other 
q4.3.6.5.1.description 
HEALTH/DISEASES RELATED DATA New born / 
infant biometry/health - APGAR score: Moment 
of measurement of the APGAR score 
Please specify the moment 
of measurement of the 
APGAR score 
 
For this question, content analysis will be 
done and results will be reported in a 
frequency table 
q4.3.6.8.1 
HEALTH/DISEASES RELATED DATA New born / 
infant biometry/health - Birth defects: Urogenital 
Which data were collected 
regarding birth defects? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q4.3.6.8.2 
HEALTH/DISEASES RELATED DATA New born / 
infant biometry/health - Birth defects: Heart 
q4.3.6.8.3 
HEALTH/DISEASES RELATED DATA New born / 
infant biometry/health - Birth defects: Kidneys 
q4.3.6.8.other 
HEALTH/DISEASES RELATED DATA New born / 
infant biometry/health - Birth defects: Other 
q4.3.7 
HEALTH/DISEASES RELATED DATA Does the 
study/project/activity collect data about 
unspecified health complaints? 
Does the 
study/project/activity 
collect data about 
unspecified health 
complaints? 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q4.3.7.1 
HEALTH/DISEASES RELATED DATA Unspecified 
health complaints: Headache 
Which data were collected 
regarding unspecified 
health complaints? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
q4.3.7.2 
HEALTH/DISEASES RELATED DATA Unspecified 
health complaints: Wheezing 
q4.3.7.3 
HEALTH/DISEASES RELATED DATA Unspecified 
health complaints: Deficiency of concentration 
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q4.3.7.4 
HEALTH/DISEASES RELATED DATA Unspecified 
health complaints: Absence of appetite 
multiple-choice-set. 
q4.3.7.5 
HEALTH/DISEASES RELATED DATA Unspecified 
health complaints: Menstrual disorders 
q4.3.7.other 
HEALTH/DISEASES RELATED DATA Unspecified 
health complaints: Other 
q4.3.8 
HEALTH/DISEASES RELATED DATA Does the 




collect data about 
accidents? 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q4.3.8.1 
HEALTH/DISEASES RELATED DATA Accidents: 
Leisure 
Which data were collected 
regarding accidents? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q4.3.8.2 
HEALTH/DISEASES RELATED DATA Accidents: 
Domestic 
q4.3.8.3 
HEALTH/DISEASES RELATED DATA Accidents: 
Occupational 
q4.3.8.other 
HEALTH/DISEASES RELATED DATA Accidents: 
Other 
q4.4.1 
PARENTAL EXPOSURE Does the 
study/project/activity collect data about 




collect data about 
exposure during pregnancy 
and/or breastfeeding? 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q4.4.1.1.1 
PARENTAL EXPOSURE Exposure during 
pregnancy and/or breastfeeding: 
Periconceptional period - Parental medication 
Which data were collected 
regarding the 
periconceptional period? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for q4.4.1.1.other 
PARENTAL EXPOSURE Exposure during 
pregnancy and/or breastfeeding: 
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Periconceptional period - Other descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q4.4.1.2.1 
PARENTAL EXPOSURE Exposure during 
pregnancy and/or breastfeeding: Pregnancy and 
delivery - Alcohol use during pregnancy 
Which data were collected 
regarding pregnancy and 
delivery? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q4.4.1.2.2 
PARENTAL EXPOSURE Exposure during 
pregnancy and/or breastfeeding: Pregnancy and 
delivery - Smoking during pregnancy 
q4.4.1.2.3 
PARENTAL EXPOSURE Exposure during 
pregnancy and/or breastfeeding: Pregnancy and 
delivery - Medication during pregnancy 
q4.4.1.2.4 
PARENTAL EXPOSURE Exposure during 
pregnancy and/or breastfeeding: Pregnancy and 
delivery - Medication during delivery 
q4.4.1.2.other 
PARENTAL EXPOSURE Exposure during 
pregnancy and/or breastfeeding: Pregnancy and 
delivery - Other 
q4.4.1.3.1 
PARENTAL EXPOSURE Exposure during 
pregnancy and/or breastfeeding: Breastfeeding - 
Duration of breastfeeding 
Which data were collected 
regarding breastfeeding? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q4.4.1.3.2 
PARENTAL EXPOSURE Exposure during 
pregnancy and/or breastfeeding: Breastfeeding - 
Alcohol use during breastfeeding 
q4.4.1.3.3 
PARENTAL EXPOSURE Exposure during 
pregnancy and/or breastfeeding: Breastfeeding - 
Smoking during breastfeeding 
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q4.4.1.3.4 
PARENTAL EXPOSURE Exposure during 
pregnancy and/or breastfeeding: Breastfeeding - 
Medication during breastfeeding 
q4.4.1.3.other 
PARENTAL EXPOSURE Exposure during 
pregnancy and/or breastfeeding: Breastfeeding - 
Other 
q4.4.2 
PARENTAL EXPOSURE Does the 




collect data about 
occupational exposure? 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q4.4.2.1 
PARENTAL EXPOSURE Occupational exposure: 
Mother 
Which data were collected 
regarding occupational 
exposure? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q4.4.2.2 
PARENTAL EXPOSURE Occupational exposure: 
Father 
q4.4.2.3 
PARENTAL EXPOSURE Occupational exposure: 
Other family member 
q4.4.2.4 
PARENTAL EXPOSURE Occupational exposure: 
Occupational exposure to Phthalates / DINCH 
q4.4.2.5 
PARENTAL EXPOSURE Occupational exposure: 
Occupational exposure to Bisphenols 
q4.4.2.6 
PARENTAL EXPOSURE Occupational exposure: 
Occupational exposure to Per-/Polyfluorinated 
compounds 
q4.4.2.7 
PARENTAL EXPOSURE Occupational exposure: 
Occupational exposure to Flame Retardants 
q4.4.2.8 
PARENTAL EXPOSURE Occupational exposure: 
Occupational exposure to Cadmium 
 
VARIABLE NAME LABEL QUESTION VALUES AND CODES ANALYSIS 
q4.4.2.9 
PARENTAL EXPOSURE Occupational exposure: 
Occupational exposure to Chromium VI 
q4.4.2.10 
PARENTAL EXPOSURE Occupational exposure: 
Occupational exposure to PAHs 
q4.4.2.11 
PARENTAL EXPOSURE Occupational exposure: 
Occupational exposure to Anilin family: Anilines, 
MOCA 
q4.4.2.12 
PARENTAL EXPOSURE Occupational exposure: 
Occupational exposure to Chemical mixtures 
q4.4.2.13 
PARENTAL EXPOSURE Occupational exposure: 
Occupational exposure to Emerging chemicals 
q4.4.2.other 
PARENTAL EXPOSURE Occupational exposure: 
Other 
q4.4.3 
PARENTAL EXPOSURE Does the 
study/project/activity collect data about other 
types of exposure? 
Does the 
study/project/activity 
collect data about other 
types of exposure? 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q4.4.3.1.1 
PARENTAL EXPOSURE Other types of exposure: 
Parental smoking -  Number of cigarettes, cigars 
or pipes smoked in the house 
Which data were collected 
regarding parental 
smoking? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q4.4.3.1.2 
PARENTAL EXPOSURE Other types of exposure: 
Parental smoking - X-ray exposure 
q4.4.3.1.other 
PARENTAL EXPOSURE Other types of exposure: 
Parental smoking - Other 
q4.5.1 
MEDICATION Does the study/project/activity 
collect data about medication during pregnancy, 
delivery or breastfeeding? 
Does the 
study/project/activity 
collect data about 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
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medication during 
pregnancy, delivery or 
breastfeeding? 
q4.5.1.1.1 
MEDICATION Medication during pregnancy, 
delivery or breastfeeding: Medication during 
pregnancy - Vitamins 
Which data were collected 
regarding medication 
during pregnancy? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q4.5.1.1.2 
MEDICATION Medication during pregnancy, 
delivery or breastfeeding: Medication during 
pregnancy - Minerals 
q4.5.1.1.3 
MEDICATION Medication during pregnancy, 
delivery or breastfeeding: Medication during 
pregnancy - Preparations for immunity 
q4.5.1.1.other 
MEDICATION Medication during pregnancy, 
delivery or breastfeeding: Medication during 
pregnancy - Other 
q4.5.1.2 
MEDICATION Medication during pregnancy, 
delivery or breastfeeding: Medication during 
delivery 
Which data were collected 
regarding medication 
during delivery? 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q4.5.1.3 
MEDICATION Medication during pregnancy, 
delivery or breastfeeding: Medication during 
breastfeeding 
Which data were collected 
regarding medication 
during breastfeeding? 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q4.5.1.4 
MEDICATION Medication during pregnancy, 
delivery or breastfeeding: Other medication 





MEDICATION Does the study/project/activity 
collect data about medication administered to or 
taken by children or adolescents? 
Does the 
study/project/activity 
collect data about 
medication administered 
to or taken by children or 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
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adolescents? 
q4.5.2.1 
MEDICATION Medication administered to or 
taken by children or adolescents: History of 
medication of child 
Which data were collected 
regarding medication 
administered to or taken 
by children or adolescents? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q4.5.2.2 
MEDICATION Medication administered to or 
taken by children or adolescents: Antibiotics by 
the infant 
q4.5.2.3 
MEDICATION Medication administered to or 
taken by children or adolescents Antibiotics by 
the child 
q4.5.2.4 
MEDICATION Medication administered to or 
taken by children or adolescents: Drug use of the 
adolescent 
q4.5.2.other 
MEDICATION Medication administered to or 
taken by children or adolescents: Other 
q4.5.3 
MEDICATION Does the study/project/activity 
collect data about permanent or acute 
medication for respiratory or allergic diseases? 
Does the 
study/project/activity 
collect data about 
permanent or acute 
medication for respiratory 
or allergic diseases? 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q4.5.3.1 
MEDICATION Permanent or acute medication for 
respiratory or allergic diseases: Asthma Which data were collected 
regarding permanent or 
acute medication for 
respiratory or allergic 
diseases? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
q4.5.3.2 
MEDICATION Permanent or acute medication for 
respiratory or allergic diseases: Allergic rhinitis 
q4.5.3.3 
MEDICATION Permanent or acute medication for 
respiratory or allergic diseases: Atopic dermatitis 
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q4.5.3.other 
MEDICATION Permanent or acute medication for 
respiratory or allergic diseases: Other 
multiple-choice-set. 
q4.6.1 
SOCIO-ECONOMIC FACTORS Does the 
study/project/activity collect data about socio-
demographic and/or socio-economic factors? 
Does the 
study/project/activity 
collect data about socio-
demographic and/or socio-
economic factors? 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q4.6.1.1 
SOCIO-ECONOMIC FACTORS General socio-
demographics: Age 
Which general socio-
demographics data was 
collected? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q4.6.1.2 
SOCIO-ECONOMIC FACTORS General socio-
demographics: Sex 
q4.6.1.3 
SOCIO-ECONOMIC FACTORS General socio-
demographics: Country of birth 
q4.6.1.4 
SOCIO-ECONOMIC FACTORS General socio-
demographics: Ethnic origin 
q4.6.1.5 
SOCIO-ECONOMIC FACTORS General socio-
demographics: Area of residence 
q4.6.1.6 
SOCIO-ECONOMIC FACTORS General socio-
demographics: Workplace area/address 
q4.6.1.other 
SOCIO-ECONOMIC FACTORS General socio-
demographics: Other 
q4.6.2.1 
SOCIO-ECONOMIC FACTORS Family structure: 
Civil status 
Which data were collected 
regarding family structure? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
q4.6.2.2 
SOCIO-ECONOMIC FACTORS Family structure: 
Number of children 
q4.6.2.3 SOCIO-ECONOMIC FACTORS Family structure: 
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Presence of extended family in the house frequency table will be produced for this 
multiple-choice-set. 
q4.6.2.other 
SOCIO-ECONOMIC FACTORS Family structure: 
Other 
q4.6.3.1 
SOCIO-ECONOMIC FACTORS Employment status 
and income: Profession 
Which data were collected 
regarding employment 
status and income 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q4.6.3.2 
SOCIO-ECONOMIC FACTORS Employment status 
and income: Employment status 
q4.6.3.3 
SOCIO-ECONOMIC FACTORS Employment status 
and income: Family income 
q4.6.3.other 
SOCIO-ECONOMIC FACTORS Employment status 
and income: Other 
q4.6.4.1 
SOCIO-ECONOMIC FACTORS Education: 
Educational level of parents 
Which data were collected 
regarding education? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q4.6.4.2 
SOCIO-ECONOMIC FACTORS Education: 
Educational level of children 
q4.6.4.3 
SOCIO-ECONOMIC FACTORS Education: School 
achievements of child attending school 
q4.6.4.other SOCIO-ECONOMIC FACTORS Education: Other 
q4.6.5.1 
SOCIO-ECONOMIC FACTORS Other socio-




economic data were 
collected? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q4.6.5.2 
SOCIO-ECONOMIC FACTORS Other socio-
demographic and/or socio-economic: Social 
network 
q4.6.5.3 
SOCIO-ECONOMIC FACTORS Other socio-
demographic and/or socio-economic: Leisure 
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activities 
q4.6.5.other 
SOCIO-ECONOMIC FACTORS Other socio-
demographic and/or socio-economic: Other 
q4.7.description OTHER DATA 
Which other data were 
collected? 
 
For this question, content analysis will be 
done and results will be reported in a 
frequency table 
5. QUALITY CONTROL PROCEDURES 
q5.1.1 
Pre-analytical Quality Assurance/Quality Control: 




No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q5.1.2 
Pre-analytical Quality Assurance/Quality Control: 
Trained fieldworkers 
q5.1.3 
Pre-analytical Quality Assurance/Quality Control: 
Control of background contamination in the 
sampling material 
q5.1.4 
Pre-analytical Quality Assurance/Quality Control: 
Control of the transport conditions 
q5.1.5 
Pre-analytical Quality Assurance/Quality Control: 
Control of background contamination in the 
conservation material 
q5.1.6 
Pre-analytical Quality Assurance/Quality Control: 
Identification/traceability of the samples 
q5.1.7 
Pre-analytical Quality Assurance/Quality Control: 
Criteria for acceptation/rejection of the samples 
q5.1.8 
Pre-analytical Quality Assurance/Quality Control: 
Use of field blanks 
q5.1.9 Pre-analytical Quality Assurance/Quality Control: 
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Setting the conditions for sample storage 
q5.1.other 
Pre-analytical Quality Assurance/Quality Control: 
Other 
q5.2.1.1 
Internal QA/QC: Identification of critical phases - 
Quality control samples 
Internal QA/QC: 
Identification of critical 
phases 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q5.2.1.2 
Internal QA/QC: Identification of critical phases - 
Blank matrix for calibration 
q5.2.1.3 
Internal QA/QC: Identification of critical phases - 
Pre-treatment of samples 
q5.2.1.4 
Internal QA/QC: Identification of critical phases - 
Analytical technique 
q5.2.1.5 
Internal QA/QC: Identification of critical phases - 
Reference materials 
q5.2.1.6 
Internal QA/QC: Identification of critical phases - 
Process control 
q5.2.1.7 
Internal QA/QC: Identification of critical phases - 
Instrument calibration 
q5.2.1.8 
Internal QA/QC: Identification of critical phases - 
Internal proficiency testing (blind samples) 
q5.2.1.9 
Internal QA/QC: Identification of critical phases - 
Reporting of analytical data 
q5.2.1.other 
Internal QA/QC: Identification of critical phases - 
Other 
q5.2.2.1.1 
Internal QA/QC: Quality control procedures - 
Internal quality control procedures: Routine 
Internal QA/QC: Quality 
control procedures - 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
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checking of equipment Internal quality control 
procedures 
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q5.2.2.1.2 
Internal QA/QC: Quality control procedures - 
Internal quality control procedures: Routine 
calibration of equipment 
q5.2.2.1.3 
Internal QA/QC: Quality control procedures - 
Internal quality control procedures: Routine 
checking of culture media 
q5.2.2.1.4 
Internal QA/QC: Quality control procedures - 
Internal quality control procedures: Routine 
checking of water 
q5.2.2.1.5 
Internal QA/QC: Quality control procedures - 
Internal quality control procedures: Routine 
checking of analytical reagents 
q5.2.2.1.6 
Internal QA/QC: Quality control procedures - 
Internal quality control procedures: Blinded 
quality controls 
q5.2.2.1.other 
Internal QA/QC: Quality control procedures - 
Internal quality control procedures: Other 
q5.2.2.2.1 
Internal QA/QC: Quality control procedures - 
Standard operating procedures: Sample 
preparation 
Internal QA/QC: Quality 
control procedures - 
Standard operating 
procedures 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q5.2.2.2.2 
Internal QA/QC: Quality control procedures - 
Standard operating procedures: Analytical 
methods 
q5.2.2.2.3 
Internal QA/QC: Quality control procedures - 
Standard operating procedures: Storage and 
retention of records and materials 
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q5.2.2.2.other 
Internal QA/QC: Quality control procedures - 
Standard operating procedures: Other 
q5.2.2.2.2.1 
Internal QA/QC: Quality control procedures - 
Standard operating procedures: Analytical 
methods - Replication measures 
Which data were collected 
regarding analytical 
methods? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q5.2.2.2.2.2 
Internal QA/QC: Quality control procedures - 
Standard operating procedures: Analytical 
methods - Methods validation 
q5.2.2.2.2.3 
Internal QA/QC: Quality control procedures - 
Standard operating procedures: Analytical 
methods - Laboratory/Reagent blanks 
q5.2.2.2.2.4 
Internal QA/QC: Quality control procedures - 
Standard operating procedures: Analytical 
methods - Use of reference materials 
q5.2.2.2.2.5 
Internal QA/QC: Quality control procedures - 
Standard operating procedures: Analytical 
methods - Training according to detailed manual 
q5.2.2.2.2.6 
Internal QA/QC: Quality control procedures - 
Standard operating procedures: Analytical 
methods - Use of standard laboratory / uniform 
methods 
q5.2.2.2.2.7 
Internal QA/QC: Quality control procedures - 
Standard operating procedures: Analytical 
methods - Waste disposal 
q5.2.2.2.2.8 
Internal QA/QC: Quality control procedures - 
Standard operating procedures: Analytical 
methods - Use of commercial standards of 
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precision and accuracy 
q5.2.2.2.2.other 
Internal QA/QC: Quality control procedures - 
Standard operating procedures: Analytical 
methods - Other 
q5.2.2.3.1 
Internal QA/QC: Quality control procedures - 
Intra-laboratory tests: Sampling instruments 
Internal QA/QC: Quality 
control procedures - Intra-
laboratory tests 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q5.2.2.3.2 
Internal QA/QC: Quality control procedures - 
Intra-laboratory tests: Sample measurements 
q5.2.2.4 
Internal QA/QC: Quality control procedures - 
Other data collected 
Internal QA/QC: Quality 
control procedures - Other 
data collected 
 
For this question, content analysis will be 
done and results will be reported in a 
frequency table 
q5.2.3.1 
Internal QA/QC: Other inter / intra laboratory 
testing - Calibration according to manufacturer’s 
instructions 
Internal QA/QC: Other inter 
/ intra laboratory testing 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q5.2.3.2 
Internal QA/QC: Other inter / intra laboratory 
testing - Inter-laboratory assessment for dioxin-
activity 
q5.2.3.3 
Internal QA/QC: Other inter / intra laboratory 
testing - Field duplicates 
q5.2.3.4 
Internal QA/QC: Other inter / intra laboratory 
testing - Field blanks 
q5.2.3.5 
Internal QA/QC: Other inter / intra laboratory 
testing - Field visits of supervisors 
q5.2.3.6 Internal QA/QC: Other inter / intra laboratory 
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testing - Inter-laboratory quality control 
available for contracting analytical laboratories 
q5.2.3.other 
Internal QA/QC: Other inter / intra laboratory 
testing - Other 
q5.3.1.1 External QA/QC: Round-robin test - PCB 
External QA/QC: Round-
robin test 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q5.3.1.2 External QA/QC: Round-robin test - ttMA 
q5.3.1.3 External QA/QC: Round-robin test - VOC 
q5.3.1.4 
External QA/QC: Round-robin test - Heavy 
metals 
q5.3.1.5 External QA/QC: Round-robin test - Mould fungi 
q5.3.1.other External QA/QC: Round-robin test - Other 
q5.3.2.1 
External QA/QC: Quality control programs - 
International institutions 
External QA/QC: Quality 
control programs 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q5.3.2.2 
External QA/QC: Quality control programs - 
National institutions 
q5.3.2.3 
External QA/QC: Quality control programs - 
Proficiency tests 
q5.3.2.4 
External QA/QC: Quality control programs - 
Certified reference materials 
q5.3.2.5 
External QA/QC: Quality control programs - 
Duplicate analysis, through different methods 
q5.3.2.6 
External QA/QC: Quality control programs - 
Inter-laboratory comparison exercises 
q5.3.2.7 
External QA/QC: Quality control programs - 
External Quality Assurance Scheme 
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q5.3.2.other 
External QA/QC: Quality control programs - 
Other 
q5.3.3.1.1 
External QA/QC: National external Quality 
Assessment Schemes - Accreditation: Inspection 
of non-accredited laboratories 
External QA/QC: 
Accreditation 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q5.3.3.1.2 
External QA/QC: National external Quality 
Assessment Schemes - Accreditation: Accredited 
laboratory 
q5.3.3.1.3 
External QA/QC: National external Quality 
Assessment Schemes - Accreditation: Accredited 
for certain analysis 
q5.3.3.1.2.1 
External QA/QC: National external Quality 
Assessment Schemes - Accreditation: Accredited 
laboratory - Type of accreditation: National 
External QA/QC: Type of 
accreditation 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q5.3.3.1.2.2 
External QA/QC: National external Quality 
Assessment Schemes - Accreditation: Accredited 
laboratory - ISO 17025 
q5.3.3.1.2.other 
External QA/QC: National external Quality 
Assessment Schemes - Accreditation: Accredited 
laboratory -  Other 
q5.3.3.1.3.1 
External QA/QC: National external Quality 
Assessment Schemes - Accreditation: Accredited 
for certain analysis of - Lead 
External QA/QC: For which 
analysis is the laboratory 
accredited? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q5.3.3.1.3.2 
External QA/QC: National external Quality 
Assessment Schemes - Accreditation: Accredited 
for certain analysis of - Cadmium 
q5.3.3.1.3.other External QA/QC: National external Quality 
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Assessment Schemes - Accreditation: Accredited 
for certain analysis of - Other 
q5.3.3.2.1 
External QA/QC: National external Quality 




No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q5.3.3.2.2 
External QA/QC: National external Quality 
Assessment Schemes - Certification: Bisphenols 
q5.3.3.2.3 
External QA/QC: National external Quality 
Assessment Schemes - Certification: Per-
/Polyfluorinated compounds 
q5.3.3.2.4 
External QA/QC: National external Quality 
Assessment Schemes - Certification: Flame 
Retardants 
q5.3.3.2.5 
External QA/QC: National external Quality 
Assessment Schemes - Certification: Cd, Cr 
q5.3.3.2.6 
External QA/QC: National external Quality 
Assessment Schemes - Certification: PAHs 
q5.3.3.2.7 
External QA/QC: National external Quality 
Assessment Schemes - Certification: Anilin 
family: Anilines, MOCA 
q5.3.3.2.8 
External QA/QC: National external Quality 
Assessment Schemes - Certification: Chemicals 
mixtures 
q5.3.3.2.9 
External QA/QC: National external Quality 
Assessment Schemes - Certification: Emerging 
chemicals 
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q5.3.3.2.other 
External QA/QC: National external Quality 
Assessment Schemes - Certification: Other 
q5.3.3.3 
External QA/QC: National external Quality 
Assessment Schemes - Other 
Specify other national 
external quality assessment 
schemes 
 
For this question, content analysis will be 
done and results will be reported in a 
frequency table 
6. DATA ANALYSIS 
q6.1.1 Descriptive analysis: Mean 
Descriptive analysis 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q6.1.2 Descriptive analysis: Median 
q6.1.3 Descriptive analysis: Percentiles 
q6.1.4 Descriptive analysis: Measures of dispersion 
q6.1.5 
Descriptive analysis: Incidence and prevalence 
rates 
q6.1.other Descriptive analysis: Other 
q6.2.1 
Bivariate analysis: Measures of association 
(coefficient of correlation, odds ratio, relative 
risk, …) 
Bivariate analysis 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q6.2.2 Bivariate analysis: Effect size estimation 
q6.2.other Bivariate analysis: Other 
q6.3.1 
Stratification procedures: Comparison across 
areas 
Stratification procedures 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
q6.3.2 
Stratification procedures: Gender or age-groups 
stratification 
q6.3.3 Stratification procedures: Socio-economic 
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stratification frequency table will be produced for this 
multiple-choice-set. 
q6.3.other Stratification procedures: Other 
q6.4 Geo-temporal analysis Geo-temporal analysis 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q6.5 Survival analysis or repeated measures analysis 
Survival analysis or 
repeated measures analysis 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q6.6.1 Multivariate analysis: Linear regression analysis 
Multivariate analysis 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q6.6.2 
Multivariate analysis: Multiple logistic regression 
analysis 
q6.6.other Multivariate analysis: Other 
q6.other Other type of analyses Other type of analyses  
For this question, content analysis will be 
done and results will be reported in a 
frequency table 
7. DATA PROTECTION, AVAILABILITY AND CONDITIONS OF ACCESS AND USE 
q7.1.1.1 
DATA PROTECTION Nature of personal data: 
Anonymous 
Data protection: Nature of 
personal data 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q7.1.1.2 
DATA PROTECTION Nature of personal data: 
Pseudonymised 
q7.1.1.3 
DATA PROTECTION Nature of personal data: 
Fully identifiable 
q7.1.1.other 
DATA PROTECTION Nature of personal data: 
Other 
q7.1.2.1.1 
DATA PROTECTION Methods to protect personal 
data: At data collection - Coded 
Data protection: At data 
collection 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
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questionnaires/forms  
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q7.1.2.1.2 
DATA PROTECTION Methods to protect personal 
data: At data collection - Samples 
anonymised/pseudonymised 
q7.1.2.1.other 
DATA PROTECTION Methods to protect personal 
data: At data collection - Other 
q7.1.2.2.1 
DATA PROTECTION Methods to protect personal 
data: At data storage -: Databases protection 
Data protection: At data 
storage 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q7.1.2.2.2 
DATA PROTECTION Methods to protect personal 
data: At data storage -: Deleted/destroyed at the 
end of the study 
q7.1.2.2.1.1 
DATA PROTECTION Methods to protect personal 
data: At data storage -: Databases protection - 
1995 EC Data Protection 
Data protection: At data 
storage - databases 
protection 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q7.1.2.2.1.2 
DATA PROTECTION Methods to protect personal 
data: At data storage -: Databases protection - 
National legislation 
q7.1.2.2.1.other 
DATA PROTECTION Methods to protect personal 
data: At data storage -: Databases protection - 
Other 
q7.1.2.3 
DATA PROTECTION Methods to protect personal 
data: Deleted/destroyed at the end of the study 
- When? 
Data protection: At data 
storage - 
Deleted/destroyed at the 
end of the study 
When? 
 
For this question, content analysis will be 
done and results will be reported in a 
frequency table 
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q7.2.1 
NON-BIOLOGICAL DATA - CONDITIONS OF 
ACCESS AND USE Intellectual property rights 
Non-biological data: 
Intellectual property rights 
1 – Patents 
2 – Data property 
3 – Data available to 
other members of 
consortium 
4 – Data available by 
request 
5 – Other 
 
For this single-answer format question, a 
frequency table will be produced 
q7.2.other 
NON-BIOLOGICAL DATA - CONDITIONS OF 
ACCESS AND USE Intellectual property rights: 
Other 
 
The variable representing the open 
category “other” will be recoded into 
extra values and included in the above 
options 
q7.2.2 
NON-BIOLOGICAL DATA - CONDITIONS OF 
ACCESS AND USE Data access 
Non-biological data: Data 
access 
1 – No access is 
possible 
2 – Partial access to 
database 
3 – Access to total 
database 
For this single-answer format question, a 
frequency table will be produced 
q7.2.3.1 
NON-BIOLOGICAL DATA - CONDITIONS OF 
ACCESS AND USE Type of access: Direct online 
access - website 
Non-biological data: Please 
indicate the type of access 
- Direct online access 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q7.2.3.1.coment Type of access: Comment   
q7.2.3.2 
Type of access: By request - how to apply the 
request 
Non-biological data: Please 
indicate the type of access 
- By request 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q7.2.3.2.coment Type of access: Comment   
q7.3.1 
BIOLOGICAL SAMPLES - AVAILABILITY AND 
CONDITIONS OF ACCESS AND USE Does the 




No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
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q7.3.2.1 
BIOLOGICAL SAMPLES - AVAILABILITY AND 
CONDITIONS OF ACCESS AND USE Type of 
biological samples / matrix: Blood 
Type of biological samples 
/ matrix 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q7.3.2.2 
BIOLOGICAL SAMPLES - AVAILABILITY AND 
CONDITIONS OF ACCESS AND USE Type of 
biological samples / matrix: Blood erythrocytes 
q7.3.2.3 
BIOLOGICAL SAMPLES - AVAILABILITY AND 
CONDITIONS OF ACCESS AND USE Type of 
biological samples / matrix: Blood cells isolates 
(PMBC) 
q7.3.2.4 
BIOLOGICAL SAMPLES - AVAILABILITY AND 
CONDITIONS OF ACCESS AND USE Type of 
biological samples / matrix: Plasma 
q7.3.2.5 
BIOLOGICAL SAMPLES - AVAILABILITY AND 
CONDITIONS OF ACCESS AND USE Type of 
biological samples / matrix: Serum 
q7.3.2.6 
BIOLOGICAL SAMPLES - AVAILABILITY AND 
CONDITIONS OF ACCESS AND USE Type of 
biological samples / matrix: Saliva 
q7.3.2.7 
BIOLOGICAL SAMPLES - AVAILABILITY AND 
CONDITIONS OF ACCESS AND USE Type of 
biological samples / matrix: Buccal cell 
q7.3.2.8 
BIOLOGICAL SAMPLES - AVAILABILITY AND 
CONDITIONS OF ACCESS AND USE Type of 
biological samples / matrix: Nails 
q7.3.2.9 
BIOLOGICAL SAMPLES - AVAILABILITY AND 
CONDITIONS OF ACCESS AND USE Type of 
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biological samples / matrix: DNA 
q7.3.2.10 
BIOLOGICAL SAMPLES - AVAILABILITY AND 
CONDITIONS OF ACCESS AND USE Type of 
biological samples / matrix: Cells lines 
q7.3.2.11 
BIOLOGICAL SAMPLES - AVAILABILITY AND 
CONDITIONS OF ACCESS AND USE Type of 
biological samples / matrix: 12-hours overnight 
urine 
q7.3.2.12 
BIOLOGICAL SAMPLES - AVAILABILITY AND 
CONDITIONS OF ACCESS AND USE Type of 
biological samples / matrix: Urine (24h) 
q7.3.2.13 
BIOLOGICAL SAMPLES - AVAILABILITY AND 
CONDITIONS OF ACCESS AND USE Type of 
biological samples / matrix: Urine (spot sample - 
random) 
q7.3.2.14 
BIOLOGICAL SAMPLES - AVAILABILITY AND 
CONDITIONS OF ACCESS AND USE Type of 
biological samples / matrix: Urine (spot sample – 
first morning) 
q7.3.2.15 
BIOLOGICAL SAMPLES - AVAILABILITY AND 
CONDITIONS OF ACCESS AND USE Type of 
biological samples / matrix: Human milk 
q7.3.2.16 
BIOLOGICAL SAMPLES - AVAILABILITY AND 
CONDITIONS OF ACCESS AND USE Type of 
biological samples / matrix: Hair 
(chopped/lyophilised sample) 
q7.3.2.17 BIOLOGICAL SAMPLES - AVAILABILITY AND 
 
VARIABLE NAME LABEL QUESTION VALUES AND CODES ANALYSIS 
CONDITIONS OF ACCESS AND USE Type of 
biological samples / matrix: Hair (complete locks) 
q7.3.2.18 
BIOLOGICAL SAMPLES - AVAILABILITY AND 
CONDITIONS OF ACCESS AND USE Type of 
biological samples / matrix: Fat/adipose tissue 
q7.3.2.19 
BIOLOGICAL SAMPLES - AVAILABILITY AND 
CONDITIONS OF ACCESS AND USE Type of 
biological samples / matrix: Placenta 
q7.3.2.20 
BIOLOGICAL SAMPLES - AVAILABILITY AND 
CONDITIONS OF ACCESS AND USE Type of 
biological samples / matrix: Umbilical cord blood 
q7.3.2.other 
BIOLOGICAL SAMPLES - AVAILABILITY AND 
CONDITIONS OF ACCESS AND USE Type of 
biological samples / matrix: Other 
q7.3.2.otherdescriptio
n 
BIOLOGICAL SAMPLES - AVAILABILITY AND 
CONDITIONS OF ACCESS AND USE Other 
biological sample 




For this question, content analysis will be 
done and results will be reported in a 
frequency table 
q7.3.4.exceldownload 
BIOLOGICAL SAMPLES - AVAILABILITY AND 
CONDITIONS OF ACCESS AND USE Excel 
download 
Please download, fill out 
and upload the excel sheet 
bellow and continue with 
the following questions 
  
q7.3.4.excelupload 
BIOLOGICAL SAMPLES - AVAILABILITY AND 
CONDITIONS OF ACCESS AND USE Excel upload 
0 –Does not exist excel-
based extra info 




BIOLOGICAL SAMPLES - AVAILABILITY AND 
CONDITIONS OF ACCESS AND USE Access and 
use of biobanked samples 
Biological samples: Access 
and use of biobanked 
samples 
1 – No access at all 
2 – Access (only for 
consultation) for other 
researchers/organizatio
For this single-answer format question, a 
frequency table will be produced 
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ns 




BIOMARKERS AND OTHER PARAMETERS - 
CONDITIONS OF ACCESS AND USE Access to 
analytical standards to detect biomarkers 
Biomarkers and other 
parameters: Access to 
analytical standards to 
detect biomarkers 
1 – No access at all 
2 – Access for other 
researchers/organizatio
ns 
For this single-answer format question, a 
frequency table will be produced 
q7.4.2 
BIOMARKERS AND OTHER PARAMETERS - 
CONDITIONS OF ACCESS AND USE Access and 
use of biomarkers and other parameters 
Biomarkers and other 
parameters: Access and use 
of biomarkers and other 
parameters 
1 – No access at all 
2 – Access for IPCheM* 
(only for consultation) 
3 – Access (only for 
consultation) for other 
researchers/organizatio
ns 
4 – Access and use for 
IPCheM 
5 – Access and use for 
other researchers/ 
organizations 
For this single-answer format question, a 
frequency table will be produced 
q7.4.3.1 
BIOMARKERS AND OTHER PARAMETERS - 
CONDITIONS OF ACCESS AND USE Aggregation 
level of data: Metadata 
Biomarkers and other 
parameters: Aggregation 
level of data 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q7.4.3.2 
BIOMARKERS AND OTHER PARAMETERS - 
CONDITIONS OF ACCESS AND USE Aggregation 
level of data: Aggregated data (by gender, age 
groups, population type, …) 
q7.4.3.3 
BIOMARKERS AND OTHER PARAMETERS - 
CONDITIONS OF ACCESS AND USE Aggregation 
level of data: Filtered/generalized single 
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measurement data with key parameters 
q7.4.3.4 
BIOMARKERS AND OTHER PARAMETERS - 
CONDITIONS OF ACCESS AND USE Aggregation 
level of data: Single measurement data with 
additional relevant parameters 
q7.4.4.description 
BIOMARKERS AND OTHER PARAMETERS - 
CONDITIONS OF ACCESS AND USE Licence of 
use 
Biomarkers and other 
parameters: Licence of use 
  
q7.4.5.description 
BIOMARKERS AND OTHER PARAMETERS - 
CONDITIONS OF ACCESS AND USE Access 
conditions 





BIOMARKERS AND OTHER PARAMETERS - 
CONDITIONS OF ACCESS AND USE Text for 
acknowledgement /disclaimer 
Biomarkers and other 





q8.1.1 Report of results to: Public Authority 
Reporting results to Public 
Authority 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q8.1.1.1 
Report of results to: Public Authority - EU 
authorities 
Please indicate the Public 
Autority(s) to whom the 
results where reported:  
EU authorities 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q8.1.1.1.frequencyand
comment 
Report of results to: Public Authority - EU 
authorities - Frequency and Comment 
 
For this question, content analysis will be 
done and results will be reported in a 
frequency table 
q8.1.1.2 
Report of results to: Public Authority - National 
authorities 
Please indicate the Public 
Autority(s) to whom the 
results where reported:  
National authorities 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q8.1.1.2.frequencyand
comment 
Report of results to: Public Authority - National 
authorities - Frequency and Comment 
 
For this question, content analysis will be 
done and results will be reported in a 
frequency table 
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q8.1.1.3 
Report of results to: Public Authority - Federal 
authorities 
Please indicate the Public 
Autority(s) to whom the 
results where reported:  
Federal authorities 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q8.1.1.3.frequencyand
comment 
Report of results to: Public Authority - Federal 
authorities - Frequency and Comment 
 
For this question, content analysis will be 
done and results will be reported in a 
frequency table 
q8.1.1.4 
Report of results to: Public Authority - Local 
authorities 
Please indicate the Public 
Autority(s) to whom the 
results where reported:  
Local authorities 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q8.1.1.4.frequencyand
comment 
Report of results to: Public Authority - Local 
authorities - Frequency and Comment 
 
For this question, content analysis will be 
done and results will be reported in a 
frequency table 
q8.1.1.5 Report of results to: Public Authority - Other Please indicate the Public 
Autority(s) to whom the 
results where reported:  
Other 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q8.1.1.5.frequencyand
comment 
Report of results to: Public Authority - Other - 
Frequency and Comment 
 
For this question, content analysis will be 
done and results will be reported in a 
frequency table 
q8.1.2 Report of results to: Study participants 
Reporting results to study 
participants 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q8.1.2.1 
Report of results to: Study participants - 
Personalized Reports 
Please indicate how results 
were reported to the 
study's participants 
No – 0 
Yes – 1 
For this question, content analysis will be 
done and results will be reported in a 
frequency table 
q8.1.2.2 
Report of results to: Study participants - 
Individual results compared with health 
guideline values 
q8.1.2.3 
Report of results to: Study participants - 
Participant referred to appropriate help if 
problem was identified 
q8.1.2.4 
Report of results to: Study participants - Study 
findings presented to participants at targeted 
workshops 
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q8.1.2.5 Report of results to: Study participants - Hotline 
q8.1.2.other Report of results to: Study participants - Other 
q8.1.3 Report of results to: Health Institutions 
Reporting results to Health 
Institutions 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q8.1.3.1 
Report of results to: Health Institutions - Health 
care centre 
Please indicate the Health 
Institutions to whom the 
results where reported 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q8.1.3.2 
Report of results to: Health Institutions - 
Lactariums 
q8.1.3.3 
Report of results to: Health Institutions - 
Maternity hospitals 
q8.1.3.4 
Report of results to: Health Institutions - 
Involved hospitals 
q8.1.3.5 
Report of results to: Health Institutions - 
Involved policlinics 
q8.1.3.other Report of results to: Health Institutions - Other 
q8.1.4 Report of results to: Scientific community 
Reporting results to 
scientific community 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q8.1.4.1 
Report of results to: Scientific community - 
Published through report form 
Please indicate how the 
results were reported to 
the scientific community 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q8.1.4.2 
Report of results to: Scientific community - 
Results published in book of proceedings 
q8.1.4.3 
Report of results to: Scientific community - 
Results presented in scientific posters 
q8.1.4.4 
Report of results to: Scientific community - 
Newsletters 
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q8.1.4.5 
Report of results to: Scientific community - 
Scientific journals 
q8.1.4.6 
Report of results to: Scientific community - 
Seminars 
q8.1.4.7 
Report of results to: Scientific community - 
Scientific meetings 
q8.1.4.8 
Report of results to: Scientific community - Short 
scientific presentations 
q8.1.4.9 
Report of results to: Scientific community - 
Website 
q8.1.4.other Report of results to: Scientific community - Other 
q8.1.4.1.1 Report form where the results were reported 
Please indicate the report 




Relevant publications: Pubmed and/or other 
scientific databases engines 
Relevant publications 




q8.1.6 Report of results to: General public 
Reporting results to 
general public 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q8.1.6.1.description 
How the results were reported to the general 
public 
Please indicate how the 
results were reported to 
the general public 
  
q8.2.1.1 
Public debate: Occasional symposia part 1 - 
Local symposia Public debate: Occasional 
symposia part 1 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple q8.2.1.2 
Public debate: Occasional symposia part 1 - 
Technical meetings 
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q8.2.1.3 
Public debate: Occasional symposia part 1 - 
Focus group discussions 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. q8.2.1.4 
Public debate: Occasional symposia part 1 - 
Meeting in local inhabitants 
q8.2.1.5 
Public debate: Occasional symposia part 1 - 
Public debate at the end of project 
q8.2.1.other 
Public debate: Occasional symposia part 1 - 
Other 
q8.2.2.1 
Public debate: Occasional symposia part 2 - 
Debates between different stakeholders - 
Kindergarten 
Public debate: Occasional 
symposia part 2 - Debates 
between different 
stakeholders 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q8.2.2.2 
Public debate: Occasional symposia part 2 - 
Debates between different stakeholders - City 
representatives 
q8.2.2.3 
Public debate: Occasional symposia part 2 - 
Debates between different stakeholders - 
Scientific society 
q8.2.2.other 
Public debate: Occasional symposia part 2 - 
Debates between different stakeholders - Other 
q8.2.3.1 
Public debate: Occasional symposia part 3 -
 Media - Summary report 
Public debate: Occasional 
symposia part 3 - Media 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q8.2.3.2 
Public debate: Occasional symposia part 3 -
 Media - Institutional report 
q8.2.3.3 
Public debate: Occasional symposia part 3 -
 Media - Special report 
q8.2.3.4 Public debate: Occasional symposia part 3 -
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 Media - Press conferences 
q8.2.3.other 
Public debate: Occasional symposia part 3 -
 Media - Other 
q8.3.1 
Consequences of external communication: Public 
awareness 
Public debate: 
Consequences of external 
communication 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q8.3.2 
Consequences of external communication: 
Separation between research and policy 
q8.3.3 
Consequences of external communication: 
Screening tests for segments of population 
q8.3.4 
Consequences of external communication: 
Increase in visits to specialized MD 
q8.3.5 
Consequences of external communication: 
Increase in visits to laboratories 
q8.3.6 
Consequences of external communication: 
Legislation improved 
q8.3.7 
Consequences of external communication: 
Statement from public authority 
q8.3.8 
Consequences of external communication: 
Greater incentive to participate 
q8.3.9 
Consequences of external communication: 
Clean-up of contaminated areas 
q8.3.other Consequences of external communication: Other 
q8.4 
Examples of material used to communicate with 
the study participants 
Would you be willing to 
provide some examples of 
material used to 
communicate with the 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
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study participants? 
9. OBSTACLES, SHORTCOMINGS AND DIFFICULTIES 
q9.1.1 General constraints and difficulties: Financial 
General constraints and 
difficulties: Financial 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q9.1.1.comment 




General constraints and difficulties: Human 
resources General constraints and 
difficulties: Human 
resources 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q9.1.2.comment 
General constraints and difficulties: Human 
resources - Comment 
  
q9.1.3 General constraints and difficulties: Legislation 
General constraints and 
difficulties: Legislation 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q9.1.3.comment 
General constraints and difficulties: Legislation - 
Comment 
  
q9.1.4 General constraints and difficulties: Laboratory 
General constraints and 
difficulties: Laboratory 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q9.1.4.comment 
General constraints and difficulties: Laboratory - 
Comment 
  
q9.1.5 General constraints and difficulties: Other 
General constraints and 
difficulties: Other 
No – 0 
Yes – 1 
For this yes-no answer format question, 
a frequency table will be produced 
q9.1.5.comment 




Difficulties in samples’ collection: Blood samples 
- Fear of pain (from participant) Difficulties in samples’ 
collection: Collection of 
blood samples  
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
q9.2.1.2 
Difficulties in samples’ collection: Blood samples 
- Concern about consequences (from 
participants’ perspective) 
 
VARIABLE NAME LABEL QUESTION VALUES AND CODES ANALYSIS 
q9.2.1.3 
Difficulties in samples’ collection: Blood samples 
- Time-demand (for participants) 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q9.2.1.4 
Difficulties in samples’ collection: Blood samples 
- Non-interest (from participants) 
q9.2.1.other 
Difficulties in samples’ collection: Blood samples 
- Other 
q9.2.2.1 
Difficulties in samples’ collection: Fat samples - 
Fear of pain (from participant) 
Difficulties in samples’ 
collection: Collection of fat 
samples  
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q9.2.2.2 
Difficulties in samples’ collection: Fat samples - 
Concern about consequences (from participants’ 
perspective) 
q9.2.2.3 
Difficulties in samples’ collection: Fat samples - 
Time-demand (for participants) 
q9.2.2.4 
Difficulties in samples’ collection: Fat samples - 
Non-interest (from participants) 
q9.2.2.other 
Difficulties in samples’ collection: Fat samples - 
Other 
q9.2.3.1 
Difficulties in samples’ collection: Physical 
examinations - Fear of pain (from participant) 
Difficulties in samples’ 
collection: Physical 
examinations 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q9.2.3.2 
Difficulties in samples’ collection: Physical 
examinations - Concern about consequences 
(from participants’ perspective) 
q9.2.3.3 
Difficulties in samples’ collection: Physical 
examinations - Time-demand (for participants) 
q9.2.3.4 
Difficulties in samples’ collection: Physical 
examinations - Non-interest (from participants) 
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q9.2.3.other 
Difficulties in samples’ collection: Physical 
examinations - Other 
q9.2.4.1 
Difficulties in samples’ collection: Other type of 
samples - Fear of pain (from participant) 
Difficulties in samples’ 
collection: Other type of 
samples’ collection 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q9.2.4.2 
Difficulties in samples’ collection: Other type of 
samples - Concern about consequences (from 
participants’ perspective) 
q9.2.4.3 
Difficulties in samples’ collection: Other type of 
samples - Time-demand (for participants) 
q9.2.4.4 
Difficulties in samples’ collection: Other type of 
samples - Non-interest (from participants) 
q9.2.4.other 
Difficulties in samples’ collection: Other type of 
samples - Other 
q9.3.1 
Difficulties in recruitment of participants: Time-
consuming 
Difficulties in recruitment 
of participants: Difficulties 
in recruitment of 
participants 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q9.3.2 
Difficulties in recruitment of participants: High 
drop-out rate 
q9.3.3 
Difficulties in recruitment of participants: Low 
participation level 
q9.3.4 
Difficulties in recruitment of participants: Low 
response rate 
q9.3.3.1 
Difficulties in recruitment of participants: Low 
participation level - For migrants 
Difficulties in recruitment 
of participants: Regarding 
low participation level 
please specify 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple q9.3.3.2 
Difficulties in recruitment of participants: Low 
participation level - For lower social classes 
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q9.3.3.3 
Difficulties in recruitment of participants: Low 
participation level - For single working mothers 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. q9.3.3.other 
Difficulties in recruitment of participants: Low 
participation level - Other 
q9.3.4.1 
Difficulties in recruitment of participants: Low 
response rate - Immigrants 
Difficulties in recruitment 
of participants: Regarding 
low response rate please 
specify 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q9.3.4.2 
Difficulties in recruitment of participants: Low 
response rate - Lower social classes 
q9.3.4.3 
Difficulties in recruitment of participants: Low 
response rate - Single working mothers 
q9.3.4.other 
Difficulties in recruitment of participants: Low 
response rate - Other 
q9.4.1 
Strategies for increasing response rate: Focusing 
the sampling on groups with expected higher 
participation rate 
Which of the following 
strategies you consider to 
be relevant for increasing 
response rate? 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q9.4.2 
Strategies for increasing response rate: Use of 
new and more direct/personal means of 
approaching people 
q9.4.3 
Strategies for increasing response rate: Financial 
or other incentives 
q9.4.4 
Strategies for increasing response rate: 
Cooperation with other studies, with 
governmental bodies 
q9.4.5 
Strategies for increasing response rate: 
Participatory research ("citizen science") 
q9.4.6.description Strategies for increasing response rate: 
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Recruitment bias (specification) 
q9.5.1 Other identified problems: Logistics 
Other identified problems 
No – 0 
Yes – 1 
This set of variables represents a 
multiple-choice answer format question.  
 
Therefore, a variable set for multiple 
response analysis will be created, for 
descriptive/inferential analyses. A 
frequency table will be produced for this 
multiple-choice-set. 
q9.5.2 Other identified problems: Team leadership 
q9.5.3 
Other identified problems: Burden of data 
collection 
q9.5.4 
Other identified problems: Lack of international 
guidelines 
q9.5.5 
Other identified problems: Lack of international 
standardisation 
q9.5.6 
Other identified problems: Nomenclature 
problems 
q9.5.7 
Other identified problems: High volume of 
collected information 
q9.5.8 Other identified problems: No access to data 
q9.5.other Other identified problems: Other 
q9.5.1.1.description Specification of problems with logistics 
Please specify the 
problems with logistics 
  
q9.5.2.1.description Specification of problems with team leadership 
Please specify the 
problems with team 
leadership 
  
10. ADDITIONAL INFORMATION 
q10.description Other relevant information 
Please add any relevant 
information collected that 
was not covered by the 
questionnaire 
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Protocol for the literature review, including orientation 
guidelines for keywords to include, eligibility criteria for 
the search, inclusion criteria for the identified studies 






ORIENTATION GUIDELINES FOR A NARRATIVE REVIEW ON THE AVAILABLE BIOMONITORING 
AND EXPOSURE DATA REGARDING NINE PRIORITISED SUBSTANCES 
 
Task 7.1 aims to identify the existing data and data gaps on biomonitoring and chemicals 












The questionnaire on existing surveys has already been launched (deadline to fill out the 
questionnaire is April 24). 
The identification of non-published studies in HBM-related conferences book of proceedings 
is an additional activity not included in the description of task 7.1. Therefore, it will be a 
responsibility of FMUL. 
Now, we intend to complement this work with a narrative review of the literature. The 
proposed literature aims to identify the existing studies on biomonitoring and chemicals 
exposure (including occupational exposure) regarding the nine prioritised substances: 
phthalates /DINCH, bisphenols, per-/polyfluorinated compounds, flame retardants, Cd and Cr, 






Each partner of task 7.1 will be responsible for the literature review on one of the prioritised 
substances: 
Partner Prioritised substance/s 
UKF Phthalates, DINCH 
THL PFAS and Flame retardants 
FMUL Cd 
ISS CR 




Two sets of key-words to be used as alternatives were identified and reviewed by some of the 
partners. These are only a proposal that can be changed. 
The identified key-words can be consulted in the excel document in attach (HBM4EU_Literature 
review_synoptic table cadmium_FMUL_201700410). 
 
Eligibility criteria 
 Data bases: Medline (PubMed), Web of Science and EBSCO 
 Language of the documents: English 
 Publication date: From 01/01/2007 to 31/12/2016 
Inclusion criteria 
To consider only: 
 Papers referring to studies of the HBM4EU partners 
 Documents with empirical HBM data (do not include opinion or conceptual papers that 







Data of each selected paper should be extracted into a standardized matrix (see excel document 
in attach HBM4EU_Literature review_synoptic table cadmium_FMUL_201700410) with the 
following columns: 
• Reference (author/s, title, year of publication, journal) 
• HBM Study/Project/Activity name (including acronym, if any) 
• Coordination research unit (name, acronym and country of the research unit responsible 
for the study) 
• Country/countries (where the data were collected) 
• HBM implementation level (international, national, regional, local, …) 
• Main objectives (including specific HBM objectives) 
• Population & Sampling 
o Target population 
o Number of participants 
o Inclusion/exclusion criteria 
o Sampling method 
o Recruitment 
o Time schedule (frequency) of data collection 
• Data collection 
o Period of data collection 
o Mode of data collection 
o Group/s of substances studied 
o Collected data 
• Main findings / Conclusions 
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Pubmed: from 01/01/2007 to 31/03/2017
Web of Science: from 2007-2017






Cadmium AND "Human biomonitoring" Cadmium AND "Professional exposure"
Cadmium AND Environmental monitoring Cadmium AND "Occupational data"
Cadmium AND Biological monitoring Cadmium AND workers
Cadmium AND "Environmental surveilance" Cadmium AND exposure AND industry
Cadmium AND Environmental exposure Cadmium AND Occupational health
Cadmium AND Health surveys Cadmium AND occupational groups
Cadmium AND Risk assessment Cadmium AND "workplace exposure"
Cadmium AND "Health risks" Cadmium AND "non-occupational exposure"
Cadmium AND "Health effects" Cadmium AND "population exposure"
Cadmium AND "Effect biomarkers" Cadmium AND "urine analysis"
Cadmium AND "Exposure biomarkers" Cadmium AND "exposure assessment"
Cadmium AND Occupational exposure Cadmium AND "HBM values"
1 2 3
Target population
(- general population or clinical;
- children, adolescents, adults, …)
Inclusion/exclusion criteria 
(age range, gender, …)
Sampling method
(Random, convenience / intentional, stratified, …
Recruitment
(recruitment place: school, hospital, registration office)
(recruitment via: GP, census data, health archives, mail address, door 
to door, …
other relevant information on recruitment)
Time schedule (frequency) of data collection
(every year, once a year, …)
Period of data collection
(beginning and ending date)
Mode of data collection
Group/s of substances studied
Collected data 
(Please specify, if possible, non-biological data, biological samples and 
biomarkers and other parameters collected)
Data collection
Reference
(author/s, title, year of publication, journal)
HBM Study/Project/Activity name
(including acronym, if any)
Coordination research unit
(Name, acronym and country of the research unit responsible for the study)
Country/countries
(where the data were collected)
HBM implementation level 
(international, national, regional, local, …)
Main objectives
(including specific HBM objectives)
Study design





Main findings / Conclusions
Limitations of the study
Observations
(Please insert any relevant information not covered in the previous fields)
